id	sid	tid	token	lemma	pos
cord-294854-rvrgcugn	1	1	key	key	NN
cord-294854-rvrgcugn	1	2	:	:	:
cord-294854-rvrgcugn	1	3	cord-294854-rvrgcugn	cord-294854-rvrgcugn	ADD
cord-294854-rvrgcugn	2	1	authors	author	NNS
cord-294854-rvrgcugn	2	2	:	:	:
cord-294854-rvrgcugn	2	3	Hu	Hu	NNP
cord-294854-rvrgcugn	2	4	,	,	,
cord-294854-rvrgcugn	2	5	Biying	Biying	NNP
cord-294854-rvrgcugn	2	6	;	;	:
cord-294854-rvrgcugn	2	7	Huang	Huang	NNP
cord-294854-rvrgcugn	2	8	,	,	,
cord-294854-rvrgcugn	2	9	Shaoying	Shaoying	NNP
cord-294854-rvrgcugn	2	10	;	;	:
cord-294854-rvrgcugn	2	11	Yin	Yin	NNP
cord-294854-rvrgcugn	2	12	,	,	,
cord-294854-rvrgcugn	3	1	Lianghong	Lianghong	NNP
cord-294854-rvrgcugn	3	2	title	title	NN
cord-294854-rvrgcugn	3	3	:	:	:
cord-294854-rvrgcugn	4	1	The	the	DT
cord-294854-rvrgcugn	4	2	cytokine	cytokine	NN
cord-294854-rvrgcugn	4	3	storm	storm	NN
cord-294854-rvrgcugn	4	4	and	and	CC
cord-294854-rvrgcugn	4	5	COVID‐19	covid‐19	NN
cord-294854-rvrgcugn	4	6	date	date	NN
cord-294854-rvrgcugn	4	7	:	:	:
cord-294854-rvrgcugn	4	8	2020	2020	CD
cord-294854-rvrgcugn	4	9	-	-	HYPH
cord-294854-rvrgcugn	4	10	06	06	CD
cord-294854-rvrgcugn	4	11	-	-	SYM
cord-294854-rvrgcugn	4	12	27	27	CD
cord-294854-rvrgcugn	4	13	journal	journal	NN
cord-294854-rvrgcugn	4	14	:	:	:
cord-294854-rvrgcugn	4	15	J	J	NNP
cord-294854-rvrgcugn	4	16	Med	Med	NNP
cord-294854-rvrgcugn	4	17	Virol	Virol	NNP
cord-294854-rvrgcugn	4	18	DOI	DOI	NNP
cord-294854-rvrgcugn	4	19	:	:	:
cord-294854-rvrgcugn	4	20	10.1002	10.1002	CD
cord-294854-rvrgcugn	4	21	/	/	SYM
cord-294854-rvrgcugn	4	22	jmv.26232	jmv.26232	NNP
cord-294854-rvrgcugn	5	1	sha	sha	NNP
cord-294854-rvrgcugn	5	2	:	:	:
cord-294854-rvrgcugn	6	1	25a76995eafe9c76f8320c72efe97a3461dcba30	25a76995eafe9c76f8320c72efe97a3461dcba30	CD
cord-294854-rvrgcugn	6	2	doc_id	doc_id	CD
cord-294854-rvrgcugn	6	3	:	:	:
cord-294854-rvrgcugn	6	4	294854	294854	CD
cord-294854-rvrgcugn	6	5	cord_uid	cord_uid	NNS
cord-294854-rvrgcugn	6	6	:	:	:
cord-294854-rvrgcugn	7	1	rvrgcugn	rvrgcugn	NNP
cord-294854-rvrgcugn	7	2	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	7	3	disease	disease	NN
cord-294854-rvrgcugn	7	4	2019	2019	CD
cord-294854-rvrgcugn	8	1	(	(	-LRB-
cord-294854-rvrgcugn	8	2	COVID‐19	COVID‐19	NNP
cord-294854-rvrgcugn	8	3	)	)	-RRB-
cord-294854-rvrgcugn	8	4	,	,	,
cord-294854-rvrgcugn	8	5	which	which	WDT
cord-294854-rvrgcugn	8	6	began	begin	VBD
cord-294854-rvrgcugn	8	7	in	in	IN
cord-294854-rvrgcugn	8	8	Wuhan	Wuhan	NNP
cord-294854-rvrgcugn	8	9	,	,	,
cord-294854-rvrgcugn	8	10	China	China	NNP
cord-294854-rvrgcugn	8	11	in	in	IN
cord-294854-rvrgcugn	8	12	December	December	NNP
cord-294854-rvrgcugn	8	13	2019	2019	CD
cord-294854-rvrgcugn	8	14	has	have	VBZ
cord-294854-rvrgcugn	8	15	caused	cause	VBN
cord-294854-rvrgcugn	8	16	a	a	DT
cord-294854-rvrgcugn	8	17	large	large	JJ
cord-294854-rvrgcugn	8	18	global	global	JJ
cord-294854-rvrgcugn	8	19	pandemic	pandemic	NN
cord-294854-rvrgcugn	8	20	and	and	CC
cord-294854-rvrgcugn	8	21	poses	pose	VBZ
cord-294854-rvrgcugn	8	22	a	a	DT
cord-294854-rvrgcugn	8	23	serious	serious	JJ
cord-294854-rvrgcugn	8	24	threat	threat	NN
cord-294854-rvrgcugn	8	25	to	to	IN
cord-294854-rvrgcugn	8	26	public	public	JJ
cord-294854-rvrgcugn	8	27	health	health	NN
cord-294854-rvrgcugn	8	28	.	.	.
cord-294854-rvrgcugn	9	1	More	More	JJR
cord-294854-rvrgcugn	9	2	than	than	IN
cord-294854-rvrgcugn	9	3	four	four	CD
cord-294854-rvrgcugn	9	4	million	million	CD
cord-294854-rvrgcugn	9	5	cases	case	NNS
cord-294854-rvrgcugn	9	6	of	of	IN
cord-294854-rvrgcugn	9	7	COVID‐19	covid‐19	NN
cord-294854-rvrgcugn	9	8	,	,	,
cord-294854-rvrgcugn	9	9	which	which	WDT
cord-294854-rvrgcugn	9	10	is	be	VBZ
cord-294854-rvrgcugn	9	11	caused	cause	VBN
cord-294854-rvrgcugn	9	12	by	by	IN
cord-294854-rvrgcugn	9	13	the	the	DT
cord-294854-rvrgcugn	9	14	severe	severe	JJ
cord-294854-rvrgcugn	9	15	acute	acute	JJ
cord-294854-rvrgcugn	9	16	respiratory	respiratory	JJ
cord-294854-rvrgcugn	9	17	syndrome	syndrome	NN
cord-294854-rvrgcugn	9	18	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	9	19	2	2	CD
cord-294854-rvrgcugn	9	20	(	(	-LRB-
cord-294854-rvrgcugn	9	21	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-294854-rvrgcugn	9	22	)	)	-RRB-
cord-294854-rvrgcugn	9	23	,	,	,
cord-294854-rvrgcugn	9	24	have	have	VBP
cord-294854-rvrgcugn	9	25	been	be	VBN
cord-294854-rvrgcugn	9	26	confirmed	confirm	VBN
cord-294854-rvrgcugn	9	27	as	as	IN
cord-294854-rvrgcugn	9	28	of	of	IN
cord-294854-rvrgcugn	9	29	May	May	NNP
cord-294854-rvrgcugn	9	30	11	11	CD
cord-294854-rvrgcugn	9	31	,	,	,
cord-294854-rvrgcugn	9	32	2020	2020	CD
cord-294854-rvrgcugn	9	33	.	.	.
cord-294854-rvrgcugn	10	1	SARS‐CoV‐2	SARS‐CoV‐2	NNP
cord-294854-rvrgcugn	10	2	is	be	VBZ
cord-294854-rvrgcugn	10	3	a	a	DT
cord-294854-rvrgcugn	10	4	highly	highly	RB
cord-294854-rvrgcugn	10	5	pathogenic	pathogenic	JJ
cord-294854-rvrgcugn	10	6	and	and	CC
cord-294854-rvrgcugn	10	7	transmissible	transmissible	JJ
cord-294854-rvrgcugn	10	8	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	10	9	that	that	WDT
cord-294854-rvrgcugn	10	10	primarily	primarily	RB
cord-294854-rvrgcugn	10	11	spreads	spread	VBZ
cord-294854-rvrgcugn	10	12	through	through	IN
cord-294854-rvrgcugn	10	13	respiratory	respiratory	JJ
cord-294854-rvrgcugn	10	14	droplets	droplet	NNS
cord-294854-rvrgcugn	10	15	and	and	CC
cord-294854-rvrgcugn	10	16	close	close	JJ
cord-294854-rvrgcugn	10	17	contact	contact	NN
cord-294854-rvrgcugn	10	18	.	.	.
cord-294854-rvrgcugn	11	1	A	a	DT
cord-294854-rvrgcugn	11	2	growing	grow	VBG
cord-294854-rvrgcugn	11	3	body	body	NN
cord-294854-rvrgcugn	11	4	of	of	IN
cord-294854-rvrgcugn	11	5	clinical	clinical	JJ
cord-294854-rvrgcugn	11	6	data	data	NN
cord-294854-rvrgcugn	11	7	suggests	suggest	VBZ
cord-294854-rvrgcugn	11	8	that	that	IN
cord-294854-rvrgcugn	11	9	a	a	DT
cord-294854-rvrgcugn	11	10	cytokine	cytokine	NN
cord-294854-rvrgcugn	11	11	storm	storm	NN
cord-294854-rvrgcugn	11	12	is	be	VBZ
cord-294854-rvrgcugn	11	13	associated	associate	VBN
cord-294854-rvrgcugn	11	14	with	with	IN
cord-294854-rvrgcugn	11	15	COVID‐19	covid‐19	JJ
cord-294854-rvrgcugn	11	16	severity	severity	NN
cord-294854-rvrgcugn	11	17	and	and	CC
cord-294854-rvrgcugn	11	18	is	be	VBZ
cord-294854-rvrgcugn	11	19	also	also	RB
cord-294854-rvrgcugn	11	20	a	a	DT
cord-294854-rvrgcugn	11	21	crucial	crucial	JJ
cord-294854-rvrgcugn	11	22	cause	cause	NN
cord-294854-rvrgcugn	11	23	of	of	IN
cord-294854-rvrgcugn	11	24	death	death	NN
cord-294854-rvrgcugn	11	25	from	from	IN
cord-294854-rvrgcugn	11	26	COVID‐19	COVID‐19	NNP
cord-294854-rvrgcugn	11	27	.	.	.
cord-294854-rvrgcugn	12	1	In	in	IN
cord-294854-rvrgcugn	12	2	the	the	DT
cord-294854-rvrgcugn	12	3	absence	absence	NN
cord-294854-rvrgcugn	12	4	of	of	IN
cord-294854-rvrgcugn	12	5	antivirals	antiviral	NNS
cord-294854-rvrgcugn	12	6	and	and	CC
cord-294854-rvrgcugn	12	7	vaccines	vaccine	NNS
cord-294854-rvrgcugn	12	8	for	for	IN
cord-294854-rvrgcugn	12	9	COVID‐19	covid‐19	NN
cord-294854-rvrgcugn	12	10	,	,	,
cord-294854-rvrgcugn	12	11	there	there	EX
cord-294854-rvrgcugn	12	12	is	be	VBZ
cord-294854-rvrgcugn	12	13	an	an	DT
cord-294854-rvrgcugn	12	14	urgent	urgent	JJ
cord-294854-rvrgcugn	12	15	need	need	NN
cord-294854-rvrgcugn	12	16	to	to	TO
cord-294854-rvrgcugn	12	17	understand	understand	VB
cord-294854-rvrgcugn	12	18	the	the	DT
cord-294854-rvrgcugn	12	19	cytokine	cytokine	NN
cord-294854-rvrgcugn	12	20	storm	storm	NN
cord-294854-rvrgcugn	12	21	in	in	IN
cord-294854-rvrgcugn	12	22	COVID‐19	COVID‐19	NNP
cord-294854-rvrgcugn	12	23	.	.	.
cord-294854-rvrgcugn	13	1	Here	here	RB
cord-294854-rvrgcugn	13	2	,	,	,
cord-294854-rvrgcugn	13	3	we	-PRON-	PRP
cord-294854-rvrgcugn	13	4	have	have	VBP
cord-294854-rvrgcugn	13	5	reviewed	review	VBN
cord-294854-rvrgcugn	13	6	the	the	DT
cord-294854-rvrgcugn	13	7	current	current	JJ
cord-294854-rvrgcugn	13	8	understanding	understanding	NN
cord-294854-rvrgcugn	13	9	of	of	IN
cord-294854-rvrgcugn	13	10	the	the	DT
cord-294854-rvrgcugn	13	11	features	feature	NNS
cord-294854-rvrgcugn	13	12	of	of	IN
cord-294854-rvrgcugn	13	13	SARS‐CoV‐2	sars‐cov‐2	NN
cord-294854-rvrgcugn	13	14	and	and	CC
cord-294854-rvrgcugn	13	15	the	the	DT
cord-294854-rvrgcugn	13	16	pathological	pathological	JJ
cord-294854-rvrgcugn	13	17	features	feature	NNS
cord-294854-rvrgcugn	13	18	,	,	,
cord-294854-rvrgcugn	13	19	pathophysiological	pathophysiological	JJ
cord-294854-rvrgcugn	13	20	mechanisms	mechanism	NNS
cord-294854-rvrgcugn	13	21	,	,	,
cord-294854-rvrgcugn	13	22	and	and	CC
cord-294854-rvrgcugn	13	23	treatments	treatment	NNS
cord-294854-rvrgcugn	13	24	of	of	IN
cord-294854-rvrgcugn	13	25	the	the	DT
cord-294854-rvrgcugn	13	26	cytokine	cytokine	NN
cord-294854-rvrgcugn	13	27	storm	storm	NN
cord-294854-rvrgcugn	13	28	induced	induce	VBN
cord-294854-rvrgcugn	13	29	by	by	IN
cord-294854-rvrgcugn	13	30	COVID‐19	COVID‐19	NNP
cord-294854-rvrgcugn	13	31	.	.	.
cord-294854-rvrgcugn	14	1	Additionally	additionally	RB
cord-294854-rvrgcugn	14	2	,	,	,
cord-294854-rvrgcugn	14	3	we	-PRON-	PRP
cord-294854-rvrgcugn	14	4	suggest	suggest	VBP
cord-294854-rvrgcugn	14	5	that	that	IN
cord-294854-rvrgcugn	14	6	the	the	DT
cord-294854-rvrgcugn	14	7	identification	identification	NN
cord-294854-rvrgcugn	14	8	and	and	CC
cord-294854-rvrgcugn	14	9	treatment	treatment	NN
cord-294854-rvrgcugn	14	10	of	of	IN
cord-294854-rvrgcugn	14	11	the	the	DT
cord-294854-rvrgcugn	14	12	cytokine	cytokine	NN
cord-294854-rvrgcugn	14	13	storm	storm	NN
cord-294854-rvrgcugn	14	14	are	be	VBP
cord-294854-rvrgcugn	14	15	important	important	JJ
cord-294854-rvrgcugn	14	16	components	component	NNS
cord-294854-rvrgcugn	14	17	for	for	IN
cord-294854-rvrgcugn	14	18	rescuing	rescue	VBG
cord-294854-rvrgcugn	14	19	patients	patient	NNS
cord-294854-rvrgcugn	14	20	with	with	IN
cord-294854-rvrgcugn	14	21	severe	severe	JJ
cord-294854-rvrgcugn	14	22	COVID‐19	covid‐19	NN
cord-294854-rvrgcugn	14	23	.	.	.
cord-294854-rvrgcugn	15	1	This	this	DT
cord-294854-rvrgcugn	15	2	article	article	NN
cord-294854-rvrgcugn	15	3	is	be	VBZ
cord-294854-rvrgcugn	15	4	protected	protect	VBN
cord-294854-rvrgcugn	15	5	by	by	IN
cord-294854-rvrgcugn	15	6	copyright	copyright	NN
cord-294854-rvrgcugn	15	7	.	.	.
cord-294854-rvrgcugn	16	1	All	all	DT
cord-294854-rvrgcugn	16	2	rights	right	NNS
cord-294854-rvrgcugn	16	3	reserved	reserve	VBN
cord-294854-rvrgcugn	16	4	.	.	.
cord-294854-rvrgcugn	17	1	An	an	DT
cord-294854-rvrgcugn	17	2	outbreak	outbreak	NN
cord-294854-rvrgcugn	17	3	of	of	IN
cord-294854-rvrgcugn	17	4	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	17	5	disease	disease	NN
cord-294854-rvrgcugn	17	6	2019	2019	CD
cord-294854-rvrgcugn	17	7	(	(	-LRB-
cord-294854-rvrgcugn	17	8	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	17	9	)	)	-RRB-
cord-294854-rvrgcugn	17	10	caused	cause	VBN
cord-294854-rvrgcugn	17	11	by	by	IN
cord-294854-rvrgcugn	17	12	severe	severe	JJ
cord-294854-rvrgcugn	17	13	acute	acute	JJ
cord-294854-rvrgcugn	17	14	respiratory	respiratory	JJ
cord-294854-rvrgcugn	17	15	syndrome	syndrome	NN
cord-294854-rvrgcugn	17	16	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	17	17	2	2	CD
cord-294854-rvrgcugn	18	1	(	(	-LRB-
cord-294854-rvrgcugn	18	2	SARS	SARS	NNP
cord-294854-rvrgcugn	18	3	-	-	HYPH
cord-294854-rvrgcugn	18	4	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	18	5	)	)	-RRB-
cord-294854-rvrgcugn	18	6	has	have	VBZ
cord-294854-rvrgcugn	18	7	rapidly	rapidly	RB
cord-294854-rvrgcugn	18	8	spread	spread	VBN
cord-294854-rvrgcugn	18	9	throughout	throughout	IN
cord-294854-rvrgcugn	18	10	the	the	DT
cord-294854-rvrgcugn	18	11	world	world	NN
cord-294854-rvrgcugn	18	12	1	1	CD
cord-294854-rvrgcugn	18	13	.	.	.
cord-294854-rvrgcugn	19	1	The	the	DT
cord-294854-rvrgcugn	19	2	initial	initial	JJ
cord-294854-rvrgcugn	19	3	symptoms	symptom	NNS
cord-294854-rvrgcugn	19	4	of	of	IN
cord-294854-rvrgcugn	19	5	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	19	6	mainly	mainly	RB
cord-294854-rvrgcugn	19	7	include	include	VBP
cord-294854-rvrgcugn	19	8	fever	fever	NN
cord-294854-rvrgcugn	19	9	,	,	,
cord-294854-rvrgcugn	19	10	cough	cough	NN
cord-294854-rvrgcugn	19	11	,	,	,
cord-294854-rvrgcugn	19	12	myalgia	myalgia	NN
cord-294854-rvrgcugn	19	13	,	,	,
cord-294854-rvrgcugn	19	14	fatigue	fatigue	NN
cord-294854-rvrgcugn	19	15	,	,	,
cord-294854-rvrgcugn	19	16	or	or	CC
cord-294854-rvrgcugn	19	17	dyspnea	dyspnea	NN
cord-294854-rvrgcugn	19	18	.	.	.
cord-294854-rvrgcugn	20	1	In	in	IN
cord-294854-rvrgcugn	20	2	the	the	DT
cord-294854-rvrgcugn	20	3	later	later	JJ
cord-294854-rvrgcugn	20	4	stages	stage	NNS
cord-294854-rvrgcugn	20	5	of	of	IN
cord-294854-rvrgcugn	20	6	the	the	DT
cord-294854-rvrgcugn	20	7	disease	disease	NN
cord-294854-rvrgcugn	20	8	,	,	,
cord-294854-rvrgcugn	20	9	dyspnea	dyspnea	NN
cord-294854-rvrgcugn	20	10	may	may	MD
cord-294854-rvrgcugn	20	11	occur	occur	VB
cord-294854-rvrgcugn	20	12	and	and	CC
cord-294854-rvrgcugn	20	13	gradually	gradually	RB
cord-294854-rvrgcugn	20	14	develop	develop	VB
cord-294854-rvrgcugn	20	15	into	into	IN
cord-294854-rvrgcugn	20	16	acute	acute	JJ
cord-294854-rvrgcugn	20	17	respiratory	respiratory	JJ
cord-294854-rvrgcugn	20	18	distress	distress	NN
cord-294854-rvrgcugn	20	19	syndrome	syndrome	NN
cord-294854-rvrgcugn	20	20	(	(	-LRB-
cord-294854-rvrgcugn	20	21	ARDS	ARDS	NNP
cord-294854-rvrgcugn	20	22	)	)	-RRB-
cord-294854-rvrgcugn	20	23	or	or	CC
cord-294854-rvrgcugn	20	24	multiple	multiple	JJ
cord-294854-rvrgcugn	20	25	organ	organ	NN
cord-294854-rvrgcugn	20	26	failure	failure	NN
cord-294854-rvrgcugn	20	27	(	(	-LRB-
cord-294854-rvrgcugn	20	28	MOF	MOF	NNP
cord-294854-rvrgcugn	20	29	)	)	-RRB-
cord-294854-rvrgcugn	20	30	2	2	CD
cord-294854-rvrgcugn	20	31	.	.	.
cord-294854-rvrgcugn	21	1	It	-PRON-	PRP
cord-294854-rvrgcugn	21	2	has	have	VBZ
cord-294854-rvrgcugn	21	3	been	be	VBN
cord-294854-rvrgcugn	21	4	reported	report	VBN
cord-294854-rvrgcugn	21	5	that	that	IN
cord-294854-rvrgcugn	21	6	a	a	DT
cord-294854-rvrgcugn	21	7	cytokine	cytokine	NN
cord-294854-rvrgcugn	21	8	storm	storm	NN
cord-294854-rvrgcugn	21	9	is	be	VBZ
cord-294854-rvrgcugn	21	10	Accepted	accept	VBN
cord-294854-rvrgcugn	21	11	Article	Article	NNP
cord-294854-rvrgcugn	21	12	associated	associate	VBN
cord-294854-rvrgcugn	21	13	with	with	IN
cord-294854-rvrgcugn	21	14	the	the	DT
cord-294854-rvrgcugn	21	15	deterioration	deterioration	NN
cord-294854-rvrgcugn	21	16	of	of	IN
cord-294854-rvrgcugn	21	17	many	many	JJ
cord-294854-rvrgcugn	21	18	infectious	infectious	JJ
cord-294854-rvrgcugn	21	19	diseases	disease	NNS
cord-294854-rvrgcugn	21	20	,	,	,
cord-294854-rvrgcugn	21	21	including	include	VBG
cord-294854-rvrgcugn	21	22	severe	severe	JJ
cord-294854-rvrgcugn	21	23	acute	acute	JJ
cord-294854-rvrgcugn	21	24	respiratory	respiratory	JJ
cord-294854-rvrgcugn	21	25	syndrome	syndrome	NN
cord-294854-rvrgcugn	21	26	(	(	-LRB-
cord-294854-rvrgcugn	21	27	SARS	SARS	NNP
cord-294854-rvrgcugn	21	28	)	)	-RRB-
cord-294854-rvrgcugn	21	29	3	3	CD
cord-294854-rvrgcugn	21	30	and	and	CC
cord-294854-rvrgcugn	21	31	Middle	Middle	NNP
cord-294854-rvrgcugn	21	32	East	East	NNP
cord-294854-rvrgcugn	21	33	respiratory	respiratory	JJ
cord-294854-rvrgcugn	21	34	syndrome	syndrome	NN
cord-294854-rvrgcugn	21	35	(	(	-LRB-
cord-294854-rvrgcugn	21	36	MERS	MERS	NNP
cord-294854-rvrgcugn	21	37	)	)	-RRB-
cord-294854-rvrgcugn	21	38	4	4	CD
cord-294854-rvrgcugn	21	39	.	.	.
cord-294854-rvrgcugn	22	1	The	the	DT
cord-294854-rvrgcugn	22	2	cytokine	cytokine	NN
cord-294854-rvrgcugn	22	3	storm	storm	NN
cord-294854-rvrgcugn	22	4	caused	cause	VBN
cord-294854-rvrgcugn	22	5	by	by	IN
cord-294854-rvrgcugn	22	6	has	have	VBZ
cord-294854-rvrgcugn	22	7	been	be	VBN
cord-294854-rvrgcugn	22	8	suggested	suggest	VBN
cord-294854-rvrgcugn	22	9	to	to	TO
cord-294854-rvrgcugn	22	10	be	be	VB
cord-294854-rvrgcugn	22	11	associated	associate	VBN
cord-294854-rvrgcugn	22	12	with	with	IN
cord-294854-rvrgcugn	22	13	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	22	14	severity	severity	NN
cord-294854-rvrgcugn	22	15	2	2	CD
cord-294854-rvrgcugn	22	16	,	,	,
cord-294854-rvrgcugn	22	17	5	5	CD
cord-294854-rvrgcugn	22	18	.	.	.
cord-294854-rvrgcugn	23	1	However	however	RB
cord-294854-rvrgcugn	23	2	,	,	,
cord-294854-rvrgcugn	23	3	there	there	EX
cord-294854-rvrgcugn	23	4	is	be	VBZ
cord-294854-rvrgcugn	23	5	currently	currently	RB
cord-294854-rvrgcugn	23	6	a	a	DT
cord-294854-rvrgcugn	23	7	limited	limited	JJ
cord-294854-rvrgcugn	23	8	understanding	understanding	NN
cord-294854-rvrgcugn	23	9	of	of	IN
cord-294854-rvrgcugn	23	10	the	the	DT
cord-294854-rvrgcugn	23	11	cytokine	cytokine	NN
cord-294854-rvrgcugn	23	12	storm	storm	NN
cord-294854-rvrgcugn	23	13	in	in	IN
cord-294854-rvrgcugn	23	14	severe	severe	JJ
cord-294854-rvrgcugn	23	15	COVID-19	covid-19	NN
cord-294854-rvrgcugn	23	16	.	.	.
cord-294854-rvrgcugn	24	1	Therefore	therefore	RB
cord-294854-rvrgcugn	24	2	,	,	,
cord-294854-rvrgcugn	24	3	here	here	RB
cord-294854-rvrgcugn	24	4	,	,	,
cord-294854-rvrgcugn	24	5	we	-PRON-	PRP
cord-294854-rvrgcugn	24	6	have	have	VBP
cord-294854-rvrgcugn	24	7	discussed	discuss	VBN
cord-294854-rvrgcugn	24	8	the	the	DT
cord-294854-rvrgcugn	24	9	current	current	JJ
cord-294854-rvrgcugn	24	10	findings	finding	NNS
cord-294854-rvrgcugn	24	11	and	and	CC
cord-294854-rvrgcugn	24	12	treatment	treatment	NN
cord-294854-rvrgcugn	24	13	strategies	strategy	NNS
cord-294854-rvrgcugn	24	14	for	for	IN
cord-294854-rvrgcugn	24	15	the	the	DT
cord-294854-rvrgcugn	24	16	cytokine	cytokine	NN
cord-294854-rvrgcugn	24	17	storm	storm	NN
cord-294854-rvrgcugn	24	18	in	in	IN
cord-294854-rvrgcugn	24	19	severe	severe	JJ
cord-294854-rvrgcugn	24	20	COVID-19	covid-19	NN
cord-294854-rvrgcugn	24	21	.	.	.
cord-294854-rvrgcugn	25	1	SARS	SARS	NNP
cord-294854-rvrgcugn	25	2	-	-	HYPH
cord-294854-rvrgcugn	25	3	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	25	4	is	be	VBZ
cord-294854-rvrgcugn	25	5	the	the	DT
cord-294854-rvrgcugn	25	6	newest	new	JJS
cord-294854-rvrgcugn	25	7	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	25	8	known	know	VBN
cord-294854-rvrgcugn	25	9	to	to	TO
cord-294854-rvrgcugn	25	10	infect	infect	VB
cord-294854-rvrgcugn	25	11	humans	human	NNS
cord-294854-rvrgcugn	25	12	.	.	.
cord-294854-rvrgcugn	26	1	SARS	SARS	NNP
cord-294854-rvrgcugn	26	2	-	-	HYPH
cord-294854-rvrgcugn	26	3	CoV	CoV	NNP
cord-294854-rvrgcugn	26	4	,	,	,
cord-294854-rvrgcugn	26	5	MERS	MERS	NNP
cord-294854-rvrgcugn	26	6	-	-	HYPH
cord-294854-rvrgcugn	26	7	CoV	CoV	NNP
cord-294854-rvrgcugn	26	8	,	,	,
cord-294854-rvrgcugn	26	9	and	and	CC
cord-294854-rvrgcugn	26	10	SARS	SARS	NNP
cord-294854-rvrgcugn	26	11	-	-	HYPH
cord-294854-rvrgcugn	26	12	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	26	13	cause	cause	VB
cord-294854-rvrgcugn	26	14	severe	severe	JJ
cord-294854-rvrgcugn	26	15	pneumonia	pneumonia	NN
cord-294854-rvrgcugn	26	16	,	,	,
cord-294854-rvrgcugn	26	17	while	while	IN
cord-294854-rvrgcugn	26	18	other	other	JJ
cord-294854-rvrgcugn	26	19	human	human	JJ
cord-294854-rvrgcugn	26	20	coronaviruses	coronaviruse	NNS
cord-294854-rvrgcugn	26	21	,	,	,
cord-294854-rvrgcugn	26	22	including	include	VBG
cord-294854-rvrgcugn	26	23	229E	229e	CD
cord-294854-rvrgcugn	26	24	,	,	,
cord-294854-rvrgcugn	26	25	OC43	OC43	NNP
cord-294854-rvrgcugn	26	26	,	,	,
cord-294854-rvrgcugn	26	27	HKU1	HKU1	NNP
cord-294854-rvrgcugn	26	28	,	,	,
cord-294854-rvrgcugn	26	29	and	and	CC
cord-294854-rvrgcugn	26	30	NL63	NL63	NNP
cord-294854-rvrgcugn	26	31	,	,	,
cord-294854-rvrgcugn	26	32	cause	cause	VB
cord-294854-rvrgcugn	26	33	only	only	RB
cord-294854-rvrgcugn	26	34	the	the	DT
cord-294854-rvrgcugn	26	35	common	common	JJ
cord-294854-rvrgcugn	26	36	cold	cold	JJ
cord-294854-rvrgcugn	26	37	6	6	CD
cord-294854-rvrgcugn	26	38	.	.	.
cord-294854-rvrgcugn	27	1	SARS	SARS	NNP
cord-294854-rvrgcugn	27	2	-	-	HYPH
cord-294854-rvrgcugn	27	3	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	27	4	belongs	belong	VBZ
cord-294854-rvrgcugn	27	5	to	to	IN
cord-294854-rvrgcugn	27	6	the	the	DT
cord-294854-rvrgcugn	27	7	genus	genus	NN
cord-294854-rvrgcugn	27	8	Betacoronavirus	Betacoronavirus	NNP
cord-294854-rvrgcugn	27	9	,	,	,
cord-294854-rvrgcugn	27	10	which	which	WDT
cord-294854-rvrgcugn	27	11	also	also	RB
cord-294854-rvrgcugn	27	12	includes	include	VBZ
cord-294854-rvrgcugn	27	13	SARS	SARS	NNP
cord-294854-rvrgcugn	27	14	-	-	HYPH
cord-294854-rvrgcugn	27	15	CoV	CoV	NNP
cord-294854-rvrgcugn	27	16	and	and	CC
cord-294854-rvrgcugn	27	17	MERS	MERS	NNP
cord-294854-rvrgcugn	27	18	-	-	HYPH
cord-294854-rvrgcugn	27	19	CoV	CoV	NNP
cord-294854-rvrgcugn	27	20	,	,	,
cord-294854-rvrgcugn	27	21	both	both	DT
cord-294854-rvrgcugn	27	22	of	of	IN
cord-294854-rvrgcugn	27	23	which	which	WDT
cord-294854-rvrgcugn	27	24	have	have	VBP
cord-294854-rvrgcugn	27	25	caused	cause	VBN
cord-294854-rvrgcugn	27	26	SARS	SARS	NNP
cord-294854-rvrgcugn	27	27	and	and	CC
cord-294854-rvrgcugn	27	28	MERS	MERS	NNP
cord-294854-rvrgcugn	27	29	,	,	,
cord-294854-rvrgcugn	27	30	respectively	respectively	RB
cord-294854-rvrgcugn	27	31	7	7	CD
cord-294854-rvrgcugn	27	32	.	.	.
cord-294854-rvrgcugn	28	1	SARS	SARS	NNP
cord-294854-rvrgcugn	28	2	-	-	HYPH
cord-294854-rvrgcugn	28	3	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	28	4	,	,	,
cord-294854-rvrgcugn	28	5	SARS	SARS	NNP
cord-294854-rvrgcugn	28	6	-	-	HYPH
cord-294854-rvrgcugn	28	7	CoV	CoV	NNP
cord-294854-rvrgcugn	28	8	,	,	,
cord-294854-rvrgcugn	28	9	and	and	CC
cord-294854-rvrgcugn	28	10	MERS	MERS	NNP
cord-294854-rvrgcugn	28	11	-	-	HYPH
cord-294854-rvrgcugn	28	12	CoV	CoV	NNP
cord-294854-rvrgcugn	28	13	have	have	VBP
cord-294854-rvrgcugn	28	14	similarities	similarity	NNS
cord-294854-rvrgcugn	28	15	and	and	CC
cord-294854-rvrgcugn	28	16	differences	difference	NNS
cord-294854-rvrgcugn	28	17	.	.	.
cord-294854-rvrgcugn	29	1	Genetic	genetic	JJ
cord-294854-rvrgcugn	29	2	sequence	sequence	NN
cord-294854-rvrgcugn	29	3	analysis	analysis	NN
cord-294854-rvrgcugn	29	4	has	have	VBZ
cord-294854-rvrgcugn	29	5	revealed	reveal	VBN
cord-294854-rvrgcugn	29	6	that	that	IN
cord-294854-rvrgcugn	29	7	SARS	SARS	NNP
cord-294854-rvrgcugn	29	8	-	-	HYPH
cord-294854-rvrgcugn	29	9	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	29	10	shares	share	VBZ
cord-294854-rvrgcugn	29	11	79	79	CD
cord-294854-rvrgcugn	29	12	%	%	NN
cord-294854-rvrgcugn	29	13	sequence	sequence	NN
cord-294854-rvrgcugn	29	14	identity	identity	NN
cord-294854-rvrgcugn	29	15	with	with	IN
cord-294854-rvrgcugn	29	16	SARS	SARS	NNP
cord-294854-rvrgcugn	29	17	-	-	HYPH
cord-294854-rvrgcugn	29	18	CoV	CoV	NNP
cord-294854-rvrgcugn	29	19	and	and	CC
cord-294854-rvrgcugn	29	20	50	50	CD
cord-294854-rvrgcugn	29	21	%	%	NN
cord-294854-rvrgcugn	29	22	identity	identity	NN
cord-294854-rvrgcugn	29	23	with	with	IN
cord-294854-rvrgcugn	29	24	MERS	MERS	NNP
cord-294854-rvrgcugn	29	25	-	-	HYPH
cord-294854-rvrgcugn	29	26	CoV	CoV	NNP
cord-294854-rvrgcugn	29	27	8	8	CD
cord-294854-rvrgcugn	29	28	.	.	.
cord-294854-rvrgcugn	30	1	The	the	DT
cord-294854-rvrgcugn	30	2	genomes	genome	NNS
cord-294854-rvrgcugn	30	3	of	of	IN
cord-294854-rvrgcugn	30	4	SARS	SARS	NNP
cord-294854-rvrgcugn	30	5	-	-	HYPH
cord-294854-rvrgcugn	30	6	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	30	7	and	and	CC
cord-294854-rvrgcugn	30	8	the	the	DT
cord-294854-rvrgcugn	30	9	bat	bat	NN
cord-294854-rvrgcugn	30	10	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	30	11	RaTG13	ratg13	NN
cord-294854-rvrgcugn	30	12	are	be	VBP
cord-294854-rvrgcugn	30	13	96.2	96.2	CD
cord-294854-rvrgcugn	30	14	%	%	NN
cord-294854-rvrgcugn	30	15	homologous	homologous	JJ
cord-294854-rvrgcugn	30	16	9	9	CD
cord-294854-rvrgcugn	30	17	.	.	.
cord-294854-rvrgcugn	31	1	As	as	IN
cord-294854-rvrgcugn	31	2	of	of	IN
cord-294854-rvrgcugn	31	3	May	May	NNP
cord-294854-rvrgcugn	31	4	11	11	CD
cord-294854-rvrgcugn	31	5	,	,	,
cord-294854-rvrgcugn	31	6	2020	2020	CD
cord-294854-rvrgcugn	31	7	,	,	,
cord-294854-rvrgcugn	31	8	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	31	9	has	have	VBZ
cord-294854-rvrgcugn	31	10	resulted	result	VBN
cord-294854-rvrgcugn	31	11	in	in	IN
cord-294854-rvrgcugn	31	12	278,892	278,892	CD
cord-294854-rvrgcugn	31	13	deaths	death	NNS
cord-294854-rvrgcugn	31	14	and	and	CC
cord-294854-rvrgcugn	31	15	4,006,257	4,006,257	CD
cord-294854-rvrgcugn	31	16	cases	case	NNS
cord-294854-rvrgcugn	31	17	,	,	,
cord-294854-rvrgcugn	31	18	with	with	IN
cord-294854-rvrgcugn	31	19	an	an	DT
cord-294854-rvrgcugn	31	20	approximate	approximate	JJ
cord-294854-rvrgcugn	31	21	case	case	NN
cord-294854-rvrgcugn	31	22	fatality	fatality	NN
cord-294854-rvrgcugn	31	23	rate	rate	NN
cord-294854-rvrgcugn	31	24	of	of	IN
cord-294854-rvrgcugn	31	25	7.0	7.0	CD
cord-294854-rvrgcugn	31	26	%	%	NN
cord-294854-rvrgcugn	31	27	10	10	CD
cord-294854-rvrgcugn	31	28	.	.	.
cord-294854-rvrgcugn	32	1	SARS	SARS	NNP
cord-294854-rvrgcugn	32	2	-	-	HYPH
cord-294854-rvrgcugn	32	3	CoV	CoV	NNP
cord-294854-rvrgcugn	32	4	and	and	CC
cord-294854-rvrgcugn	32	5	MERS	MERS	NNP
cord-294854-rvrgcugn	32	6	-	-	HYPH
cord-294854-rvrgcugn	32	7	CoV	CoV	NNP
cord-294854-rvrgcugn	32	8	had	have	VBD
cord-294854-rvrgcugn	32	9	a	a	DT
cord-294854-rvrgcugn	32	10	case	case	NN
cord-294854-rvrgcugn	32	11	fatality	fatality	NN
cord-294854-rvrgcugn	32	12	rate	rate	NN
cord-294854-rvrgcugn	32	13	of	of	IN
cord-294854-rvrgcugn	32	14	9.6	9.6	CD
cord-294854-rvrgcugn	32	15	%	%	NN
cord-294854-rvrgcugn	32	16	(	(	-LRB-
cord-294854-rvrgcugn	32	17	774/8,096	774/8,096	NN
cord-294854-rvrgcugn	32	18	)	)	-RRB-
cord-294854-rvrgcugn	32	19	and	and	CC
cord-294854-rvrgcugn	32	20	34.4	34.4	CD
cord-294854-rvrgcugn	32	21	%	%	NN
cord-294854-rvrgcugn	32	22	(	(	-LRB-
cord-294854-rvrgcugn	32	23	858/2,494	858/2,494	NN
cord-294854-rvrgcugn	32	24	)	)	-RRB-
cord-294854-rvrgcugn	32	25	,	,	,
cord-294854-rvrgcugn	32	26	respectively	respectively	RB
cord-294854-rvrgcugn	32	27	11	11	CD
cord-294854-rvrgcugn	32	28	.	.	.
cord-294854-rvrgcugn	33	1	The	the	DT
cord-294854-rvrgcugn	33	2	reproduction	reproduction	NN
cord-294854-rvrgcugn	33	3	number	number	NN
cord-294854-rvrgcugn	33	4	(	(	-LRB-
cord-294854-rvrgcugn	33	5	R0	R0	NNP
cord-294854-rvrgcugn	33	6	)	)	-RRB-
cord-294854-rvrgcugn	33	7	of	of	IN
cord-294854-rvrgcugn	33	8	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	33	9	is	be	VBZ
cord-294854-rvrgcugn	33	10	thought	think	VBN
cord-294854-rvrgcugn	33	11	to	to	TO
cord-294854-rvrgcugn	33	12	be	be	VB
cord-294854-rvrgcugn	33	13	This	this	DT
cord-294854-rvrgcugn	33	14	article	article	NN
cord-294854-rvrgcugn	33	15	is	be	VBZ
cord-294854-rvrgcugn	33	16	protected	protect	VBN
cord-294854-rvrgcugn	33	17	by	by	IN
cord-294854-rvrgcugn	33	18	copyright	copyright	NN
cord-294854-rvrgcugn	33	19	.	.	.
cord-294854-rvrgcugn	34	1	All	all	DT
cord-294854-rvrgcugn	34	2	rights	right	NNS
cord-294854-rvrgcugn	34	3	reserved	reserve	VBN
cord-294854-rvrgcugn	34	4	.	.	.
cord-294854-rvrgcugn	35	1	Accepted	accepted	JJ
cord-294854-rvrgcugn	35	2	Article	Article	NNP
cord-294854-rvrgcugn	35	3	between	between	IN
cord-294854-rvrgcugn	35	4	2	2	CD
cord-294854-rvrgcugn	35	5	and	and	CC
cord-294854-rvrgcugn	35	6	2.5	2.5	CD
cord-294854-rvrgcugn	35	7	12	12	CD
cord-294854-rvrgcugn	35	8	,	,	,
cord-294854-rvrgcugn	35	9	which	which	WDT
cord-294854-rvrgcugn	35	10	is	be	VBZ
cord-294854-rvrgcugn	35	11	slightly	slightly	RB
cord-294854-rvrgcugn	35	12	higher	high	JJR
cord-294854-rvrgcugn	35	13	than	than	IN
cord-294854-rvrgcugn	35	14	of	of	IN
cord-294854-rvrgcugn	35	15	SARS	SARS	NNP
cord-294854-rvrgcugn	35	16	(	(	-LRB-
cord-294854-rvrgcugn	35	17	1.7.1.9	1.7.1.9	CD
cord-294854-rvrgcugn	35	18	)	)	-RRB-
cord-294854-rvrgcugn	35	19	and	and	CC
cord-294854-rvrgcugn	35	20	MERS	MERS	NNP
cord-294854-rvrgcugn	35	21	(	(	-LRB-
cord-294854-rvrgcugn	35	22	<	<	NNP
cord-294854-rvrgcugn	35	23	1	1	CD
cord-294854-rvrgcugn	35	24	)	)	-RRB-
cord-294854-rvrgcugn	35	25	13	13	CD
cord-294854-rvrgcugn	35	26	.	.	.
cord-294854-rvrgcugn	36	1	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	36	2	appears	appear	VBZ
cord-294854-rvrgcugn	36	3	to	to	TO
cord-294854-rvrgcugn	36	4	be	be	VB
cord-294854-rvrgcugn	36	5	more	more	RBR
cord-294854-rvrgcugn	36	6	infectious	infectious	JJ
cord-294854-rvrgcugn	36	7	than	than	IN
cord-294854-rvrgcugn	36	8	SARS	SARS	NNP
cord-294854-rvrgcugn	36	9	and	and	CC
cord-294854-rvrgcugn	36	10	MERS	MERS	NNP
cord-294854-rvrgcugn	36	11	,	,	,
cord-294854-rvrgcugn	36	12	but	but	CC
cord-294854-rvrgcugn	36	13	may	may	MD
cord-294854-rvrgcugn	36	14	be	be	VB
cord-294854-rvrgcugn	36	15	less	less	RBR
cord-294854-rvrgcugn	36	16	severe	severe	JJ
cord-294854-rvrgcugn	36	17	.	.	.
cord-294854-rvrgcugn	37	1	The	the	DT
cord-294854-rvrgcugn	37	2	origins	origin	NNS
cord-294854-rvrgcugn	37	3	of	of	IN
cord-294854-rvrgcugn	37	4	SARS	SARS	NNP
cord-294854-rvrgcugn	37	5	-	-	HYPH
cord-294854-rvrgcugn	37	6	CoV	CoV	NNP
cord-294854-rvrgcugn	37	7	,	,	,
cord-294854-rvrgcugn	37	8	MERS	MERS	NNP
cord-294854-rvrgcugn	37	9	-	-	HYPH
cord-294854-rvrgcugn	37	10	CoV	CoV	NNP
cord-294854-rvrgcugn	37	11	,	,	,
cord-294854-rvrgcugn	37	12	and	and	CC
cord-294854-rvrgcugn	37	13	SARS	SARS	NNP
cord-294854-rvrgcugn	37	14	-	-	HYPH
cord-294854-rvrgcugn	37	15	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	37	16	are	be	VBP
cord-294854-rvrgcugn	37	17	considered	consider	VBN
cord-294854-rvrgcugn	37	18	to	to	TO
cord-294854-rvrgcugn	37	19	be	be	VB
cord-294854-rvrgcugn	37	20	zoonotic	zoonotic	JJ
cord-294854-rvrgcugn	37	21	.	.	.
cord-294854-rvrgcugn	38	1	Both	both	DT
cord-294854-rvrgcugn	38	2	SARS	SARS	NNP
cord-294854-rvrgcugn	38	3	-	-	HYPH
cord-294854-rvrgcugn	38	4	CoV	CoV	NNP
cord-294854-rvrgcugn	38	5	and	and	CC
cord-294854-rvrgcugn	38	6	MERS	MERS	NNP
cord-294854-rvrgcugn	38	7	-	-	HYPH
cord-294854-rvrgcugn	38	8	CoV	CoV	NNP
cord-294854-rvrgcugn	38	9	originated	originate	VBD
cord-294854-rvrgcugn	38	10	in	in	IN
cord-294854-rvrgcugn	38	11	bats	bat	NNS
cord-294854-rvrgcugn	38	12	and	and	CC
cord-294854-rvrgcugn	38	13	spread	spread	VBD
cord-294854-rvrgcugn	38	14	directly	directly	RB
cord-294854-rvrgcugn	38	15	to	to	IN
cord-294854-rvrgcugn	38	16	humans	human	NNS
cord-294854-rvrgcugn	38	17	from	from	IN
cord-294854-rvrgcugn	38	18	marked	marked	JJ
cord-294854-rvrgcugn	38	19	palm	palm	NN
cord-294854-rvrgcugn	38	20	civets	civet	NNS
cord-294854-rvrgcugn	38	21	and	and	CC
cord-294854-rvrgcugn	38	22	dromedary	dromedary	NN
cord-294854-rvrgcugn	38	23	camels	camel	NNS
cord-294854-rvrgcugn	38	24	,	,	,
cord-294854-rvrgcugn	38	25	respectively	respectively	RB
cord-294854-rvrgcugn	38	26	14	14	CD
cord-294854-rvrgcugn	38	27	.	.	.
cord-294854-rvrgcugn	39	1	However	however	RB
cord-294854-rvrgcugn	39	2	,	,	,
cord-294854-rvrgcugn	39	3	the	the	DT
cord-294854-rvrgcugn	39	4	origin	origin	NN
cord-294854-rvrgcugn	39	5	of	of	IN
cord-294854-rvrgcugn	39	6	SARS	SARS	NNP
cord-294854-rvrgcugn	39	7	-	-	HYPH
cord-294854-rvrgcugn	39	8	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	39	9	remains	remain	VBZ
cord-294854-rvrgcugn	39	10	unclear	unclear	JJ
cord-294854-rvrgcugn	39	11	.	.	.
cord-294854-rvrgcugn	40	1	SARS	SARS	NNP
cord-294854-rvrgcugn	40	2	-	-	HYPH
cord-294854-rvrgcugn	40	3	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	40	4	has	have	VBZ
cord-294854-rvrgcugn	40	5	been	be	VBN
cord-294854-rvrgcugn	40	6	reported	report	VBN
cord-294854-rvrgcugn	40	7	to	to	TO
cord-294854-rvrgcugn	40	8	be	be	VB
cord-294854-rvrgcugn	40	9	transmitted	transmit	VBN
cord-294854-rvrgcugn	40	10	between	between	IN
cord-294854-rvrgcugn	40	11	humans	human	NNS
cord-294854-rvrgcugn	40	12	through	through	IN
cord-294854-rvrgcugn	40	13	direct	direct	JJ
cord-294854-rvrgcugn	40	14	contact	contact	NN
cord-294854-rvrgcugn	40	15	,	,	,
cord-294854-rvrgcugn	40	16	aerosol	aerosol	NN
cord-294854-rvrgcugn	40	17	droplets	droplet	NNS
cord-294854-rvrgcugn	40	18	,	,	,
cord-294854-rvrgcugn	40	19	the	the	DT
cord-294854-rvrgcugn	40	20	fecal	fecal	JJ
cord-294854-rvrgcugn	40	21	-	-	HYPH
cord-294854-rvrgcugn	40	22	oral	oral	JJ
cord-294854-rvrgcugn	40	23	route	route	NN
cord-294854-rvrgcugn	40	24	,	,	,
cord-294854-rvrgcugn	40	25	and	and	CC
cord-294854-rvrgcugn	40	26	intermediate	intermediate	JJ
cord-294854-rvrgcugn	40	27	viruses	virus	NNS
cord-294854-rvrgcugn	40	28	from	from	IN
cord-294854-rvrgcugn	40	29	symptomatic	symptomatic	JJ
cord-294854-rvrgcugn	40	30	and	and	CC
cord-294854-rvrgcugn	40	31	asymptomatic	asymptomatic	JJ
cord-294854-rvrgcugn	40	32	patients	patient	NNS
cord-294854-rvrgcugn	40	33	15	15	CD
cord-294854-rvrgcugn	40	34	.	.	.
cord-294854-rvrgcugn	41	1	SARS	SARS	NNP
cord-294854-rvrgcugn	41	2	-	-	HYPH
cord-294854-rvrgcugn	41	3	CoV	CoV	NNP
cord-294854-rvrgcugn	41	4	and	and	CC
cord-294854-rvrgcugn	41	5	MERS	MERS	NNP
cord-294854-rvrgcugn	41	6	-	-	HYPH
cord-294854-rvrgcugn	41	7	CoV	CoV	NNP
cord-294854-rvrgcugn	41	8	are	be	VBP
cord-294854-rvrgcugn	41	9	also	also	RB
cord-294854-rvrgcugn	41	10	thought	think	VBN
cord-294854-rvrgcugn	41	11	to	to	TO
cord-294854-rvrgcugn	41	12	spread	spread	VB
cord-294854-rvrgcugn	41	13	from	from	IN
cord-294854-rvrgcugn	41	14	infected	infect	VBN
cord-294854-rvrgcugn	41	15	to	to	IN
cord-294854-rvrgcugn	41	16	non	non	JJ
cord-294854-rvrgcugn	41	17	-	-	JJ
cord-294854-rvrgcugn	41	18	infected	infected	JJ
cord-294854-rvrgcugn	41	19	individuals	individual	NNS
cord-294854-rvrgcugn	41	20	through	through	IN
cord-294854-rvrgcugn	41	21	direct	direct	JJ
cord-294854-rvrgcugn	41	22	or	or	CC
cord-294854-rvrgcugn	41	23	indirect	indirect	JJ
cord-294854-rvrgcugn	41	24	contact	contact	NN
cord-294854-rvrgcugn	41	25	15	15	CD
cord-294854-rvrgcugn	41	26	19	19	CD
cord-294854-rvrgcugn	41	27	proposed	propose	VBD
cord-294854-rvrgcugn	41	28	that	that	IN
cord-294854-rvrgcugn	41	29	SARS	SARS	NNP
cord-294854-rvrgcugn	41	30	-	-	HYPH
cord-294854-rvrgcugn	41	31	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	41	32	infection	infection	NN
cord-294854-rvrgcugn	41	33	triggers	trigger	VBZ
cord-294854-rvrgcugn	41	34	an	an	DT
cord-294854-rvrgcugn	41	35	excessive	excessive	JJ
cord-294854-rvrgcugn	41	36	immune	immune	JJ
cord-294854-rvrgcugn	41	37	response	response	NN
cord-294854-rvrgcugn	41	38	known	know	VBN
cord-294854-rvrgcugn	41	39	as	as	IN
cord-294854-rvrgcugn	41	40	a	a	DT
cord-294854-rvrgcugn	41	41	cytokine	cytokine	NN
cord-294854-rvrgcugn	41	42	storm	storm	NN
cord-294854-rvrgcugn	41	43	in	in	IN
cord-294854-rvrgcugn	41	44	cases	case	NNS
cord-294854-rvrgcugn	41	45	of	of	IN
cord-294854-rvrgcugn	41	46	severe	severe	JJ
cord-294854-rvrgcugn	41	47	COVID-19	covid-19	NN
cord-294854-rvrgcugn	41	48	.	.	.
cord-294854-rvrgcugn	42	1	A	a	DT
cord-294854-rvrgcugn	42	2	cytokine	cytokine	NN
cord-294854-rvrgcugn	42	3	storm	storm	NN
cord-294854-rvrgcugn	42	4	is	be	VBZ
cord-294854-rvrgcugn	42	5	a	a	DT
cord-294854-rvrgcugn	42	6	potentially	potentially	RB
cord-294854-rvrgcugn	42	7	fatal	fatal	JJ
cord-294854-rvrgcugn	42	8	immune	immune	JJ
cord-294854-rvrgcugn	42	9	disease	disease	NN
cord-294854-rvrgcugn	42	10	characterized	characterize	VBN
cord-294854-rvrgcugn	42	11	by	by	IN
cord-294854-rvrgcugn	42	12	the	the	DT
cord-294854-rvrgcugn	42	13	high	high	JJ
cord-294854-rvrgcugn	42	14	-	-	HYPH
cord-294854-rvrgcugn	42	15	level	level	NN
cord-294854-rvrgcugn	42	16	activation	activation	NN
cord-294854-rvrgcugn	42	17	of	of	IN
cord-294854-rvrgcugn	42	18	immune	immune	JJ
cord-294854-rvrgcugn	42	19	cells	cell	NNS
cord-294854-rvrgcugn	42	20	and	and	CC
cord-294854-rvrgcugn	42	21	excessive	excessive	JJ
cord-294854-rvrgcugn	42	22	production	production	NN
cord-294854-rvrgcugn	42	23	of	of	IN
cord-294854-rvrgcugn	42	24	massive	massive	JJ
cord-294854-rvrgcugn	42	25	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	42	26	cytokines	cytokine	NNS
cord-294854-rvrgcugn	42	27	and	and	CC
cord-294854-rvrgcugn	42	28	chemical	chemical	NN
cord-294854-rvrgcugn	42	29	mediators	mediator	NNS
cord-294854-rvrgcugn	42	30	20	20	CD
cord-294854-rvrgcugn	42	31	.	.	.
cord-294854-rvrgcugn	43	1	It	-PRON-	PRP
cord-294854-rvrgcugn	43	2	is	be	VBZ
cord-294854-rvrgcugn	43	3	considered	consider	VBN
cord-294854-rvrgcugn	43	4	to	to	TO
cord-294854-rvrgcugn	43	5	be	be	VB
cord-294854-rvrgcugn	43	6	the	the	DT
cord-294854-rvrgcugn	43	7	main	main	JJ
cord-294854-rvrgcugn	43	8	cause	cause	NN
cord-294854-rvrgcugn	43	9	of	of	IN
cord-294854-rvrgcugn	43	10	disease	disease	NN
cord-294854-rvrgcugn	43	11	severity	severity	NN
cord-294854-rvrgcugn	43	12	and	and	CC
cord-294854-rvrgcugn	43	13	death	death	NN
cord-294854-rvrgcugn	43	14	in	in	IN
cord-294854-rvrgcugn	43	15	Accepted	Accepted	NNP
cord-294854-rvrgcugn	43	16	Article	Article	NNP
cord-294854-rvrgcugn	44	1	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	44	2	patients	patient	NNS
cord-294854-rvrgcugn	44	3	5	5	CD
cord-294854-rvrgcugn	44	4	,	,	,
cord-294854-rvrgcugn	44	5	and	and	CC
cord-294854-rvrgcugn	44	6	is	be	VBZ
cord-294854-rvrgcugn	44	7	related	relate	VBN
cord-294854-rvrgcugn	44	8	to	to	IN
cord-294854-rvrgcugn	44	9	high	high	JJ
cord-294854-rvrgcugn	44	10	levels	level	NNS
cord-294854-rvrgcugn	44	11	of	of	IN
cord-294854-rvrgcugn	44	12	circulating	circulate	VBG
cord-294854-rvrgcugn	44	13	cytokines	cytokine	NNS
cord-294854-rvrgcugn	44	14	,	,	,
cord-294854-rvrgcugn	44	15	severe	severe	JJ
cord-294854-rvrgcugn	44	16	lymphopenia	lymphopenia	NNP
cord-294854-rvrgcugn	44	17	,	,	,
cord-294854-rvrgcugn	44	18	thrombosis	thrombosis	NN
cord-294854-rvrgcugn	44	19	,	,	,
cord-294854-rvrgcugn	44	20	and	and	CC
cord-294854-rvrgcugn	44	21	massive	massive	JJ
cord-294854-rvrgcugn	44	22	mononuclear	mononuclear	JJ
cord-294854-rvrgcugn	44	23	cell	cell	NN
cord-294854-rvrgcugn	44	24	infiltration	infiltration	NN
cord-294854-rvrgcugn	44	25	in	in	IN
cord-294854-rvrgcugn	44	26	multiple	multiple	JJ
cord-294854-rvrgcugn	44	27	organs	organ	NNS
cord-294854-rvrgcugn	44	28	21	21	CD
cord-294854-rvrgcugn	44	29	.	.	.
cord-294854-rvrgcugn	45	1	It	-PRON-	PRP
cord-294854-rvrgcugn	45	2	has	have	VBZ
cord-294854-rvrgcugn	45	3	been	be	VBN
cord-294854-rvrgcugn	45	4	found	find	VBN
cord-294854-rvrgcugn	45	5	that	that	IN
cord-294854-rvrgcugn	45	6	SARS	SARS	NNP
cord-294854-rvrgcugn	45	7	-	-	HYPH
cord-294854-rvrgcugn	45	8	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	45	9	genomes	genome	NNS
cord-294854-rvrgcugn	45	10	from	from	IN
cord-294854-rvrgcugn	45	11	different	different	JJ
cord-294854-rvrgcugn	45	12	parts	part	NNS
cord-294854-rvrgcugn	45	13	of	of	IN
cord-294854-rvrgcugn	45	14	the	the	DT
cord-294854-rvrgcugn	45	15	world	world	NN
cord-294854-rvrgcugn	45	16	have	have	VBP
cord-294854-rvrgcugn	45	17	evolved	evolve	VBN
cord-294854-rvrgcugn	45	18	in	in	IN
cord-294854-rvrgcugn	45	19	different	different	JJ
cord-294854-rvrgcugn	45	20	clusters	cluster	NNS
cord-294854-rvrgcugn	45	21	22	22	CD
cord-294854-rvrgcugn	45	22	,	,	,
cord-294854-rvrgcugn	45	23	23	23	CD
cord-294854-rvrgcugn	45	24	.	.	.
cord-294854-rvrgcugn	46	1	Forster	Forster	NNP
cord-294854-rvrgcugn	46	2	et	et	NNP
cord-294854-rvrgcugn	46	3	al	al	NNP
cord-294854-rvrgcugn	46	4	.	.	.
cord-294854-rvrgcugn	47	1	23	23	CD
cord-294854-rvrgcugn	47	2	reported	report	VBD
cord-294854-rvrgcugn	47	3	there	there	RB
cord-294854-rvrgcugn	47	4	to	to	TO
cord-294854-rvrgcugn	47	5	be	be	VB
cord-294854-rvrgcugn	47	6	at	at	RB
cord-294854-rvrgcugn	47	7	least	least	RBS
cord-294854-rvrgcugn	47	8	three	three	CD
cord-294854-rvrgcugn	47	9	central	central	JJ
cord-294854-rvrgcugn	47	10	variants	variant	NNS
cord-294854-rvrgcugn	47	11	of	of	IN
cord-294854-rvrgcugn	47	12	SARS	SARS	NNP
cord-294854-rvrgcugn	47	13	-	-	:
cord-294854-rvrgcugn	47	14	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	47	15	globally	globally	RB
cord-294854-rvrgcugn	47	16	,	,	,
cord-294854-rvrgcugn	47	17	named	name	VBN
cord-294854-rvrgcugn	47	18	A	A	NNP
cord-294854-rvrgcugn	47	19	,	,	,
cord-294854-rvrgcugn	47	20	B	b	NN
cord-294854-rvrgcugn	47	21	,	,	,
cord-294854-rvrgcugn	47	22	and	and	CC
cord-294854-rvrgcugn	47	23	C.	C.	NNP
cord-294854-rvrgcugn	48	1	The	the	DT
cord-294854-rvrgcugn	48	2	A	a	DT
cord-294854-rvrgcugn	48	3	type	type	NN
cord-294854-rvrgcugn	48	4	is	be	VBZ
cord-294854-rvrgcugn	48	5	the	the	DT
cord-294854-rvrgcugn	48	6	most	most	RBS
cord-294854-rvrgcugn	48	7	similar	similar	JJ
cord-294854-rvrgcugn	48	8	to	to	IN
cord-294854-rvrgcugn	48	9	the	the	DT
cord-294854-rvrgcugn	48	10	bat	bat	NN
cord-294854-rvrgcugn	48	11	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	48	12	and	and	CC
cord-294854-rvrgcugn	48	13	is	be	VBZ
cord-294854-rvrgcugn	48	14	mainly	mainly	RB
cord-294854-rvrgcugn	48	15	found	find	VBN
cord-294854-rvrgcugn	48	16	in	in	IN
cord-294854-rvrgcugn	48	17	the	the	DT
cord-294854-rvrgcugn	48	18	United	United	NNP
cord-294854-rvrgcugn	48	19	States	States	NNP
cord-294854-rvrgcugn	48	20	and	and	CC
cord-294854-rvrgcugn	48	21	Australia	Australia	NNP
cord-294854-rvrgcugn	48	22	.	.	.
cord-294854-rvrgcugn	49	1	The	the	DT
cord-294854-rvrgcugn	49	2	B	b	NN
cord-294854-rvrgcugn	49	3	type	type	NN
cord-294854-rvrgcugn	49	4	is	be	VBZ
cord-294854-rvrgcugn	49	5	more	more	RBR
cord-294854-rvrgcugn	49	6	common	common	JJ
cord-294854-rvrgcugn	49	7	in	in	IN
cord-294854-rvrgcugn	49	8	East	East	NNP
cord-294854-rvrgcugn	49	9	Asia	Asia	NNP
cord-294854-rvrgcugn	49	10	and	and	CC
cord-294854-rvrgcugn	49	11	has	have	VBZ
cord-294854-rvrgcugn	49	12	evolved	evolve	VBN
cord-294854-rvrgcugn	49	13	through	through	IN
cord-294854-rvrgcugn	49	14	several	several	JJ
cord-294854-rvrgcugn	49	15	mutations	mutation	NNS
cord-294854-rvrgcugn	49	16	.	.	.
cord-294854-rvrgcugn	50	1	The	the	DT
cord-294854-rvrgcugn	50	2	C	c	NN
cord-294854-rvrgcugn	50	3	type	type	NN
cord-294854-rvrgcugn	50	4	is	be	VBZ
cord-294854-rvrgcugn	50	5	primarily	primarily	RB
cord-294854-rvrgcugn	50	6	found	find	VBN
cord-294854-rvrgcugn	50	7	in	in	IN
cord-294854-rvrgcugn	50	8	Europe	Europe	NNP
cord-294854-rvrgcugn	50	9	.	.	.
cord-294854-rvrgcugn	51	1	Different	different	JJ
cord-294854-rvrgcugn	51	2	viral	viral	JJ
cord-294854-rvrgcugn	51	3	isolates	isolate	NNS
cord-294854-rvrgcugn	51	4	exhibit	exhibit	VBP
cord-294854-rvrgcugn	51	5	significant	significant	JJ
cord-294854-rvrgcugn	51	6	differences	difference	NNS
cord-294854-rvrgcugn	51	7	in	in	IN
cord-294854-rvrgcugn	51	8	pathogenicity	pathogenicity	NN
cord-294854-rvrgcugn	51	9	and	and	CC
cord-294854-rvrgcugn	51	10	viral	viral	JJ
cord-294854-rvrgcugn	51	11	load	load	NN
cord-294854-rvrgcugn	51	12	24	24	CD
cord-294854-rvrgcugn	51	13	.	.	.
cord-294854-rvrgcugn	52	1	Notably	notably	RB
cord-294854-rvrgcugn	52	2	,	,	,
cord-294854-rvrgcugn	52	3	given	give	VBN
cord-294854-rvrgcugn	52	4	the	the	DT
cord-294854-rvrgcugn	52	5	diverse	diverse	JJ
cord-294854-rvrgcugn	52	6	clinical	clinical	JJ
cord-294854-rvrgcugn	52	7	symptoms	symptom	NNS
cord-294854-rvrgcugn	52	8	of	of	IN
cord-294854-rvrgcugn	52	9	patients	patient	NNS
cord-294854-rvrgcugn	52	10	,	,	,
cord-294854-rvrgcugn	52	11	it	-PRON-	PRP
cord-294854-rvrgcugn	52	12	will	will	MD
cord-294854-rvrgcugn	52	13	be	be	VB
cord-294854-rvrgcugn	52	14	challenging	challenge	VBG
cord-294854-rvrgcugn	52	15	to	to	TO
cord-294854-rvrgcugn	52	16	establish	establish	VB
cord-294854-rvrgcugn	52	17	a	a	DT
cord-294854-rvrgcugn	52	18	genotype	genotype	NN
cord-294854-rvrgcugn	52	19	-	-	HYPH
cord-294854-rvrgcugn	52	20	phenotype	phenotype	NN
cord-294854-rvrgcugn	52	21	relationship	relationship	NN
cord-294854-rvrgcugn	52	22	.	.	.
cord-294854-rvrgcugn	53	1	With	with	IN
cord-294854-rvrgcugn	53	2	new	new	JJ
cord-294854-rvrgcugn	53	3	sequences	sequence	NNS
cord-294854-rvrgcugn	53	4	being	be	VBG
cord-294854-rvrgcugn	53	5	uploaded	upload	VBN
cord-294854-rvrgcugn	53	6	to	to	IN
cord-294854-rvrgcugn	53	7	the	the	DT
cord-294854-rvrgcugn	53	8	GIASID	GIASID	NNP
cord-294854-rvrgcugn	53	9	(	(	-LRB-
cord-294854-rvrgcugn	53	10	Global	global	JJ
cord-294854-rvrgcugn	53	11	initiative	initiative	NN
cord-294854-rvrgcugn	53	12	on	on	IN
cord-294854-rvrgcugn	53	13	sharing	share	VBG
cord-294854-rvrgcugn	53	14	all	all	DT
cord-294854-rvrgcugn	53	15	influenza	influenza	NN
cord-294854-rvrgcugn	53	16	data	datum	NNS
cord-294854-rvrgcugn	53	17	)	)	-RRB-
cord-294854-rvrgcugn	53	18	every	every	DT
cord-294854-rvrgcugn	53	19	day	day	NN
cord-294854-rvrgcugn	53	20	,	,	,
cord-294854-rvrgcugn	53	21	new	new	JJ
cord-294854-rvrgcugn	53	22	results	result	NNS
cord-294854-rvrgcugn	53	23	may	may	MD
cord-294854-rvrgcugn	53	24	be	be	VB
cord-294854-rvrgcugn	53	25	produced	produce	VBN
cord-294854-rvrgcugn	53	26	as	as	IN
cord-294854-rvrgcugn	53	27	more	more	JJR
cord-294854-rvrgcugn	53	28	data	datum	NNS
cord-294854-rvrgcugn	53	29	become	become	VBP
cord-294854-rvrgcugn	53	30	available	available	JJ
cord-294854-rvrgcugn	53	31	.	.	.
cord-294854-rvrgcugn	54	1	The	the	DT
cord-294854-rvrgcugn	54	2	emergence	emergence	NN
cord-294854-rvrgcugn	54	3	of	of	IN
cord-294854-rvrgcugn	54	4	variants	variant	NNS
cord-294854-rvrgcugn	54	5	may	may	MD
cord-294854-rvrgcugn	54	6	add	add	VB
cord-294854-rvrgcugn	54	7	to	to	IN
cord-294854-rvrgcugn	54	8	the	the	DT
cord-294854-rvrgcugn	54	9	challenges	challenge	NNS
cord-294854-rvrgcugn	54	10	of	of	IN
cord-294854-rvrgcugn	54	11	vaccine	vaccine	NN
cord-294854-rvrgcugn	54	12	development	development	NN
cord-294854-rvrgcugn	54	13	.	.	.
cord-294854-rvrgcugn	55	1	Pathological	pathological	JJ
cord-294854-rvrgcugn	55	2	alterations	alteration	NNS
cord-294854-rvrgcugn	55	3	in	in	IN
cord-294854-rvrgcugn	55	4	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	55	5	patients	patient	NNS
cord-294854-rvrgcugn	55	6	include	include	VBP
cord-294854-rvrgcugn	55	7	pulmonary	pulmonary	JJ
cord-294854-rvrgcugn	55	8	edema	edema	NN
cord-294854-rvrgcugn	55	9	,	,	,
cord-294854-rvrgcugn	55	10	diffuse	diffuse	VB
cord-294854-rvrgcugn	55	11	alveolar	alveolar	NN
cord-294854-rvrgcugn	55	12	injury	injury	NN
cord-294854-rvrgcugn	55	13	with	with	IN
cord-294854-rvrgcugn	55	14	the	the	DT
cord-294854-rvrgcugn	55	15	formation	formation	NN
cord-294854-rvrgcugn	55	16	of	of	IN
cord-294854-rvrgcugn	55	17	hyaline	hyaline	JJ
cord-294854-rvrgcugn	55	18	membranes	membrane	NNS
cord-294854-rvrgcugn	55	19	,	,	,
cord-294854-rvrgcugn	55	20	the	the	DT
cord-294854-rvrgcugn	55	21	presence	presence	NN
cord-294854-rvrgcugn	55	22	of	of	IN
cord-294854-rvrgcugn	55	23	reactive	reactive	JJ
cord-294854-rvrgcugn	55	24	type	type	NN
cord-294854-rvrgcugn	55	25	II	II	NNP
cord-294854-rvrgcugn	55	26	pneumocyte	pneumocyte	NNP
cord-294854-rvrgcugn	55	27	hyperplasia	hyperplasia	NN
cord-294854-rvrgcugn	55	28	,	,	,
cord-294854-rvrgcugn	55	29	proteinaceous	proteinaceous	JJ
cord-294854-rvrgcugn	55	30	aggregates	aggregate	NNS
cord-294854-rvrgcugn	55	31	,	,	,
cord-294854-rvrgcugn	55	32	fibrinous	fibrinous	NNP
cord-294854-rvrgcugn	55	33	Accepted	Accepted	NNP
cord-294854-rvrgcugn	55	34	Article	Article	NNP
cord-294854-rvrgcugn	55	35	exudates	exudate	NNS
cord-294854-rvrgcugn	55	36	,	,	,
cord-294854-rvrgcugn	55	37	monocytes	monocyte	NNS
cord-294854-rvrgcugn	55	38	and	and	CC
cord-294854-rvrgcugn	55	39	macrophages	macrophage	NNS
cord-294854-rvrgcugn	55	40	within	within	IN
cord-294854-rvrgcugn	55	41	alveolar	alveolar	JJ
cord-294854-rvrgcugn	55	42	spaces	space	NNS
cord-294854-rvrgcugn	55	43	,	,	,
cord-294854-rvrgcugn	55	44	and	and	CC
cord-294854-rvrgcugn	55	45	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	55	46	infiltration	infiltration	NN
cord-294854-rvrgcugn	55	47	of	of	IN
cord-294854-rvrgcugn	55	48	interstitial	interstitial	JJ
cord-294854-rvrgcugn	55	49	mononuclear	mononuclear	NN
cord-294854-rvrgcugn	55	50	cells	cell	NNS
cord-294854-rvrgcugn	55	51	[	[	-LRB-
cord-294854-rvrgcugn	55	52	25	25	CD
cord-294854-rvrgcugn	55	53	]	]	-RRB-
cord-294854-rvrgcugn	55	54	[	[	-LRB-
cord-294854-rvrgcugn	55	55	26	26	CD
cord-294854-rvrgcugn	55	56	]	]	-RRB-
cord-294854-rvrgcugn	55	57	[	[	-LRB-
cord-294854-rvrgcugn	55	58	27	27	CD
cord-294854-rvrgcugn	55	59	]	]	-RRB-
cord-294854-rvrgcugn	55	60	[	[	-LRB-
cord-294854-rvrgcugn	55	61	28	28	CD
cord-294854-rvrgcugn	55	62	]	]	-RRB-
cord-294854-rvrgcugn	55	63	.	.	.
cord-294854-rvrgcugn	56	1	Electron	electron	NN
cord-294854-rvrgcugn	56	2	microscopy	microscopy	NN
cord-294854-rvrgcugn	56	3	has	have	VBZ
cord-294854-rvrgcugn	56	4	revealed	reveal	VBN
cord-294854-rvrgcugn	56	5	the	the	DT
cord-294854-rvrgcugn	56	6	presence	presence	NN
cord-294854-rvrgcugn	56	7	of	of	IN
cord-294854-rvrgcugn	56	8	SARS	SARS	NNP
cord-294854-rvrgcugn	56	9	-	-	HYPH
cord-294854-rvrgcugn	56	10	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	56	11	virus	virus	NN
cord-294854-rvrgcugn	56	12	particles	particle	NNS
cord-294854-rvrgcugn	56	13	in	in	IN
cord-294854-rvrgcugn	56	14	bronchial	bronchial	JJ
cord-294854-rvrgcugn	56	15	and	and	CC
cord-294854-rvrgcugn	56	16	alveolar	alveolar	JJ
cord-294854-rvrgcugn	56	17	type	type	NN
cord-294854-rvrgcugn	56	18	II	ii	CD
cord-294854-rvrgcugn	56	19	epithelial	epithelial	JJ
cord-294854-rvrgcugn	56	20	cells	cell	NNS
cord-294854-rvrgcugn	56	21	,	,	,
cord-294854-rvrgcugn	56	22	but	but	CC
cord-294854-rvrgcugn	56	23	not	not	RB
cord-294854-rvrgcugn	56	24	in	in	IN
cord-294854-rvrgcugn	56	25	other	other	JJ
cord-294854-rvrgcugn	56	26	tissues	tissue	NNS
cord-294854-rvrgcugn	56	27	26	26	CD
cord-294854-rvrgcugn	56	28	,	,	,
cord-294854-rvrgcugn	56	29	27	27	CD
cord-294854-rvrgcugn	56	30	.	.	.
cord-294854-rvrgcugn	57	1	Therefore	therefore	RB
cord-294854-rvrgcugn	57	2	,	,	,
cord-294854-rvrgcugn	57	3	although	although	IN
cord-294854-rvrgcugn	57	4	a	a	DT
cord-294854-rvrgcugn	57	5	PCR	PCR	NNP
cord-294854-rvrgcugn	57	6	test	test	NN
cord-294854-rvrgcugn	57	7	may	may	MD
cord-294854-rvrgcugn	57	8	be	be	VB
cord-294854-rvrgcugn	57	9	negative	negative	JJ
cord-294854-rvrgcugn	57	10	from	from	IN
cord-294854-rvrgcugn	57	11	blood	blood	NN
cord-294854-rvrgcugn	57	12	or	or	CC
cord-294854-rvrgcugn	57	13	throat	throat	NN
cord-294854-rvrgcugn	57	14	swabs	swab	NNS
cord-294854-rvrgcugn	57	15	,	,	,
cord-294854-rvrgcugn	57	16	SARS	SARS	NNP
cord-294854-rvrgcugn	57	17	-	-	HYPH
cord-294854-rvrgcugn	57	18	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	57	19	viral	viral	JJ
cord-294854-rvrgcugn	57	20	inclusions	inclusion	NNS
cord-294854-rvrgcugn	57	21	may	may	MD
cord-294854-rvrgcugn	57	22	be	be	VB
cord-294854-rvrgcugn	57	23	detected	detect	VBN
cord-294854-rvrgcugn	57	24	in	in	IN
cord-294854-rvrgcugn	57	25	the	the	DT
cord-294854-rvrgcugn	57	26	lungs	lung	NNS
cord-294854-rvrgcugn	57	27	.	.	.
cord-294854-rvrgcugn	58	1	Immunohistochemical	immunohistochemical	JJ
cord-294854-rvrgcugn	58	2	staining	staining	NN
cord-294854-rvrgcugn	58	3	indicated	indicate	VBD
cord-294854-rvrgcugn	58	4	that	that	IN
cord-294854-rvrgcugn	58	5	CD68	CD68	NNS
cord-294854-rvrgcugn	58	6	+	+	CC
cord-294854-rvrgcugn	58	7	macrophages	macrophage	NNS
cord-294854-rvrgcugn	58	8	,	,	,
cord-294854-rvrgcugn	58	9	CD20	cd20	NN
cord-294854-rvrgcugn	58	10	+	+	CC
cord-294854-rvrgcugn	58	11	B	b	NN
cord-294854-rvrgcugn	58	12	cells	cell	NNS
cord-294854-rvrgcugn	58	13	,	,	,
cord-294854-rvrgcugn	58	14	and	and	CC
cord-294854-rvrgcugn	58	15	CD8	CD8	NNP
cord-294854-rvrgcugn	58	16	+	+	CC
cord-294854-rvrgcugn	58	17	T	T	NNP
cord-294854-rvrgcugn	58	18	cells	cell	NNS
cord-294854-rvrgcugn	58	19	infiltrated	infiltrate	VBD
cord-294854-rvrgcugn	58	20	the	the	DT
cord-294854-rvrgcugn	58	21	alveolar	alveolar	NN
cord-294854-rvrgcugn	58	22	cavity	cavity	NN
cord-294854-rvrgcugn	58	23	and	and	CC
cord-294854-rvrgcugn	58	24	alveoli	alveolus	NNS
cord-294854-rvrgcugn	58	25	26	26	CD
cord-294854-rvrgcugn	58	26	.	.	.
cord-294854-rvrgcugn	59	1	The	the	DT
cord-294854-rvrgcugn	59	2	levels	level	NNS
cord-294854-rvrgcugn	59	3	of	of	IN
cord-294854-rvrgcugn	59	4	CD8	CD8	NNP
cord-294854-rvrgcugn	59	5	＋	＋	NNP
cord-294854-rvrgcugn	59	6	T	T	NNP
cord-294854-rvrgcugn	59	7	cells	cell	NNS
cord-294854-rvrgcugn	59	8	may	may	MD
cord-294854-rvrgcugn	59	9	be	be	VB
cord-294854-rvrgcugn	59	10	slightly	slightly	RB
cord-294854-rvrgcugn	59	11	higher	high	JJR
cord-294854-rvrgcugn	59	12	than	than	IN
cord-294854-rvrgcugn	59	13	that	that	DT
cord-294854-rvrgcugn	59	14	of	of	IN
cord-294854-rvrgcugn	59	15	CD4	CD4	NNP
cord-294854-rvrgcugn	59	16	＋	＋	NNP
cord-294854-rvrgcugn	59	17	T	T	NNP
cord-294854-rvrgcugn	59	18	cells	cell	NNS
cord-294854-rvrgcugn	59	19	within	within	IN
cord-294854-rvrgcugn	59	20	the	the	DT
cord-294854-rvrgcugn	59	21	alveolar	alveolar	JJ
cord-294854-rvrgcugn	59	22	septa	septa	NNP
cord-294854-rvrgcugn	59	23	29	29	CD
cord-294854-rvrgcugn	59	24	 	 	_SP
cord-294854-rvrgcugn	59	25	Cellular	Cellular	NNP
cord-294854-rvrgcugn	59	26	entry	entry	NN
cord-294854-rvrgcugn	59	27	of	of	IN
cord-294854-rvrgcugn	59	28	SARS	SARS	NNP
cord-294854-rvrgcugn	59	29	-	-	HYPH
cord-294854-rvrgcugn	59	30	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	59	31	depends	depend	VBZ
cord-294854-rvrgcugn	59	32	on	on	IN
cord-294854-rvrgcugn	59	33	the	the	DT
cord-294854-rvrgcugn	59	34	binding	binding	NN
cord-294854-rvrgcugn	59	35	of	of	IN
cord-294854-rvrgcugn	59	36	S	S	NNP
cord-294854-rvrgcugn	59	37	proteins	protein	NNS
cord-294854-rvrgcugn	59	38	covering	cover	VBG
cord-294854-rvrgcugn	59	39	the	the	DT
cord-294854-rvrgcugn	59	40	surface	surface	NN
cord-294854-rvrgcugn	59	41	of	of	IN
cord-294854-rvrgcugn	59	42	the	the	DT
cord-294854-rvrgcugn	59	43	virion	virion	NN
cord-294854-rvrgcugn	59	44	to	to	IN
cord-294854-rvrgcugn	59	45	the	the	DT
cord-294854-rvrgcugn	59	46	cellular	cellular	JJ
cord-294854-rvrgcugn	59	47	ACE2	ACE2	NNP
cord-294854-rvrgcugn	59	48	receptor	receptor	NN
cord-294854-rvrgcugn	59	49	9	9	CD
cord-294854-rvrgcugn	59	50	,	,	,
cord-294854-rvrgcugn	59	51	33	33	CD
cord-294854-rvrgcugn	59	52	and	and	CC
cord-294854-rvrgcugn	59	53	on	on	IN
cord-294854-rvrgcugn	59	54	S	s	NN
cord-294854-rvrgcugn	59	55	protein	protein	NN
cord-294854-rvrgcugn	60	1	This	this	DT
cord-294854-rvrgcugn	60	2	article	article	NN
cord-294854-rvrgcugn	60	3	is	be	VBZ
cord-294854-rvrgcugn	60	4	protected	protect	VBN
cord-294854-rvrgcugn	60	5	by	by	IN
cord-294854-rvrgcugn	60	6	copyright	copyright	NN
cord-294854-rvrgcugn	60	7	.	.	.
cord-294854-rvrgcugn	61	1	All	all	DT
cord-294854-rvrgcugn	61	2	rights	right	NNS
cord-294854-rvrgcugn	61	3	reserved	reserve	VBN
cord-294854-rvrgcugn	61	4	.	.	.
cord-294854-rvrgcugn	62	1	priming	prime	VBG
cord-294854-rvrgcugn	62	2	by	by	IN
cord-294854-rvrgcugn	62	3	TMPRSS2	TMPRSS2	NNP
cord-294854-rvrgcugn	62	4	,	,	,
cord-294854-rvrgcugn	62	5	a	a	DT
cord-294854-rvrgcugn	62	6	host	host	NN
cord-294854-rvrgcugn	62	7	membrane	membrane	NN
cord-294854-rvrgcugn	62	8	serine	serine	NN
cord-294854-rvrgcugn	62	9	protease	protease	NN
cord-294854-rvrgcugn	62	10	33	33	CD
cord-294854-rvrgcugn	62	11	Table	table	NN
cord-294854-rvrgcugn	62	12	1	1	CD
cord-294854-rvrgcugn	62	13	,	,	,
cord-294854-rvrgcugn	62	14	and	and	CC
cord-294854-rvrgcugn	62	15	cytokine	cytokine	JJ
cord-294854-rvrgcugn	62	16	secretion	secretion	NN
cord-294854-rvrgcugn	62	17	patterns	pattern	NNS
cord-294854-rvrgcugn	62	18	based	base	VBN
cord-294854-rvrgcugn	62	19	on	on	IN
cord-294854-rvrgcugn	62	20	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	62	21	severity	severity	NN
cord-294854-rvrgcugn	62	22	are	be	VBP
cord-294854-rvrgcugn	62	23	shown	show	VBN
cord-294854-rvrgcugn	62	24	in	in	IN
cord-294854-rvrgcugn	62	25	Table	Table	NNP
cord-294854-rvrgcugn	62	26	2	2	CD
cord-294854-rvrgcugn	62	27	.	.	.
cord-294854-rvrgcugn	63	1	Prevention	prevention	NN
cord-294854-rvrgcugn	63	2	and	and	CC
cord-294854-rvrgcugn	63	3	mitigation	mitigation	NN
cord-294854-rvrgcugn	63	4	of	of	IN
cord-294854-rvrgcugn	63	5	the	the	DT
cord-294854-rvrgcugn	63	6	cytokine	cytokine	NN
cord-294854-rvrgcugn	63	7	storm	storm	NN
cord-294854-rvrgcugn	63	8	may	may	MD
cord-294854-rvrgcugn	63	9	be	be	VB
cord-294854-rvrgcugn	63	10	the	the	DT
cord-294854-rvrgcugn	63	11	crux	crux	NN
cord-294854-rvrgcugn	63	12	to	to	IN
cord-294854-rvrgcugn	63	13	saving	save	VBG
cord-294854-rvrgcugn	63	14	patients	patient	NNS
cord-294854-rvrgcugn	63	15	with	with	IN
cord-294854-rvrgcugn	63	16	severe	severe	JJ
cord-294854-rvrgcugn	63	17	COVID-19	covid-19	NN
cord-294854-rvrgcugn	63	18	.	.	.
cord-294854-rvrgcugn	64	1	Currently	currently	RB
cord-294854-rvrgcugn	64	2	,	,	,
cord-294854-rvrgcugn	64	3	many	many	JJ
cord-294854-rvrgcugn	64	4	therapies	therapy	NNS
cord-294854-rvrgcugn	64	5	are	be	VBP
cord-294854-rvrgcugn	64	6	being	be	VBG
cord-294854-rvrgcugn	64	7	evaluated	evaluate	VBN
cord-294854-rvrgcugn	64	8	in	in	IN
cord-294854-rvrgcugn	64	9	clinical	clinical	JJ
cord-294854-rvrgcugn	64	10	trials	trial	NNS
cord-294854-rvrgcugn	64	11	due	due	JJ
cord-294854-rvrgcugn	64	12	to	to	IN
cord-294854-rvrgcugn	64	13	a	a	DT
cord-294854-rvrgcugn	64	14	lack	lack	NN
cord-294854-rvrgcugn	64	15	of	of	IN
cord-294854-rvrgcugn	64	16	high	high	JJ
cord-294854-rvrgcugn	64	17	-	-	HYPH
cord-294854-rvrgcugn	64	18	quality	quality	NN
cord-294854-rvrgcugn	64	19	evidence	evidence	NN
cord-294854-rvrgcugn	64	20	.	.	.
cord-294854-rvrgcugn	65	1	Corticosteroids	corticosteroid	NNS
cord-294854-rvrgcugn	65	2	inhibit	inhibit	VBP
cord-294854-rvrgcugn	65	3	the	the	DT
cord-294854-rvrgcugn	65	4	host	host	NN
cord-294854-rvrgcugn	65	5	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	65	6	response	response	NN
cord-294854-rvrgcugn	65	7	and	and	CC
cord-294854-rvrgcugn	65	8	suppress	suppress	VB
cord-294854-rvrgcugn	65	9	the	the	DT
cord-294854-rvrgcugn	65	10	immune	immune	JJ
cord-294854-rvrgcugn	65	11	response	response	NN
cord-294854-rvrgcugn	65	12	and	and	CC
cord-294854-rvrgcugn	65	13	pathogen	pathogen	NN
cord-294854-rvrgcugn	65	14	clearance	clearance	NN
cord-294854-rvrgcugn	65	15	46	46	CD
cord-294854-rvrgcugn	66	1	Overall	overall	RB
cord-294854-rvrgcugn	66	2	,	,	,
cord-294854-rvrgcugn	66	3	although	although	IN
cord-294854-rvrgcugn	66	4	evidence	evidence	NN
cord-294854-rvrgcugn	66	5	indicates	indicate	VBZ
cord-294854-rvrgcugn	66	6	a	a	DT
cord-294854-rvrgcugn	66	7	potential	potential	JJ
cord-294854-rvrgcugn	66	8	role	role	NN
cord-294854-rvrgcugn	66	9	for	for	IN
cord-294854-rvrgcugn	66	10	the	the	DT
cord-294854-rvrgcugn	66	11	use	use	NN
cord-294854-rvrgcugn	66	12	of	of	IN
cord-294854-rvrgcugn	66	13	corticosteroids	corticosteroid	NNS
cord-294854-rvrgcugn	66	14	This	this	DT
cord-294854-rvrgcugn	66	15	article	article	NN
cord-294854-rvrgcugn	66	16	is	be	VBZ
cord-294854-rvrgcugn	66	17	protected	protect	VBN
cord-294854-rvrgcugn	66	18	by	by	IN
cord-294854-rvrgcugn	66	19	copyright	copyright	NN
cord-294854-rvrgcugn	66	20	.	.	.
cord-294854-rvrgcugn	67	1	All	all	DT
cord-294854-rvrgcugn	67	2	rights	right	NNS
cord-294854-rvrgcugn	67	3	reserved	reserve	VBN
cord-294854-rvrgcugn	67	4	.	.	.
cord-294854-rvrgcugn	68	1	in	in	IN
cord-294854-rvrgcugn	68	2	patients	patient	NNS
cord-294854-rvrgcugn	68	3	with	with	IN
cord-294854-rvrgcugn	68	4	severe	severe	JJ
cord-294854-rvrgcugn	68	5	COVID-19	covid-19	NN
cord-294854-rvrgcugn	68	6	,	,	,
cord-294854-rvrgcugn	68	7	caution	caution	NN
cord-294854-rvrgcugn	68	8	should	should	MD
cord-294854-rvrgcugn	68	9	be	be	VB
cord-294854-rvrgcugn	68	10	exercised	exercise	VBN
cord-294854-rvrgcugn	68	11	given	give	VBN
cord-294854-rvrgcugn	68	12	the	the	DT
cord-294854-rvrgcugn	68	13	possibilities	possibility	NNS
cord-294854-rvrgcugn	68	14	of	of	IN
cord-294854-rvrgcugn	68	15	viral	viral	JJ
cord-294854-rvrgcugn	68	16	rebound	rebound	NN
cord-294854-rvrgcugn	68	17	and	and	CC
cord-294854-rvrgcugn	68	18	adverse	adverse	JJ
cord-294854-rvrgcugn	68	19	events	event	NNS
cord-294854-rvrgcugn	68	20	.	.	.
cord-294854-rvrgcugn	69	1	Given	give	VBN
cord-294854-rvrgcugn	69	2	their	-PRON-	PRP$
cord-294854-rvrgcugn	69	3	in	in	IN
cord-294854-rvrgcugn	69	4	vitro	vitro	FW
cord-294854-rvrgcugn	69	5	antiviral	antiviral	JJ
cord-294854-rvrgcugn	69	6	effects	effect	NNS
cord-294854-rvrgcugn	69	7	and	and	CC
cord-294854-rvrgcugn	69	8	anti	anti	JJ
cord-294854-rvrgcugn	69	9	-	-	JJ
cord-294854-rvrgcugn	69	10	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	69	11	properties	property	NNS
cord-294854-rvrgcugn	69	12	,	,	,
cord-294854-rvrgcugn	69	13	CQ	CQ	NNP
cord-294854-rvrgcugn	69	14	and	and	CC
cord-294854-rvrgcugn	69	15	its	-PRON-	PRP$
cord-294854-rvrgcugn	69	16	analog	analog	JJ
cord-294854-rvrgcugn	69	17	HCQ	HCQ	NNP
cord-294854-rvrgcugn	69	18	are	be	VBP
cord-294854-rvrgcugn	69	19	considered	consider	VBN
cord-294854-rvrgcugn	69	20	to	to	TO
cord-294854-rvrgcugn	69	21	be	be	VB
cord-294854-rvrgcugn	69	22	potential	potential	JJ
cord-294854-rvrgcugn	69	23	therapies	therapy	NNS
cord-294854-rvrgcugn	69	24	for	for	IN
cord-294854-rvrgcugn	69	25	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	69	26	.	.	.
cord-294854-rvrgcugn	70	1	Considering	consider	VBG
cord-294854-rvrgcugn	70	2	the	the	DT
cord-294854-rvrgcugn	70	3	severe	severe	JJ
cord-294854-rvrgcugn	70	4	side	side	NN
cord-294854-rvrgcugn	70	5	effects	effect	NNS
cord-294854-rvrgcugn	70	6	of	of	IN
cord-294854-rvrgcugn	70	7	CQ	CQ	NNP
cord-294854-rvrgcugn	70	8	,	,	,
cord-294854-rvrgcugn	70	9	HCQ	HCQ	NNP
cord-294854-rvrgcugn	70	10	may	may	MD
cord-294854-rvrgcugn	70	11	be	be	VB
cord-294854-rvrgcugn	70	12	a	a	DT
cord-294854-rvrgcugn	70	13	better	well	RBR
cord-294854-rvrgcugn	70	14	therapeutic	therapeutic	JJ
cord-294854-rvrgcugn	70	15	option	option	NN
cord-294854-rvrgcugn	70	16	.	.	.
cord-294854-rvrgcugn	71	1	CQ	CQ	NNP
cord-294854-rvrgcugn	71	2	and	and	CC
cord-294854-rvrgcugn	71	3	HCQ	HCQ	NNP
cord-294854-rvrgcugn	71	4	are	be	VBP
cord-294854-rvrgcugn	71	5	able	able	JJ
cord-294854-rvrgcugn	71	6	to	to	TO
cord-294854-rvrgcugn	71	7	reduce	reduce	VB
cord-294854-rvrgcugn	71	8	CD154	cd154	CD
cord-294854-rvrgcugn	71	9	expression	expression	NN
cord-294854-rvrgcugn	71	10	in	in	IN
cord-294854-rvrgcugn	71	11	T	T	NNP
cord-294854-rvrgcugn	71	12	cells	cell	NNS
cord-294854-rvrgcugn	71	13	52	52	CD
cord-294854-rvrgcugn	72	1	However	however	RB
cord-294854-rvrgcugn	72	2	,	,	,
cord-294854-rvrgcugn	72	3	the	the	DT
cord-294854-rvrgcugn	72	4	risks	risk	NNS
cord-294854-rvrgcugn	72	5	associated	associate	VBN
cord-294854-rvrgcugn	72	6	with	with	IN
cord-294854-rvrgcugn	72	7	TCZ	tcz	NN
cord-294854-rvrgcugn	72	8	(	(	-LRB-
cord-294854-rvrgcugn	72	9	e.g.	e.g.	RB
cord-294854-rvrgcugn	72	10	,	,	,
cord-294854-rvrgcugn	72	11	severe	severe	JJ
cord-294854-rvrgcugn	72	12	infections	infection	NNS
cord-294854-rvrgcugn	72	13	,	,	,
cord-294854-rvrgcugn	72	14	thrombocytopenia	thrombocytopenia	NN
cord-294854-rvrgcugn	72	15	,	,	,
cord-294854-rvrgcugn	72	16	neutropenia	neutropenia	NN
cord-294854-rvrgcugn	72	17	,	,	,
cord-294854-rvrgcugn	72	18	liver	liver	NN
cord-294854-rvrgcugn	72	19	damage	damage	NN
cord-294854-rvrgcugn	72	20	)	)	-RRB-
cord-294854-rvrgcugn	72	21	should	should	MD
cord-294854-rvrgcugn	72	22	also	also	RB
cord-294854-rvrgcugn	72	23	be	be	VB
cord-294854-rvrgcugn	72	24	noted	note	VBN
cord-294854-rvrgcugn	72	25	64	64	CD
cord-294854-rvrgcugn	72	26	.	.	.
cord-294854-rvrgcugn	73	1	It	-PRON-	PRP
cord-294854-rvrgcugn	73	2	is	be	VBZ
cord-294854-rvrgcugn	73	3	unclear	unclear	JJ
cord-294854-rvrgcugn	73	4	whether	whether	IN
cord-294854-rvrgcugn	73	5	there	there	EX
cord-294854-rvrgcugn	73	6	are	be	VBP
cord-294854-rvrgcugn	73	7	different	different	JJ
cord-294854-rvrgcugn	73	8	effects	effect	NNS
cord-294854-rvrgcugn	73	9	between	between	IN
cord-294854-rvrgcugn	73	10	IL-6	IL-6	NNP
cord-294854-rvrgcugn	73	11	antagonists	antagonist	NNS
cord-294854-rvrgcugn	73	12	(	(	-LRB-
cord-294854-rvrgcugn	73	13	siltuximab	siltuximab	NNP
cord-294854-rvrgcugn	73	14	)	)	-RRB-
cord-294854-rvrgcugn	73	15	and	and	CC
cord-294854-rvrgcugn	73	16	IL-6R	IL-6R	NNP
cord-294854-rvrgcugn	73	17	antagonists	antagonist	NNS
cord-294854-rvrgcugn	73	18	(	(	-LRB-
cord-294854-rvrgcugn	73	19	TCZ	TCZ	NNP
cord-294854-rvrgcugn	73	20	)	)	-RRB-
cord-294854-rvrgcugn	73	21	.	.	.
cord-294854-rvrgcugn	74	1	Siltuximab	Siltuximab	NNP
cord-294854-rvrgcugn	74	2	binds	bind	VBZ
cord-294854-rvrgcugn	74	3	to	to	IN
cord-294854-rvrgcugn	74	4	sIL-6	sIL-6	NNP
cord-294854-rvrgcugn	74	5	and	and	CC
cord-294854-rvrgcugn	74	6	inhibits	inhibit	VBZ
cord-294854-rvrgcugn	74	7	only	only	RB
cord-294854-rvrgcugn	74	8	cis	cis	NNP
cord-294854-rvrgcugn	74	9	and	and	CC
cord-294854-rvrgcugn	74	10	trans	trans	NNP
cord-294854-rvrgcugn	74	11	signaling	signal	VBG
cord-294854-rvrgcugn	74	12	.	.	.
cord-294854-rvrgcugn	75	1	TCZ	tcz	NN
cord-294854-rvrgcugn	75	2	binds	bind	VBZ
cord-294854-rvrgcugn	75	3	to	to	IN
cord-294854-rvrgcugn	75	4	both	both	DT
cord-294854-rvrgcugn	75	5	mIL-6R	mIL-6R	NNP
cord-294854-rvrgcugn	75	6	and	and	CC
cord-294854-rvrgcugn	75	7	sIL-6R	sIL-6R	NNP
cord-294854-rvrgcugn	75	8	and	and	CC
cord-294854-rvrgcugn	75	9	inhibits	inhibit	VBZ
cord-294854-rvrgcugn	75	10	both	both	DT
cord-294854-rvrgcugn	75	11	cis	cis	NNP
cord-294854-rvrgcugn	75	12	and	and	CC
cord-294854-rvrgcugn	75	13	trans	trans	NNP
cord-294854-rvrgcugn	75	14	signaling	signal	VBG
cord-294854-rvrgcugn	75	15	and	and	CC
cord-294854-rvrgcugn	75	16	trans	trans	NNP
cord-294854-rvrgcugn	75	17	presentation	presentation	NN
cord-294854-rvrgcugn	75	18	40	40	CD
cord-294854-rvrgcugn	75	19	,	,	,
cord-294854-rvrgcugn	75	20	65	65	CD
cord-294854-rvrgcugn	75	21	.	.	.
cord-294854-rvrgcugn	76	1	Of	of	IN
cord-294854-rvrgcugn	76	2	note	note	NN
cord-294854-rvrgcugn	76	3	,	,	,
cord-294854-rvrgcugn	76	4	IL-6	IL-6	NNP
cord-294854-rvrgcugn	76	5	inhibitors	inhibitor	NNS
cord-294854-rvrgcugn	76	6	are	be	VBP
cord-294854-rvrgcugn	76	7	not	not	RB
cord-294854-rvrgcugn	76	8	able	able	JJ
cord-294854-rvrgcugn	76	9	to	to	TO
cord-294854-rvrgcugn	76	10	bind	bind	VB
cord-294854-rvrgcugn	76	11	to	to	IN
cord-294854-rvrgcugn	76	12	IL-6	IL-6	NNP
cord-294854-rvrgcugn	76	13	produced	produce	VBN
cord-294854-rvrgcugn	76	14	by	by	IN
cord-294854-rvrgcugn	76	15	viruses	virus	NNS
cord-294854-rvrgcugn	76	16	such	such	JJ
cord-294854-rvrgcugn	76	17	as	as	IN
cord-294854-rvrgcugn	76	18	HIV	HIV	NNP
cord-294854-rvrgcugn	76	19	and	and	CC
cord-294854-rvrgcugn	76	20	human	human	JJ
cord-294854-rvrgcugn	76	21	herpesvirus-8	herpesvirus-8	NNP
cord-294854-rvrgcugn	76	22	65	65	CD
cord-294854-rvrgcugn	76	23	.	.	.
cord-294854-rvrgcugn	77	1	Currently	currently	RB
cord-294854-rvrgcugn	77	2	,	,	,
cord-294854-rvrgcugn	77	3	the	the	DT
cord-294854-rvrgcugn	77	4	application	application	NN
cord-294854-rvrgcugn	77	5	of	of	IN
cord-294854-rvrgcugn	77	6	TCZ	TCZ	NNP
cord-294854-rvrgcugn	77	7	for	for	IN
cord-294854-rvrgcugn	77	8	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	77	9	treatment	treatment	NN
cord-294854-rvrgcugn	77	10	is	be	VBZ
cord-294854-rvrgcugn	77	11	under	under	IN
cord-294854-rvrgcugn	77	12	study	study	NN
cord-294854-rvrgcugn	77	13	.	.	.
cord-294854-rvrgcugn	78	1	The	the	DT
cord-294854-rvrgcugn	78	2	three	three	CD
cord-294854-rvrgcugn	78	3	drugs	drug	NNS
cord-294854-rvrgcugn	78	4	mentioned	mention	VBN
cord-294854-rvrgcugn	78	5	above	above	RB
cord-294854-rvrgcugn	78	6	(	(	-LRB-
cord-294854-rvrgcugn	78	7	corticosteroids	corticosteroid	NNS
cord-294854-rvrgcugn	78	8	,	,	,
cord-294854-rvrgcugn	78	9	HCQ	HCQ	NNP
cord-294854-rvrgcugn	78	10	,	,	,
cord-294854-rvrgcugn	78	11	TCZ	TCZ	NNP
cord-294854-rvrgcugn	78	12	)	)	-RRB-
cord-294854-rvrgcugn	78	13	are	be	VBP
cord-294854-rvrgcugn	78	14	immunosuppressants	immunosuppressant	NNS
cord-294854-rvrgcugn	78	15	.	.	.
cord-294854-rvrgcugn	79	1	Owing	owe	VBG
cord-294854-rvrgcugn	79	2	to	to	IN
cord-294854-rvrgcugn	79	3	overall	overall	JJ
cord-294854-rvrgcugn	79	4	damage	damage	NN
cord-294854-rvrgcugn	79	5	to	to	IN
cord-294854-rvrgcugn	79	6	the	the	DT
cord-294854-rvrgcugn	79	7	immune	immune	JJ
cord-294854-rvrgcugn	79	8	system	system	NN
cord-294854-rvrgcugn	79	9	caused	cause	VBN
cord-294854-rvrgcugn	79	10	by	by	IN
cord-294854-rvrgcugn	79	11	autoimmune	autoimmune	JJ
cord-294854-rvrgcugn	79	12	diseases	disease	NNS
cord-294854-rvrgcugn	79	13	and	and	CC
cord-294854-rvrgcugn	79	14	the	the	DT
cord-294854-rvrgcugn	79	15	iatrogenic	iatrogenic	JJ
cord-294854-rvrgcugn	79	16	effects	effect	NNS
cord-294854-rvrgcugn	79	17	of	of	IN
cord-294854-rvrgcugn	79	18	immunosuppressants	immunosuppressant	NNS
cord-294854-rvrgcugn	79	19	,	,	,
cord-294854-rvrgcugn	79	20	the	the	DT
cord-294854-rvrgcugn	79	21	risk	risk	NN
cord-294854-rvrgcugn	79	22	of	of	IN
cord-294854-rvrgcugn	79	23	infection	infection	NN
cord-294854-rvrgcugn	79	24	in	in	IN
cord-294854-rvrgcugn	79	25	patients	patient	NNS
cord-294854-rvrgcugn	79	26	with	with	IN
cord-294854-rvrgcugn	79	27	autoimmune	autoimmune	JJ
cord-294854-rvrgcugn	79	28	diseases	disease	NNS
cord-294854-rvrgcugn	79	29	will	will	MD
cord-294854-rvrgcugn	79	30	be	be	VB
cord-294854-rvrgcugn	79	31	increased	increase	VBN
cord-294854-rvrgcugn	79	32	compared	compare	VBN
cord-294854-rvrgcugn	79	33	to	to	IN
cord-294854-rvrgcugn	79	34	the	the	DT
cord-294854-rvrgcugn	79	35	general	general	JJ
cord-294854-rvrgcugn	79	36	population	population	NN
cord-294854-rvrgcugn	79	37	.	.	.
cord-294854-rvrgcugn	80	1	Currently	currently	RB
cord-294854-rvrgcugn	80	2	,	,	,
cord-294854-rvrgcugn	80	3	rheumatology	rheumatology	NN
cord-294854-rvrgcugn	80	4	societies	society	NNS
cord-294854-rvrgcugn	80	5	66	66	CD
cord-294854-rvrgcugn	80	6	-	-	SYM
cord-294854-rvrgcugn	80	7	69	69	CD
cord-294854-rvrgcugn	80	8	recommend	recommend	VBP
cord-294854-rvrgcugn	80	9	the	the	DT
cord-294854-rvrgcugn	80	10	use	use	NN
cord-294854-rvrgcugn	80	11	of	of	IN
cord-294854-rvrgcugn	80	12	immunosuppressive	immunosuppressive	JJ
cord-294854-rvrgcugn	80	13	drugs	drug	NNS
cord-294854-rvrgcugn	80	14	(	(	-LRB-
cord-294854-rvrgcugn	80	15	except	except	IN
cord-294854-rvrgcugn	80	16	glucocorticoids	glucocorticoid	NNS
cord-294854-rvrgcugn	80	17	)	)	-RRB-
cord-294854-rvrgcugn	80	18	to	to	TO
cord-294854-rvrgcugn	80	19	be	be	VB
cord-294854-rvrgcugn	80	20	suspended	suspend	VBN
cord-294854-rvrgcugn	80	21	in	in	IN
cord-294854-rvrgcugn	80	22	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	80	23	patients	patient	NNS
cord-294854-rvrgcugn	80	24	.	.	.
cord-294854-rvrgcugn	81	1	MSCs	msc	NNS
cord-294854-rvrgcugn	81	2	have	have	VBP
cord-294854-rvrgcugn	81	3	a	a	DT
cord-294854-rvrgcugn	81	4	wide	wide	JJ
cord-294854-rvrgcugn	81	5	range	range	NN
cord-294854-rvrgcugn	81	6	of	of	IN
cord-294854-rvrgcugn	81	7	immune	immune	JJ
cord-294854-rvrgcugn	81	8	regulatory	regulatory	JJ
cord-294854-rvrgcugn	81	9	functions	function	NNS
cord-294854-rvrgcugn	81	10	and	and	CC
cord-294854-rvrgcugn	81	11	can	can	MD
cord-294854-rvrgcugn	81	12	inhibit	inhibit	VB
cord-294854-rvrgcugn	81	13	the	the	DT
cord-294854-rvrgcugn	81	14	abnormal	abnormal	JJ
cord-294854-rvrgcugn	81	15	activation	activation	NN
cord-294854-rvrgcugn	81	16	of	of	IN
cord-294854-rvrgcugn	81	17	T	T	NNP
cord-294854-rvrgcugn	81	18	lymphocytes	lymphocyte	NNS
cord-294854-rvrgcugn	81	19	and	and	CC
cord-294854-rvrgcugn	81	20	macrophages	macrophage	NNS
cord-294854-rvrgcugn	81	21	and	and	CC
cord-294854-rvrgcugn	81	22	the	the	DT
cord-294854-rvrgcugn	81	23	secretion	secretion	NN
cord-294854-rvrgcugn	81	24	of	of	IN
cord-294854-rvrgcugn	81	25	pro	pro	JJ
cord-294854-rvrgcugn	81	26	-	-	JJ
cord-294854-rvrgcugn	81	27	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	81	28	cytokines	cytokine	NNS
cord-294854-rvrgcugn	81	29	70	70	CD
cord-294854-rvrgcugn	81	30	.	.	.
cord-294854-rvrgcugn	82	1	MSC	MSC	NNP
cord-294854-rvrgcugn	82	2	therapy	therapy	NN
cord-294854-rvrgcugn	82	3	was	be	VBD
cord-294854-rvrgcugn	82	4	found	find	VBN
cord-294854-rvrgcugn	82	5	to	to	TO
cord-294854-rvrgcugn	82	6	significantly	significantly	RB
cord-294854-rvrgcugn	82	7	reduce	reduce	VB
cord-294854-rvrgcugn	82	8	the	the	DT
cord-294854-rvrgcugn	82	9	mortality	mortality	NN
cord-294854-rvrgcugn	82	10	of	of	IN
cord-294854-rvrgcugn	82	11	patients	patient	NNS
cord-294854-rvrgcugn	82	12	with	with	IN
cord-294854-rvrgcugn	82	13	H7N9-induced	H7N9-induced	NNP
cord-294854-rvrgcugn	82	14	ARDS	ARDS	NNP
cord-294854-rvrgcugn	82	15	and	and	CC
cord-294854-rvrgcugn	82	16	had	have	VBD
cord-294854-rvrgcugn	82	17	no	no	DT
cord-294854-rvrgcugn	82	18	harmful	harmful	JJ
cord-294854-rvrgcugn	82	19	side	side	NN
cord-294854-rvrgcugn	82	20	effects	effect	NNS
cord-294854-rvrgcugn	82	21	71	71	CD
cord-294854-rvrgcugn	82	22	.	.	.
cord-294854-rvrgcugn	83	1	A	a	DT
cord-294854-rvrgcugn	83	2	clinical	clinical	JJ
cord-294854-rvrgcugn	83	3	trial	trial	NN
cord-294854-rvrgcugn	83	4	of	of	IN
cord-294854-rvrgcugn	83	5	MSC	MSC	NNP
cord-294854-rvrgcugn	83	6	therapy	therapy	NN
cord-294854-rvrgcugn	83	7	revealed	reveal	VBD
cord-294854-rvrgcugn	83	8	that	that	IN
cord-294854-rvrgcugn	83	9	MSCs	msc	NNS
cord-294854-rvrgcugn	83	10	were	be	VBD
cord-294854-rvrgcugn	83	11	able	able	JJ
cord-294854-rvrgcugn	83	12	to	to	TO
cord-294854-rvrgcugn	83	13	rapidly	rapidly	RB
cord-294854-rvrgcugn	83	14	and	and	CC
cord-294854-rvrgcugn	83	15	significantly	significantly	RB
cord-294854-rvrgcugn	83	16	improve	improve	VB
cord-294854-rvrgcugn	83	17	the	the	DT
cord-294854-rvrgcugn	83	18	clinical	clinical	JJ
cord-294854-rvrgcugn	83	19	symptoms	symptom	NNS
cord-294854-rvrgcugn	83	20	of	of	IN
cord-294854-rvrgcugn	83	21	COVID-19	covid-19	NN
cord-294854-rvrgcugn	83	22	without	without	IN
cord-294854-rvrgcugn	83	23	any	any	DT
cord-294854-rvrgcugn	83	24	observed	observed	JJ
cord-294854-rvrgcugn	83	25	adverse	adverse	JJ
cord-294854-rvrgcugn	83	26	effects	effect	NNS
cord-294854-rvrgcugn	83	27	72	72	CD
cord-294854-rvrgcugn	83	28	.	.	.
cord-294854-rvrgcugn	84	1	Although	although	IN
cord-294854-rvrgcugn	84	2	side	side	JJ
cord-294854-rvrgcugn	84	3	effects	effect	NNS
cord-294854-rvrgcugn	84	4	of	of	IN
cord-294854-rvrgcugn	84	5	MSC	MSC	NNP
cord-294854-rvrgcugn	84	6	treatment	treatment	NN
cord-294854-rvrgcugn	84	7	are	be	VBP
cord-294854-rvrgcugn	84	8	rarely	rarely	RB
cord-294854-rvrgcugn	84	9	reported	report	VBN
cord-294854-rvrgcugn	84	10	,	,	,
cord-294854-rvrgcugn	84	11	the	the	DT
cord-294854-rvrgcugn	84	12	safety	safety	NN
cord-294854-rvrgcugn	84	13	and	and	CC
cord-294854-rvrgcugn	84	14	effectiveness	effectiveness	NN
cord-294854-rvrgcugn	84	15	of	of	IN
cord-294854-rvrgcugn	84	16	this	this	DT
cord-294854-rvrgcugn	84	17	treatment	treatment	NN
cord-294854-rvrgcugn	84	18	require	require	VBP
cord-294854-rvrgcugn	84	19	further	further	JJ
cord-294854-rvrgcugn	84	20	investigation	investigation	NN
cord-294854-rvrgcugn	84	21	.	.	.
cord-294854-rvrgcugn	85	1	Anakinra	Anakinra	NNP
cord-294854-rvrgcugn	85	2	,	,	,
cord-294854-rvrgcugn	85	3	an	an	DT
cord-294854-rvrgcugn	85	4	IL-1	IL-1	NNP
cord-294854-rvrgcugn	85	5	receptor	receptor	NN
cord-294854-rvrgcugn	85	6	antagonist	antagonist	NN
cord-294854-rvrgcugn	85	7	that	that	WDT
cord-294854-rvrgcugn	85	8	blocks	block	VBZ
cord-294854-rvrgcugn	85	9	the	the	DT
cord-294854-rvrgcugn	85	10	activity	activity	NN
cord-294854-rvrgcugn	85	11	of	of	IN
cord-294854-rvrgcugn	85	12	pro	pro	JJ
cord-294854-rvrgcugn	85	13	-	-	JJ
cord-294854-rvrgcugn	85	14	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	85	15	cytokines	cytokine	NNS
cord-294854-rvrgcugn	85	16	IL-1α	il-1α	NN
cord-294854-rvrgcugn	85	17	and	and	CC
cord-294854-rvrgcugn	85	18	IL-1β	IL-1β	NNP
cord-294854-rvrgcugn	85	19	,	,	,
cord-294854-rvrgcugn	85	20	has	have	VBZ
cord-294854-rvrgcugn	85	21	been	be	VBN
cord-294854-rvrgcugn	85	22	reported	report	VBN
cord-294854-rvrgcugn	85	23	to	to	TO
cord-294854-rvrgcugn	85	24	improve	improve	VB
cord-294854-rvrgcugn	85	25	respiratory	respiratory	JJ
cord-294854-rvrgcugn	85	26	function	function	NN
cord-294854-rvrgcugn	85	27	and	and	CC
cord-294854-rvrgcugn	85	28	increase	increase	VB
cord-294854-rvrgcugn	85	29	the	the	DT
cord-294854-rvrgcugn	85	30	survival	survival	NN
cord-294854-rvrgcugn	85	31	rate	rate	NN
cord-294854-rvrgcugn	85	32	of	of	IN
cord-294854-rvrgcugn	85	33	COVID-19	covid-19	CD
cord-294854-rvrgcugn	85	34	patients	patient	NNS
cord-294854-rvrgcugn	85	35	73	73	CD
cord-294854-rvrgcugn	85	36	.	.	.
cord-294854-rvrgcugn	86	1	IL-1	IL-1	NNP
cord-294854-rvrgcugn	87	1	receptor	receptor	NN
cord-294854-rvrgcugn	87	2	antagonists	antagonist	NNS
cord-294854-rvrgcugn	87	3	increase	increase	VBP
cord-294854-rvrgcugn	87	4	the	the	DT
cord-294854-rvrgcugn	87	5	risk	risk	NN
cord-294854-rvrgcugn	87	6	of	of	IN
cord-294854-rvrgcugn	87	7	bacterial	bacterial	JJ
cord-294854-rvrgcugn	87	8	infections	infection	NNS
cord-294854-rvrgcugn	87	9	,	,	,
cord-294854-rvrgcugn	87	10	but	but	CC
cord-294854-rvrgcugn	87	11	this	this	DT
cord-294854-rvrgcugn	87	12	is	be	VBZ
cord-294854-rvrgcugn	87	13	extremely	extremely	RB
cord-294854-rvrgcugn	87	14	rare	rare	JJ
cord-294854-rvrgcugn	87	15	for	for	IN
cord-294854-rvrgcugn	87	16	anakinra	anakinra	NNP
cord-294854-rvrgcugn	87	17	65	65	CD
cord-294854-rvrgcugn	87	18	.	.	.
cord-294854-rvrgcugn	88	1	Janus	Janus	NNP
cord-294854-rvrgcugn	88	2	kinase	kinase	NN
cord-294854-rvrgcugn	88	3	(	(	-LRB-
cord-294854-rvrgcugn	88	4	JAK	JAK	NNP
cord-294854-rvrgcugn	88	5	)	)	-RRB-
cord-294854-rvrgcugn	88	6	inhibitors	inhibitor	NNS
cord-294854-rvrgcugn	88	7	can	can	MD
cord-294854-rvrgcugn	88	8	inhibit	inhibit	VB
cord-294854-rvrgcugn	88	9	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	88	10	cytokines	cytokine	NNS
cord-294854-rvrgcugn	88	11	and	and	CC
cord-294854-rvrgcugn	88	12	reduce	reduce	VB
cord-294854-rvrgcugn	88	13	the	the	DT
cord-294854-rvrgcugn	88	14	ability	ability	NN
cord-294854-rvrgcugn	88	15	of	of	IN
cord-294854-rvrgcugn	88	16	viruses	virus	NNS
cord-294854-rvrgcugn	88	17	to	to	TO
cord-294854-rvrgcugn	88	18	infect	infect	VB
cord-294854-rvrgcugn	88	19	cells	cell	NNS
cord-294854-rvrgcugn	88	20	74	74	CD
cord-294854-rvrgcugn	88	21	Table	table	NN
cord-294854-rvrgcugn	88	22	3	3	CD
cord-294854-rvrgcugn	88	23	.	.	.
cord-294854-rvrgcugn	89	1	The	the	DT
cord-294854-rvrgcugn	89	2	cytokine	cytokine	NN
cord-294854-rvrgcugn	89	3	storm	storm	NN
cord-294854-rvrgcugn	89	4	leads	lead	VBZ
cord-294854-rvrgcugn	89	5	to	to	IN
cord-294854-rvrgcugn	89	6	deleterious	deleterious	JJ
cord-294854-rvrgcugn	89	7	clinical	clinical	JJ
cord-294854-rvrgcugn	89	8	manifestations	manifestation	NNS
cord-294854-rvrgcugn	89	9	or	or	CC
cord-294854-rvrgcugn	89	10	even	even	RB
cord-294854-rvrgcugn	89	11	acute	acute	JJ
cord-294854-rvrgcugn	89	12	mortality	mortality	NN
cord-294854-rvrgcugn	89	13	in	in	IN
cord-294854-rvrgcugn	89	14	critically	critically	RB
cord-294854-rvrgcugn	89	15	ill	ill	JJ
cord-294854-rvrgcugn	89	16	patients	patient	NNS
cord-294854-rvrgcugn	89	17	with	with	IN
cord-294854-rvrgcugn	89	18	COVD-19	COVD-19	NNP
cord-294854-rvrgcugn	89	19	.	.	.
cord-294854-rvrgcugn	90	1	Impaired	impair	VBN
cord-294854-rvrgcugn	90	2	acquired	acquire	VBN
cord-294854-rvrgcugn	90	3	immune	immune	JJ
cord-294854-rvrgcugn	91	1	This	this	DT
cord-294854-rvrgcugn	91	2	article	article	NN
cord-294854-rvrgcugn	91	3	is	be	VBZ
cord-294854-rvrgcugn	91	4	protected	protect	VBN
cord-294854-rvrgcugn	91	5	by	by	IN
cord-294854-rvrgcugn	91	6	copyright	copyright	NN
cord-294854-rvrgcugn	91	7	.	.	.
cord-294854-rvrgcugn	92	1	All	all	DT
cord-294854-rvrgcugn	92	2	rights	right	NNS
cord-294854-rvrgcugn	92	3	reserved	reserve	VBN
cord-294854-rvrgcugn	92	4	.	.	.
cord-294854-rvrgcugn	93	1	responses	response	NNS
cord-294854-rvrgcugn	93	2	and	and	CC
cord-294854-rvrgcugn	93	3	uncontrolled	uncontrolled	JJ
cord-294854-rvrgcugn	93	4	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	93	5	innate	innate	JJ
cord-294854-rvrgcugn	93	6	responses	response	NNS
cord-294854-rvrgcugn	93	7	may	may	MD
cord-294854-rvrgcugn	93	8	be	be	VB
cord-294854-rvrgcugn	93	9	associated	associate	VBN
cord-294854-rvrgcugn	93	10	with	with	IN
cord-294854-rvrgcugn	93	11	the	the	DT
cord-294854-rvrgcugn	93	12	mechanism	mechanism	NN
cord-294854-rvrgcugn	93	13	of	of	IN
cord-294854-rvrgcugn	93	14	the	the	DT
cord-294854-rvrgcugn	93	15	cytokine	cytokine	NN
cord-294854-rvrgcugn	93	16	storm	storm	NN
cord-294854-rvrgcugn	93	17	in	in	IN
cord-294854-rvrgcugn	93	18	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	93	19	.	.	.
cord-294854-rvrgcugn	94	1	Early	early	JJ
cord-294854-rvrgcugn	94	2	control	control	NN
cord-294854-rvrgcugn	94	3	of	of	IN
cord-294854-rvrgcugn	94	4	the	the	DT
cord-294854-rvrgcugn	94	5	cytokine	cytokine	NN
cord-294854-rvrgcugn	94	6	storm	storm	NN
cord-294854-rvrgcugn	94	7	through	through	IN
cord-294854-rvrgcugn	94	8	therapies	therapy	NNS
cord-294854-rvrgcugn	94	9	such	such	JJ
cord-294854-rvrgcugn	94	10	as	as	IN
cord-294854-rvrgcugn	94	11	immunomodulators	immunomodulator	NNS
cord-294854-rvrgcugn	94	12	and	and	CC
cord-294854-rvrgcugn	94	13	cytokine	cytokine	NN
cord-294854-rvrgcugn	94	14	antagonists	antagonist	NNS
cord-294854-rvrgcugn	94	15	is	be	VBZ
cord-294854-rvrgcugn	94	16	essential	essential	JJ
cord-294854-rvrgcugn	94	17	to	to	TO
cord-294854-rvrgcugn	94	18	improve	improve	VB
cord-294854-rvrgcugn	94	19	the	the	DT
cord-294854-rvrgcugn	94	20	survival	survival	NN
cord-294854-rvrgcugn	94	21	rate	rate	NN
cord-294854-rvrgcugn	94	22	of	of	IN
cord-294854-rvrgcugn	94	23	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	94	24	patients	patient	NNS
cord-294854-rvrgcugn	94	25	.	.	.
cord-294854-rvrgcugn	95	1	Although	although	IN
cord-294854-rvrgcugn	95	2	many	many	JJ
cord-294854-rvrgcugn	95	3	research	research	NN
cord-294854-rvrgcugn	95	4	articles	article	NNS
cord-294854-rvrgcugn	95	5	are	be	VBP
cord-294854-rvrgcugn	95	6	published	publish	VBN
cord-294854-rvrgcugn	95	7	each	each	DT
cord-294854-rvrgcugn	95	8	month	month	NN
cord-294854-rvrgcugn	95	9	,	,	,
cord-294854-rvrgcugn	95	10	majority	majority	NN
cord-294854-rvrgcugn	95	11	of	of	IN
cord-294854-rvrgcugn	95	12	the	the	DT
cord-294854-rvrgcugn	95	13	existing	exist	VBG
cord-294854-rvrgcugn	95	14	literature	literature	NN
cord-294854-rvrgcugn	95	15	about	about	IN
cord-294854-rvrgcugn	95	16	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	95	17	comes	come	VBZ
cord-294854-rvrgcugn	95	18	from	from	IN
cord-294854-rvrgcugn	95	19	descriptive	descriptive	JJ
cord-294854-rvrgcugn	95	20	works	work	NNS
cord-294854-rvrgcugn	95	21	.	.	.
cord-294854-rvrgcugn	96	1	Additionally	additionally	RB
cord-294854-rvrgcugn	96	2	,	,	,
cord-294854-rvrgcugn	96	3	high	high	JJ
cord-294854-rvrgcugn	96	4	-	-	HYPH
cord-294854-rvrgcugn	96	5	quality	quality	NN
cord-294854-rvrgcugn	96	6	evidence	evidence	NN
cord-294854-rvrgcugn	96	7	will	will	MD
cord-294854-rvrgcugn	96	8	be	be	VB
cord-294854-rvrgcugn	96	9	necessary	necessary	JJ
cord-294854-rvrgcugn	96	10	to	to	TO
cord-294854-rvrgcugn	96	11	understand	understand	VB
cord-294854-rvrgcugn	96	12	and	and	CC
cord-294854-rvrgcugn	96	13	treat	treat	VB
cord-294854-rvrgcugn	96	14	the	the	DT
cord-294854-rvrgcugn	96	15	cytokine	cytokine	NN
cord-294854-rvrgcugn	96	16	storm	storm	NN
cord-294854-rvrgcugn	96	17	of	of	IN
cord-294854-rvrgcugn	96	18	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	96	19	.	.	.
cord-294854-rvrgcugn	96	20	 	 	_SP
cord-294854-rvrgcugn	97	1	Potential	potential	JJ
cord-294854-rvrgcugn	97	2	for	for	IN
cord-294854-rvrgcugn	97	3	global	global	JJ
cord-294854-rvrgcugn	97	4	spread	spread	NN
cord-294854-rvrgcugn	97	5	of	of	IN
cord-294854-rvrgcugn	97	6	a	a	DT
cord-294854-rvrgcugn	97	7	novel	novel	JJ
cord-294854-rvrgcugn	97	8	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	97	9	from	from	IN
cord-294854-rvrgcugn	97	10	China	China	NNP
cord-294854-rvrgcugn	97	11	Clinical	clinical	JJ
cord-294854-rvrgcugn	97	12	features	feature	NNS
cord-294854-rvrgcugn	97	13	of	of	IN
cord-294854-rvrgcugn	97	14	patients	patient	NNS
cord-294854-rvrgcugn	97	15	infected	infect	VBN
cord-294854-rvrgcugn	97	16	with	with	IN
cord-294854-rvrgcugn	97	17	2019	2019	CD
cord-294854-rvrgcugn	97	18	novel	novel	JJ
cord-294854-rvrgcugn	97	19	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	97	20	in	in	IN
cord-294854-rvrgcugn	97	21	Wuhan	Wuhan	NNP
cord-294854-rvrgcugn	98	1	An	an	DT
cord-294854-rvrgcugn	98	2	interferon	interferon	NN
cord-294854-rvrgcugn	98	3	-	-	HYPH
cord-294854-rvrgcugn	98	4	gamma	gamma	NN
cord-294854-rvrgcugn	98	5	-	-	HYPH
cord-294854-rvrgcugn	98	6	related	relate	VBN
cord-294854-rvrgcugn	98	7	cytokine	cytokine	NN
cord-294854-rvrgcugn	98	8	storm	storm	NN
cord-294854-rvrgcugn	98	9	in	in	IN
cord-294854-rvrgcugn	98	10	SARS	SARS	NNP
cord-294854-rvrgcugn	98	11	patients	patient	NNS
cord-294854-rvrgcugn	98	12	Active	active	JJ
cord-294854-rvrgcugn	98	13	replication	replication	NN
cord-294854-rvrgcugn	98	14	of	of	IN
cord-294854-rvrgcugn	98	15	Middle	Middle	NNP
cord-294854-rvrgcugn	98	16	East	East	NNP
cord-294854-rvrgcugn	98	17	respiratory	respiratory	JJ
cord-294854-rvrgcugn	98	18	syndrome	syndrome	NN
cord-294854-rvrgcugn	98	19	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	98	20	and	and	CC
cord-294854-rvrgcugn	98	21	aberrant	aberrant	JJ
cord-294854-rvrgcugn	98	22	induction	induction	NN
cord-294854-rvrgcugn	98	23	of	of	IN
cord-294854-rvrgcugn	98	24	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	98	25	cytokines	cytokine	NNS
cord-294854-rvrgcugn	98	26	and	and	CC
cord-294854-rvrgcugn	98	27	chemokines	chemokine	NNS
cord-294854-rvrgcugn	98	28	in	in	IN
cord-294854-rvrgcugn	98	29	human	human	JJ
cord-294854-rvrgcugn	98	30	macrophages	macrophage	NNS
cord-294854-rvrgcugn	98	31	:	:	:
cord-294854-rvrgcugn	98	32	implications	implication	NNS
cord-294854-rvrgcugn	98	33	for	for	IN
cord-294854-rvrgcugn	98	34	pathogenesis	pathogenesis	NN
cord-294854-rvrgcugn	98	35	COVID-19	covid-19	NN
cord-294854-rvrgcugn	98	36	:	:	:
cord-294854-rvrgcugn	98	37	consider	consider	VB
cord-294854-rvrgcugn	98	38	cytokine	cytokine	JJ
cord-294854-rvrgcugn	98	39	storm	storm	NN
cord-294854-rvrgcugn	98	40	syndromes	syndrome	NNS
cord-294854-rvrgcugn	98	41	and	and	CC
cord-294854-rvrgcugn	98	42	immunosuppression	immunosuppression	NN
cord-294854-rvrgcugn	98	43	Chapter	chapter	NN
cord-294854-rvrgcugn	98	44	Eight	eight	CD
cord-294854-rvrgcugn	99	1	-Hosts	-host	NNS
cord-294854-rvrgcugn	100	1	and	and	CC
cord-294854-rvrgcugn	100	2	Sources	source	NNS
cord-294854-rvrgcugn	100	3	of	of	IN
cord-294854-rvrgcugn	100	4	Endemic	Endemic	NNP
cord-294854-rvrgcugn	100	5	Human	Human	NNP
cord-294854-rvrgcugn	100	6	Coronaviruses	Coronaviruses	NNPS
cord-294854-rvrgcugn	100	7	Coronaviridae	Coronaviridae	NNP
cord-294854-rvrgcugn	100	8	Study	Study	NNP
cord-294854-rvrgcugn	100	9	Group	Group	NNP
cord-294854-rvrgcugn	100	10	of	of	IN
cord-294854-rvrgcugn	100	11	the	the	DT
cord-294854-rvrgcugn	100	12	International	International	NNP
cord-294854-rvrgcugn	100	13	Committee	Committee	NNP
cord-294854-rvrgcugn	100	14	on	on	IN
cord-294854-rvrgcugn	100	15	Taxonomy	Taxonomy	NNP
cord-294854-rvrgcugn	100	16	of	of	IN
cord-294854-rvrgcugn	100	17	Viruses	Viruses	NNPS
cord-294854-rvrgcugn	100	18	.	.	.
cord-294854-rvrgcugn	101	1	The	the	DT
cord-294854-rvrgcugn	101	2	species	specie	NNS
cord-294854-rvrgcugn	101	3	Severe	severe	JJ
cord-294854-rvrgcugn	101	4	acute	acute	JJ
cord-294854-rvrgcugn	101	5	respiratory	respiratory	JJ
cord-294854-rvrgcugn	101	6	syndrome	syndrome	NN
cord-294854-rvrgcugn	101	7	-	-	HYPH
cord-294854-rvrgcugn	101	8	related	relate	VBN
cord-294854-rvrgcugn	101	9	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	101	10	:	:	:
cord-294854-rvrgcugn	101	11	classifying	classify	VBG
cord-294854-rvrgcugn	101	12	2019-nCoV	2019-ncov	CD
cord-294854-rvrgcugn	101	13	and	and	CC
cord-294854-rvrgcugn	101	14	naming	name	VBG
cord-294854-rvrgcugn	101	15	it	-PRON-	PRP
cord-294854-rvrgcugn	101	16	SARS	SARS	NNP
cord-294854-rvrgcugn	101	17	-	-	HYPH
cord-294854-rvrgcugn	101	18	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	101	19	Genomic	genomic	JJ
cord-294854-rvrgcugn	101	20	characterisation	characterisation	NN
cord-294854-rvrgcugn	101	21	and	and	CC
cord-294854-rvrgcugn	101	22	epidemiology	epidemiology	NN
cord-294854-rvrgcugn	101	23	of	of	IN
cord-294854-rvrgcugn	101	24	2019	2019	CD
cord-294854-rvrgcugn	101	25	novel	novel	JJ
cord-294854-rvrgcugn	101	26	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	101	27	:	:	:
cord-294854-rvrgcugn	101	28	implications	implication	NNS
cord-294854-rvrgcugn	101	29	for	for	IN
cord-294854-rvrgcugn	101	30	virus	virus	NN
cord-294854-rvrgcugn	101	31	origins	origin	NNS
cord-294854-rvrgcugn	101	32	and	and	CC
cord-294854-rvrgcugn	101	33	receptor	receptor	NN
cord-294854-rvrgcugn	101	34	binding	bind	VBG
cord-294854-rvrgcugn	101	35	A	a	DT
cord-294854-rvrgcugn	101	36	pneumonia	pneumonia	NN
cord-294854-rvrgcugn	101	37	outbreak	outbreak	NN
cord-294854-rvrgcugn	101	38	associated	associate	VBN
cord-294854-rvrgcugn	101	39	with	with	IN
cord-294854-rvrgcugn	101	40	a	a	DT
cord-294854-rvrgcugn	101	41	new	new	JJ
cord-294854-rvrgcugn	101	42	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	101	43	of	of	IN
cord-294854-rvrgcugn	101	44	probable	probable	JJ
cord-294854-rvrgcugn	101	45	bat	bat	NN
cord-294854-rvrgcugn	101	46	origin	origin	NN
cord-294854-rvrgcugn	101	47	World	World	NNP
cord-294854-rvrgcugn	101	48	Health	Health	NNP
cord-294854-rvrgcugn	101	49	Organization	Organization	NNP
cord-294854-rvrgcugn	101	50	W.	W.	NNP
cord-294854-rvrgcugn	101	51	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	101	52	disease	disease	NN
cord-294854-rvrgcugn	101	53	(	(	-LRB-
cord-294854-rvrgcugn	101	54	COVID-19)Situation	COVID-19)Situation	NNP
cord-294854-rvrgcugn	101	55	Report	Report	NNP
cord-294854-rvrgcugn	101	56	-112	-112	NNP
cord-294854-rvrgcugn	101	57	Genetic	Genetic	NNP
cord-294854-rvrgcugn	101	58	Recombination	Recombination	NNP
cord-294854-rvrgcugn	101	59	,	,	,
cord-294854-rvrgcugn	101	60	and	and	CC
cord-294854-rvrgcugn	101	61	Pathogenesis	Pathogenesis	NNP
cord-294854-rvrgcugn	101	62	of	of	IN
cord-294854-rvrgcugn	101	63	Coronaviruses	Coronaviruses	NNP
cord-294854-rvrgcugn	101	64	Report	Report	NNP
cord-294854-rvrgcugn	101	65	of	of	IN
cord-294854-rvrgcugn	101	66	the	the	DT
cord-294854-rvrgcugn	101	67	WHO	WHO	NNP
cord-294854-rvrgcugn	101	68	-	-	HYPH
cord-294854-rvrgcugn	101	69	China	China	NNP
cord-294854-rvrgcugn	101	70	joint	joint	JJ
cord-294854-rvrgcugn	101	71	mission	mission	NN
cord-294854-rvrgcugn	101	72	on	on	IN
cord-294854-rvrgcugn	101	73	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	101	74	disease	disease	NN
cord-294854-rvrgcugn	101	75	2019	2019	CD
cord-294854-rvrgcugn	101	76	(	(	-LRB-
cord-294854-rvrgcugn	102	1	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	102	2	)	)	-RRB-
cord-294854-rvrgcugn	102	3	2020	2020	CD
cord-294854-rvrgcugn	102	4	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	102	5	,	,	,
cord-294854-rvrgcugn	102	6	SARS	SARS	NNP
cord-294854-rvrgcugn	102	7	and	and	CC
cord-294854-rvrgcugn	102	8	MERS	MERS	NNP
cord-294854-rvrgcugn	102	9	:	:	:
cord-294854-rvrgcugn	102	10	are	be	VBP
cord-294854-rvrgcugn	102	11	they	-PRON-	PRP
cord-294854-rvrgcugn	102	12	closely	closely	RB
cord-294854-rvrgcugn	102	13	related	relate	VBN
cord-294854-rvrgcugn	102	14	?	?	.
cord-294854-rvrgcugn	103	1	Origin	origin	NN
cord-294854-rvrgcugn	103	2	and	and	CC
cord-294854-rvrgcugn	103	3	evolution	evolution	NN
cord-294854-rvrgcugn	103	4	of	of	IN
cord-294854-rvrgcugn	103	5	pathogenic	pathogenic	JJ
cord-294854-rvrgcugn	103	6	coronaviruses	coronaviruse	NNS
cord-294854-rvrgcugn	104	1	The	the	DT
cord-294854-rvrgcugn	104	2	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	104	3	Pandemic	Pandemic	NNP
cord-294854-rvrgcugn	104	4	:	:	:
cord-294854-rvrgcugn	105	1	A	a	DT
cord-294854-rvrgcugn	105	2	Comprehensive	Comprehensive	NNP
cord-294854-rvrgcugn	105	3	Review	Review	NNP
cord-294854-rvrgcugn	105	4	of	of	IN
cord-294854-rvrgcugn	105	5	Coronaviruses	Coronaviruses	NNP
cord-294854-rvrgcugn	105	6	-drug	-drug	NNP
cord-294854-rvrgcugn	105	7	discovery	discovery	NN
cord-294854-rvrgcugn	105	8	and	and	CC
cord-294854-rvrgcugn	105	9	therapeutic	therapeutic	JJ
cord-294854-rvrgcugn	105	10	options	option	NNS
cord-294854-rvrgcugn	105	11	Pathogenic	pathogenic	JJ
cord-294854-rvrgcugn	105	12	human	human	JJ
cord-294854-rvrgcugn	105	13	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	105	14	infections	infection	NNS
cord-294854-rvrgcugn	105	15	:	:	:
cord-294854-rvrgcugn	105	16	causes	cause	NNS
cord-294854-rvrgcugn	105	17	and	and	CC
cord-294854-rvrgcugn	105	18	consequences	consequence	NNS
cord-294854-rvrgcugn	105	19	of	of	IN
cord-294854-rvrgcugn	105	20	cytokine	cytokine	NN
cord-294854-rvrgcugn	105	21	storm	storm	NN
cord-294854-rvrgcugn	105	22	and	and	CC
cord-294854-rvrgcugn	105	23	immunopathology	immunopathology	VBG
cord-294854-rvrgcugn	105	24	Clinical	clinical	JJ
cord-294854-rvrgcugn	105	25	Characteristics	Characteristics	NNPS
cord-294854-rvrgcugn	105	26	of	of	IN
cord-294854-rvrgcugn	105	27	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	105	28	Disease	Disease	NNP
cord-294854-rvrgcugn	105	29	2019	2019	CD
cord-294854-rvrgcugn	105	30	in	in	IN
cord-294854-rvrgcugn	105	31	China	China	NNP
cord-294854-rvrgcugn	105	32	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	105	33	with	with	IN
cord-294854-rvrgcugn	105	34	Different	different	JJ
cord-294854-rvrgcugn	105	35	Severity	severity	NN
cord-294854-rvrgcugn	105	36	:	:	:
cord-294854-rvrgcugn	105	37	A	a	DT
cord-294854-rvrgcugn	105	38	Multi	multi	JJ
cord-294854-rvrgcugn	105	39	-	-	JJ
cord-294854-rvrgcugn	105	40	center	center	JJ
cord-294854-rvrgcugn	105	41	Study	Study	NNP
cord-294854-rvrgcugn	105	42	of	of	IN
cord-294854-rvrgcugn	105	43	Clinical	Clinical	NNP
cord-294854-rvrgcugn	105	44	Features	Features	NNPS
cord-294854-rvrgcugn	105	45	Mapping	map	VBG
cord-294854-rvrgcugn	105	46	the	the	DT
cord-294854-rvrgcugn	105	47	innate	innate	JJ
cord-294854-rvrgcugn	105	48	signaling	signal	VBG
cord-294854-rvrgcugn	105	49	cascade	cascade	NN
cord-294854-rvrgcugn	105	50	essential	essential	NN
cord-294854-rvrgcugn	105	51	for	for	IN
cord-294854-rvrgcugn	105	52	cytokine	cytokine	JJ
cord-294854-rvrgcugn	105	53	storm	storm	NN
cord-294854-rvrgcugn	105	54	during	during	IN
cord-294854-rvrgcugn	105	55	influenza	influenza	NN
cord-294854-rvrgcugn	105	56	virus	virus	NN
cord-294854-rvrgcugn	105	57	infection	infection	NN
cord-294854-rvrgcugn	105	58	Pathological	pathological	JJ
cord-294854-rvrgcugn	105	59	inflammation	inflammation	NN
cord-294854-rvrgcugn	105	60	in	in	IN
cord-294854-rvrgcugn	105	61	patients	patient	NNS
cord-294854-rvrgcugn	105	62	with	with	IN
cord-294854-rvrgcugn	105	63	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	105	64	:	:	:
cord-294854-rvrgcugn	105	65	a	a	DT
cord-294854-rvrgcugn	105	66	key	key	JJ
cord-294854-rvrgcugn	105	67	role	role	NN
cord-294854-rvrgcugn	105	68	for	for	IN
cord-294854-rvrgcugn	105	69	monocytes	monocyte	NNS
cord-294854-rvrgcugn	105	70	and	and	CC
cord-294854-rvrgcugn	105	71	macrophages	macrophage	NNS
cord-294854-rvrgcugn	105	72	Analysis	Analysis	NNP
cord-294854-rvrgcugn	105	73	of	of	IN
cord-294854-rvrgcugn	105	74	the	the	DT
cord-294854-rvrgcugn	105	75	mutation	mutation	NN
cord-294854-rvrgcugn	105	76	dynamics	dynamic	NNS
cord-294854-rvrgcugn	105	77	of	of	IN
cord-294854-rvrgcugn	105	78	SARS	SARS	NNP
cord-294854-rvrgcugn	105	79	-	-	HYPH
cord-294854-rvrgcugn	105	80	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	105	81	reveals	reveal	VBZ
cord-294854-rvrgcugn	105	82	the	the	DT
cord-294854-rvrgcugn	105	83	spread	spread	NN
cord-294854-rvrgcugn	105	84	history	history	NN
cord-294854-rvrgcugn	105	85	and	and	CC
cord-294854-rvrgcugn	105	86	emergence	emergence	NN
cord-294854-rvrgcugn	105	87	of	of	IN
cord-294854-rvrgcugn	105	88	RBD	RBD	NNP
cord-294854-rvrgcugn	105	89	mutant	mutant	JJ
cord-294854-rvrgcugn	105	90	with	with	IN
cord-294854-rvrgcugn	105	91	lower	low	JJR
cord-294854-rvrgcugn	105	92	ACE2	ACE2	NNP
cord-294854-rvrgcugn	105	93	binding	bind	VBG
cord-294854-rvrgcugn	105	94	affinity	affinity	NN
cord-294854-rvrgcugn	105	95	Phylogenetic	Phylogenetic	NNP
cord-294854-rvrgcugn	105	96	network	network	NN
cord-294854-rvrgcugn	105	97	analysis	analysis	NN
cord-294854-rvrgcugn	105	98	of	of	IN
cord-294854-rvrgcugn	105	99	SARS	SARS	NNP
cord-294854-rvrgcugn	105	100	-	-	HYPH
cord-294854-rvrgcugn	105	101	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	105	102	genomes	genome	NNS
cord-294854-rvrgcugn	105	103	Patient	patient	NN
cord-294854-rvrgcugn	105	104	-	-	HYPH
cord-294854-rvrgcugn	105	105	derived	derive	VBN
cord-294854-rvrgcugn	105	106	mutations	mutation	NNS
cord-294854-rvrgcugn	105	107	impact	impact	NN
cord-294854-rvrgcugn	105	108	pathogenicity	pathogenicity	NN
cord-294854-rvrgcugn	105	109	of	of	IN
cord-294854-rvrgcugn	105	110	SARS	SARS	NNP
cord-294854-rvrgcugn	105	111	-	-	HYPH
cord-294854-rvrgcugn	105	112	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	105	113	Pathological	pathological	JJ
cord-294854-rvrgcugn	105	114	findings	finding	NNS
cord-294854-rvrgcugn	105	115	of	of	IN
cord-294854-rvrgcugn	105	116	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	105	117	associated	associate	VBN
cord-294854-rvrgcugn	105	118	with	with	IN
cord-294854-rvrgcugn	105	119	acute	acute	JJ
cord-294854-rvrgcugn	105	120	respiratory	respiratory	JJ
cord-294854-rvrgcugn	105	121	distress	distress	NN
cord-294854-rvrgcugn	105	122	syndrome	syndrome	NN
cord-294854-rvrgcugn	106	1	Pathological	pathological	JJ
cord-294854-rvrgcugn	106	2	evidence	evidence	NN
cord-294854-rvrgcugn	106	3	for	for	IN
cord-294854-rvrgcugn	106	4	residual	residual	JJ
cord-294854-rvrgcugn	106	5	SARS	SARS	NNP
cord-294854-rvrgcugn	106	6	-	-	HYPH
cord-294854-rvrgcugn	106	7	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	106	8	in	in	IN
cord-294854-rvrgcugn	106	9	pulmonary	pulmonary	JJ
cord-294854-rvrgcugn	106	10	tissues	tissue	NNS
cord-294854-rvrgcugn	106	11	of	of	IN
cord-294854-rvrgcugn	106	12	a	a	DT
cord-294854-rvrgcugn	106	13	ready	ready	JJ
cord-294854-rvrgcugn	106	14	-	-	HYPH
cord-294854-rvrgcugn	106	15	for	for	IN
cord-294854-rvrgcugn	106	16	-	-	HYPH
cord-294854-rvrgcugn	106	17	discharge	discharge	NN
cord-294854-rvrgcugn	106	18	patient	patient	NN
cord-294854-rvrgcugn	106	19	SARS	SARS	NNP
cord-294854-rvrgcugn	106	20	-	-	HYPH
cord-294854-rvrgcugn	106	21	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	106	22	and	and	CC
cord-294854-rvrgcugn	106	23	viral	viral	JJ
cord-294854-rvrgcugn	106	24	sepsis	sepsis	NN
cord-294854-rvrgcugn	106	25	:	:	:
cord-294854-rvrgcugn	107	1	observations	observation	NNS
cord-294854-rvrgcugn	107	2	and	and	CC
cord-294854-rvrgcugn	107	3	hypotheses	hypothesis	NNS
cord-294854-rvrgcugn	108	1	Histopathologic	Histopathologic	NNP
cord-294854-rvrgcugn	108	2	Changes	Changes	NNPS
cord-294854-rvrgcugn	108	3	and	and	CC
cord-294854-rvrgcugn	108	4	SARS	SARS	NNP
cord-294854-rvrgcugn	108	5	-	-	HYPH
cord-294854-rvrgcugn	108	6	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	109	1	Immunostaining	immunostaine	VBG
cord-294854-rvrgcugn	109	2	in	in	IN
cord-294854-rvrgcugn	109	3	the	the	DT
cord-294854-rvrgcugn	109	4	Lung	Lung	NNP
cord-294854-rvrgcugn	109	5	of	of	IN
cord-294854-rvrgcugn	109	6	a	a	DT
cord-294854-rvrgcugn	109	7	Patient	patient	NN
cord-294854-rvrgcugn	109	8	With	with	IN
cord-294854-rvrgcugn	110	1	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	110	2	Immune	Immune	NNP
cord-294854-rvrgcugn	110	3	response	response	NN
cord-294854-rvrgcugn	110	4	to	to	IN
cord-294854-rvrgcugn	110	5	SARS	SARS	NNP
cord-294854-rvrgcugn	110	6	-	-	HYPH
cord-294854-rvrgcugn	110	7	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	110	8	and	and	CC
cord-294854-rvrgcugn	110	9	mechanisms	mechanism	NNS
cord-294854-rvrgcugn	110	10	of	of	IN
cord-294854-rvrgcugn	110	11	immunopathological	immunopathological	JJ
cord-294854-rvrgcugn	110	12	changes	change	NNS
cord-294854-rvrgcugn	110	13	in	in	IN
cord-294854-rvrgcugn	110	14	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	110	15	The	the	DT
cord-294854-rvrgcugn	110	16	clinical	clinical	JJ
cord-294854-rvrgcugn	110	17	pathology	pathology	NN
cord-294854-rvrgcugn	110	18	of	of	IN
cord-294854-rvrgcugn	110	19	severe	severe	JJ
cord-294854-rvrgcugn	110	20	acute	acute	JJ
cord-294854-rvrgcugn	110	21	respiratory	respiratory	JJ
cord-294854-rvrgcugn	110	22	syndrome	syndrome	NN
cord-294854-rvrgcugn	110	23	(	(	-LRB-
cord-294854-rvrgcugn	110	24	SARS	SARS	NNP
cord-294854-rvrgcugn	110	25	)	)	-RRB-
cord-294854-rvrgcugn	110	26	:	:	:
cord-294854-rvrgcugn	111	1	a	a	DT
cord-294854-rvrgcugn	111	2	report	report	NN
cord-294854-rvrgcugn	111	3	from	from	IN
cord-294854-rvrgcugn	111	4	Immunohistochemical	Immunohistochemical	NNP
cord-294854-rvrgcugn	111	5	,	,	,
cord-294854-rvrgcugn	111	6	and	and	CC
cord-294854-rvrgcugn	111	7	Ultrastructural	Ultrastructural	NNP
cord-294854-rvrgcugn	111	8	Findings	Findings	NNPS
cord-294854-rvrgcugn	111	9	of	of	IN
cord-294854-rvrgcugn	111	10	a	a	DT
cord-294854-rvrgcugn	111	11	Fatal	Fatal	NNP
cord-294854-rvrgcugn	111	12	Case	Case	NNP
cord-294854-rvrgcugn	111	13	of	of	IN
cord-294854-rvrgcugn	111	14	Middle	Middle	NNP
cord-294854-rvrgcugn	111	15	East	East	NNP
cord-294854-rvrgcugn	111	16	Respiratory	Respiratory	NNP
cord-294854-rvrgcugn	111	17	Syndrome	Syndrome	NNP
cord-294854-rvrgcugn	111	18	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	111	19	Infection	infection	NN
cord-294854-rvrgcugn	111	20	in	in	IN
cord-294854-rvrgcugn	111	21	the	the	DT
cord-294854-rvrgcugn	111	22	United	United	NNP
cord-294854-rvrgcugn	111	23	Arab	Arab	NNP
cord-294854-rvrgcugn	111	24	Emirates	Emirates	NNPS
cord-294854-rvrgcugn	111	25	Lower	lower	RBR
cord-294854-rvrgcugn	111	26	tidal	tidal	JJ
cord-294854-rvrgcugn	111	27	volume	volume	NN
cord-294854-rvrgcugn	111	28	ventilation	ventilation	NN
cord-294854-rvrgcugn	111	29	and	and	CC
cord-294854-rvrgcugn	111	30	plasma	plasma	NN
cord-294854-rvrgcugn	111	31	cytokine	cytokine	NN
cord-294854-rvrgcugn	111	32	markers	marker	NNS
cord-294854-rvrgcugn	111	33	of	of	IN
cord-294854-rvrgcugn	111	34	inflammation	inflammation	NN
cord-294854-rvrgcugn	111	35	in	in	IN
cord-294854-rvrgcugn	111	36	patients	patient	NNS
cord-294854-rvrgcugn	111	37	with	with	IN
cord-294854-rvrgcugn	111	38	acute	acute	JJ
cord-294854-rvrgcugn	111	39	lung	lung	NN
cord-294854-rvrgcugn	111	40	injury	injury	NN
cord-294854-rvrgcugn	111	41	SARS	SARS	NNP
cord-294854-rvrgcugn	111	42	-	-	HYPH
cord-294854-rvrgcugn	111	43	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	111	44	Cell	Cell	NNP
cord-294854-rvrgcugn	111	45	Entry	entry	NN
cord-294854-rvrgcugn	111	46	Depends	depend	VBZ
cord-294854-rvrgcugn	111	47	on	on	IN
cord-294854-rvrgcugn	111	48	ACE2	ACE2	NNP
cord-294854-rvrgcugn	111	49	and	and	CC
cord-294854-rvrgcugn	111	50	TMPRSS2	TMPRSS2	NNP
cord-294854-rvrgcugn	111	51	and	and	CC
cord-294854-rvrgcugn	111	52	Is	be	VBZ
cord-294854-rvrgcugn	111	53	Blocked	block	VBN
cord-294854-rvrgcugn	111	54	by	by	IN
cord-294854-rvrgcugn	111	55	a	a	DT
cord-294854-rvrgcugn	111	56	Clinically	clinically	RB
cord-294854-rvrgcugn	111	57	Proven	prove	VBN
cord-294854-rvrgcugn	111	58	Protease	Protease	NNP
cord-294854-rvrgcugn	111	59	Inhibitor	Inhibitor	NNP
cord-294854-rvrgcugn	111	60	Cellular	Cellular	NNP
cord-294854-rvrgcugn	111	61	and	and	CC
cord-294854-rvrgcugn	111	62	molecular	molecular	JJ
cord-294854-rvrgcugn	111	63	pathways	pathway	NNS
cord-294854-rvrgcugn	111	64	of	of	IN
cord-294854-rvrgcugn	111	65	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	111	66	and	and	CC
cord-294854-rvrgcugn	111	67	potential	potential	JJ
cord-294854-rvrgcugn	111	68	points	point	NNS
cord-294854-rvrgcugn	111	69	of	of	IN
cord-294854-rvrgcugn	111	70	therapeutic	therapeutic	JJ
cord-294854-rvrgcugn	111	71	intervention	intervention	NN
cord-294854-rvrgcugn	111	72	Aberrant	aberrant	JJ
cord-294854-rvrgcugn	111	73	pathogenic	pathogenic	JJ
cord-294854-rvrgcugn	111	74	GM	GM	NNP
cord-294854-rvrgcugn	111	75	-	-	HYPH
cord-294854-rvrgcugn	111	76	CSF+	CSF+	NNP
cord-294854-rvrgcugn	111	77	T	T	NNP
cord-294854-rvrgcugn	111	78	cells	cell	NNS
cord-294854-rvrgcugn	111	79	and	and	CC
cord-294854-rvrgcugn	111	80	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	111	81	CD14+CD16	CD14+CD16	NNP
cord-294854-rvrgcugn	111	82	+	+	CC
cord-294854-rvrgcugn	111	83	monocytes	monocyte	NNS
cord-294854-rvrgcugn	111	84	in	in	IN
cord-294854-rvrgcugn	111	85	severe	severe	JJ
cord-294854-rvrgcugn	111	86	pulmonary	pulmonary	JJ
cord-294854-rvrgcugn	111	87	syndrome	syndrome	NN
cord-294854-rvrgcugn	111	88	patients	patient	NNS
cord-294854-rvrgcugn	111	89	of	of	IN
cord-294854-rvrgcugn	111	90	a	a	DT
cord-294854-rvrgcugn	111	91	new	new	JJ
cord-294854-rvrgcugn	111	92	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	111	93	Neutrophil	Neutrophil	NNP
cord-294854-rvrgcugn	111	94	extracellular	extracellular	JJ
cord-294854-rvrgcugn	111	95	traps	trap	NNS
cord-294854-rvrgcugn	111	96	in	in	IN
cord-294854-rvrgcugn	111	97	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	111	98	.	.	.
cord-294854-rvrgcugn	112	1	JCI	JCI	NNP
cord-294854-rvrgcugn	112	2	insight	insight	NN
cord-294854-rvrgcugn	113	1	COVID-19	covid-19	VB
cord-294854-rvrgcugn	113	2	:	:	:
cord-294854-rvrgcugn	113	3	A	a	DT
cord-294854-rvrgcugn	113	4	New	New	NNP
cord-294854-rvrgcugn	113	5	Virus	virus	NN
cord-294854-rvrgcugn	113	6	,	,	,
cord-294854-rvrgcugn	113	7	but	but	CC
cord-294854-rvrgcugn	113	8	a	a	DT
cord-294854-rvrgcugn	113	9	Familiar	familiar	JJ
cord-294854-rvrgcugn	113	10	Receptor	receptor	NN
cord-294854-rvrgcugn	113	11	and	and	CC
cord-294854-rvrgcugn	113	12	Cytokine	Cytokine	NNP
cord-294854-rvrgcugn	113	13	Release	Release	NNP
cord-294854-rvrgcugn	113	14	Syndrome	syndrome	NN
cord-294854-rvrgcugn	114	1	Understanding	understand	VBG
cord-294854-rvrgcugn	114	2	Angiotensin	Angiotensin	NNP
cord-294854-rvrgcugn	114	3	II	II	NNP
cord-294854-rvrgcugn	114	4	Type	Type	NNP
cord-294854-rvrgcugn	114	5	1	1	CD
cord-294854-rvrgcugn	114	6	Receptor	receptor	NN
cord-294854-rvrgcugn	114	7	Signaling	Signaling	NNP
cord-294854-rvrgcugn	114	8	in	in	IN
cord-294854-rvrgcugn	114	9	Vascular	Vascular	NNP
cord-294854-rvrgcugn	114	10	Pathophysiology	Pathophysiology	NNP
cord-294854-rvrgcugn	114	11	.	.	.
cord-294854-rvrgcugn	115	1	Hypertension	hypertension	NN
cord-294854-rvrgcugn	115	2	(	(	-LRB-
cord-294854-rvrgcugn	115	3	Dallas	Dallas	NNP
cord-294854-rvrgcugn	115	4	,	,	,
cord-294854-rvrgcugn	115	5	Tex	Tex	NNP
cord-294854-rvrgcugn	115	6	:	:	:
cord-294854-rvrgcugn	115	7	1979	1979	CD
cord-294854-rvrgcugn	115	8	)	)	-RRB-
cord-294854-rvrgcugn	116	1	Pleiotropy	Pleiotropy	NNP
cord-294854-rvrgcugn	116	2	and	and	CC
cord-294854-rvrgcugn	116	3	Specificity	Specificity	NNP
cord-294854-rvrgcugn	116	4	:	:	:
cord-294854-rvrgcugn	117	1	Insights	insight	NNS
cord-294854-rvrgcugn	117	2	from	from	IN
cord-294854-rvrgcugn	117	3	the	the	DT
cord-294854-rvrgcugn	117	4	Interleukin	Interleukin	NNP
cord-294854-rvrgcugn	117	5	6	6	CD
cord-294854-rvrgcugn	117	6	Family	Family	NNP
cord-294854-rvrgcugn	117	7	of	of	IN
cord-294854-rvrgcugn	117	8	Cytokines	Cytokines	NNP
cord-294854-rvrgcugn	117	9	Cytokine	Cytokine	NNP
cord-294854-rvrgcugn	117	10	release	release	NN
cord-294854-rvrgcugn	117	11	syndrome	syndrome	NN
cord-294854-rvrgcugn	117	12	in	in	IN
cord-294854-rvrgcugn	117	13	severe	severe	JJ
cord-294854-rvrgcugn	117	14	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	117	15	Plasma	Plasma	NNP
cord-294854-rvrgcugn	117	16	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	117	17	cytokines	cytokine	NNS
cord-294854-rvrgcugn	117	18	and	and	CC
cord-294854-rvrgcugn	117	19	chemokines	chemokine	NNS
cord-294854-rvrgcugn	117	20	in	in	IN
cord-294854-rvrgcugn	117	21	severe	severe	JJ
cord-294854-rvrgcugn	117	22	acute	acute	JJ
cord-294854-rvrgcugn	117	23	respiratory	respiratory	JJ
cord-294854-rvrgcugn	117	24	syndrome	syndrome	NN
cord-294854-rvrgcugn	117	25	MERS	MERS	NNP
cord-294854-rvrgcugn	117	26	-	-	HYPH
cord-294854-rvrgcugn	117	27	CoV	cov	NN
cord-294854-rvrgcugn	117	28	infection	infection	NN
cord-294854-rvrgcugn	117	29	in	in	IN
cord-294854-rvrgcugn	117	30	humans	human	NNS
cord-294854-rvrgcugn	117	31	is	be	VBZ
cord-294854-rvrgcugn	117	32	associated	associate	VBN
cord-294854-rvrgcugn	117	33	with	with	IN
cord-294854-rvrgcugn	117	34	a	a	DT
cord-294854-rvrgcugn	117	35	pro	pro	JJ
cord-294854-rvrgcugn	117	36	-	-	JJ
cord-294854-rvrgcugn	117	37	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	117	38	Th1	th1	NN
cord-294854-rvrgcugn	117	39	and	and	CC
cord-294854-rvrgcugn	117	40	Th17	Th17	NNP
cord-294854-rvrgcugn	117	41	cytokine	cytokine	NN
cord-294854-rvrgcugn	117	42	profile	profile	NN
cord-294854-rvrgcugn	117	43	Clinical	clinical	JJ
cord-294854-rvrgcugn	117	44	and	and	CC
cord-294854-rvrgcugn	117	45	immunological	immunological	JJ
cord-294854-rvrgcugn	117	46	features	feature	NNS
cord-294854-rvrgcugn	117	47	of	of	IN
cord-294854-rvrgcugn	117	48	severe	severe	JJ
cord-294854-rvrgcugn	117	49	and	and	CC
cord-294854-rvrgcugn	117	50	moderate	moderate	JJ
cord-294854-rvrgcugn	117	51	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	117	52	disease	disease	NN
cord-294854-rvrgcugn	117	53	2019	2019	CD
cord-294854-rvrgcugn	117	54	Longitudinal	longitudinal	JJ
cord-294854-rvrgcugn	117	55	characteristics	characteristic	NNS
cord-294854-rvrgcugn	117	56	of	of	IN
cord-294854-rvrgcugn	117	57	lymphocyte	lymphocyte	NN
cord-294854-rvrgcugn	117	58	responses	response	NNS
cord-294854-rvrgcugn	117	59	and	and	CC
cord-294854-rvrgcugn	117	60	cytokine	cytokine	NN
cord-294854-rvrgcugn	117	61	profiles	profile	NNS
cord-294854-rvrgcugn	117	62	in	in	IN
cord-294854-rvrgcugn	117	63	the	the	DT
cord-294854-rvrgcugn	117	64	peripheral	peripheral	JJ
cord-294854-rvrgcugn	117	65	blood	blood	NN
cord-294854-rvrgcugn	117	66	of	of	IN
cord-294854-rvrgcugn	117	67	SARS	SARS	NNP
cord-294854-rvrgcugn	117	68	-	-	HYPH
cord-294854-rvrgcugn	117	69	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	117	70	infected	infect	VBN
cord-294854-rvrgcugn	117	71	patients	patient	NNS
cord-294854-rvrgcugn	118	1	A	a	DT
cord-294854-rvrgcugn	118	2	Dynamic	dynamic	JJ
cord-294854-rvrgcugn	118	3	Immune	Immune	NNP
cord-294854-rvrgcugn	118	4	Response	response	NN
cord-294854-rvrgcugn	118	5	Shapes	Shapes	NNPS
cord-294854-rvrgcugn	118	6	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	118	7	Cell	Cell	NNP
cord-294854-rvrgcugn	118	8	host	host	NN
cord-294854-rvrgcugn	118	9	&	&	CC
cord-294854-rvrgcugn	118	10	microbe	microbe	NN
cord-294854-rvrgcugn	118	11	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	118	12	infection	infection	NN
cord-294854-rvrgcugn	118	13	and	and	CC
cord-294854-rvrgcugn	118	14	rheumatoid	rheumatoid	NN
cord-294854-rvrgcugn	118	15	arthritis	arthritis	NN
cord-294854-rvrgcugn	118	16	:	:	:
cord-294854-rvrgcugn	119	1	Faraway	faraway	RB
cord-294854-rvrgcugn	119	2	,	,	,
cord-294854-rvrgcugn	119	3	so	so	RB
cord-294854-rvrgcugn	119	4	close	close	RB
cord-294854-rvrgcugn	119	5	!	!	.
cord-294854-rvrgcugn	120	1	Autoimmun	Autoimmun	NNP
cord-294854-rvrgcugn	120	2	Rev	Rev	NNP
cord-294854-rvrgcugn	120	3	Treatment	Treatment	NNP
cord-294854-rvrgcugn	120	4	of	of	IN
cord-294854-rvrgcugn	120	5	severe	severe	JJ
cord-294854-rvrgcugn	120	6	acute	acute	JJ
cord-294854-rvrgcugn	120	7	respiratory	respiratory	JJ
cord-294854-rvrgcugn	120	8	syndrome	syndrome	NN
cord-294854-rvrgcugn	120	9	with	with	IN
cord-294854-rvrgcugn	120	10	glucosteroids	glucosteroid	NNS
cord-294854-rvrgcugn	120	11	:	:	:
cord-294854-rvrgcugn	121	1	the	the	DT
cord-294854-rvrgcugn	121	2	Guangzhou	Guangzhou	NNP
cord-294854-rvrgcugn	121	3	experience	experience	NN
cord-294854-rvrgcugn	121	4	On	on	IN
cord-294854-rvrgcugn	121	5	the	the	DT
cord-294854-rvrgcugn	121	6	use	use	NN
cord-294854-rvrgcugn	121	7	of	of	IN
cord-294854-rvrgcugn	121	8	corticosteroids	corticosteroid	NNS
cord-294854-rvrgcugn	121	9	for	for	IN
cord-294854-rvrgcugn	121	10	2019-nCoV	2019-ncov	CD
cord-294854-rvrgcugn	121	11	pneumonia	pneumonia	NN
cord-294854-rvrgcugn	121	12	Clinical	clinical	JJ
cord-294854-rvrgcugn	121	13	evidence	evidence	NN
cord-294854-rvrgcugn	121	14	does	do	VBZ
cord-294854-rvrgcugn	121	15	not	not	RB
cord-294854-rvrgcugn	121	16	support	support	VB
cord-294854-rvrgcugn	121	17	corticosteroid	corticosteroid	NN
cord-294854-rvrgcugn	121	18	treatment	treatment	NN
cord-294854-rvrgcugn	121	19	for	for	IN
cord-294854-rvrgcugn	121	20	2019-nCoV	2019-ncov	CD
cord-294854-rvrgcugn	121	21	lung	lung	NN
cord-294854-rvrgcugn	121	22	injury	injury	NN
cord-294854-rvrgcugn	122	1	The	the	DT
cord-294854-rvrgcugn	122	2	effect	effect	NN
cord-294854-rvrgcugn	122	3	of	of	IN
cord-294854-rvrgcugn	122	4	corticosteroid	corticosteroid	NN
cord-294854-rvrgcugn	122	5	treatment	treatment	NN
cord-294854-rvrgcugn	122	6	on	on	IN
cord-294854-rvrgcugn	122	7	patients	patient	NNS
cord-294854-rvrgcugn	122	8	with	with	IN
cord-294854-rvrgcugn	122	9	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	122	10	infection	infection	NN
cord-294854-rvrgcugn	122	11	:	:	:
cord-294854-rvrgcugn	122	12	a	a	DT
cord-294854-rvrgcugn	122	13	systematic	systematic	JJ
cord-294854-rvrgcugn	122	14	review	review	NN
cord-294854-rvrgcugn	122	15	and	and	CC
cord-294854-rvrgcugn	122	16	meta	meta	NNP
cord-294854-rvrgcugn	122	17	-	-	HYPH
cord-294854-rvrgcugn	122	18	analysis	analysis	NN
cord-294854-rvrgcugn	122	19	.	.	.
cord-294854-rvrgcugn	123	1	The	the	DT
cord-294854-rvrgcugn	123	2	Journal	Journal	NNP
cord-294854-rvrgcugn	123	3	of	of	IN
cord-294854-rvrgcugn	123	4	infection	infection	NN
cord-294854-rvrgcugn	123	5	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-294854-rvrgcugn	123	6	inhibits	inhibit	VBZ
cord-294854-rvrgcugn	123	7	CD154	cd154	CD
cord-294854-rvrgcugn	123	8	expression	expression	NN
cord-294854-rvrgcugn	123	9	in	in	IN
cord-294854-rvrgcugn	123	10	CD4	CD4	NNP
cord-294854-rvrgcugn	123	11	T	T	NNP
cord-294854-rvrgcugn	123	12	lymphocytes	lymphocyte	NNS
cord-294854-rvrgcugn	123	13	of	of	IN
cord-294854-rvrgcugn	123	14	systemic	systemic	JJ
cord-294854-rvrgcugn	123	15	lupus	lupus	NN
cord-294854-rvrgcugn	123	16	erythematosus	erythematosus	NN
cord-294854-rvrgcugn	123	17	through	through	IN
cord-294854-rvrgcugn	123	18	NFAT	NFAT	NNP
cord-294854-rvrgcugn	123	19	,	,	,
cord-294854-rvrgcugn	123	20	but	but	CC
cord-294854-rvrgcugn	123	21	not	not	RB
cord-294854-rvrgcugn	123	22	STAT5	stat5	RB
cord-294854-rvrgcugn	123	23	,	,	,
cord-294854-rvrgcugn	123	24	signaling	signal	VBG
cord-294854-rvrgcugn	123	25	Effects	effect	NNS
cord-294854-rvrgcugn	123	26	of	of	IN
cord-294854-rvrgcugn	123	27	chloroquine	chloroquine	NN
cord-294854-rvrgcugn	123	28	on	on	IN
cord-294854-rvrgcugn	123	29	viral	viral	JJ
cord-294854-rvrgcugn	123	30	infections	infection	NNS
cord-294854-rvrgcugn	123	31	:	:	:
cord-294854-rvrgcugn	123	32	an	an	DT
cord-294854-rvrgcugn	123	33	old	old	JJ
cord-294854-rvrgcugn	123	34	drug	drug	NN
cord-294854-rvrgcugn	123	35	against	against	IN
cord-294854-rvrgcugn	123	36	today	today	NN
cord-294854-rvrgcugn	123	37	's	's	POS
cord-294854-rvrgcugn	123	38	diseases	disease	NNS
cord-294854-rvrgcugn	123	39	?	?	.
cord-294854-rvrgcugn	124	1	In	in	IN
cord-294854-rvrgcugn	124	2	Vitro	Vitro	NNP
cord-294854-rvrgcugn	124	3	Antiviral	Antiviral	NNP
cord-294854-rvrgcugn	124	4	Activity	Activity	NNP
cord-294854-rvrgcugn	124	5	and	and	CC
cord-294854-rvrgcugn	124	6	Projection	Projection	NNP
cord-294854-rvrgcugn	124	7	of	of	IN
cord-294854-rvrgcugn	124	8	Optimized	Optimized	NNP
cord-294854-rvrgcugn	124	9	Dosing	Dosing	NNP
cord-294854-rvrgcugn	124	10	Design	Design	NNP
cord-294854-rvrgcugn	124	11	of	of	IN
cord-294854-rvrgcugn	124	12	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-294854-rvrgcugn	124	13	for	for	IN
cord-294854-rvrgcugn	124	14	the	the	DT
cord-294854-rvrgcugn	124	15	Treatment	Treatment	NNP
cord-294854-rvrgcugn	124	16	of	of	IN
cord-294854-rvrgcugn	124	17	Severe	severe	JJ
cord-294854-rvrgcugn	124	18	Acute	acute	JJ
cord-294854-rvrgcugn	124	19	Respiratory	Respiratory	NNP
cord-294854-rvrgcugn	124	20	Syndrome	Syndrome	NNP
cord-294854-rvrgcugn	124	21	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	124	22	2	2	CD
cord-294854-rvrgcugn	125	1	(	(	-LRB-
cord-294854-rvrgcugn	125	2	SARS	SARS	NNP
cord-294854-rvrgcugn	125	3	-	-	HYPH
cord-294854-rvrgcugn	125	4	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	125	5	)	)	-RRB-
cord-294854-rvrgcugn	125	6	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-294854-rvrgcugn	125	7	and	and	CC
cord-294854-rvrgcugn	125	8	azithromycin	azithromycin	NNP
cord-294854-rvrgcugn	125	9	as	as	IN
cord-294854-rvrgcugn	125	10	a	a	DT
cord-294854-rvrgcugn	125	11	treatment	treatment	NN
cord-294854-rvrgcugn	125	12	of	of	IN
cord-294854-rvrgcugn	125	13	COVID-19	covid-19	NN
cord-294854-rvrgcugn	125	14	:	:	:
cord-294854-rvrgcugn	125	15	results	result	NNS
cord-294854-rvrgcugn	125	16	of	of	IN
cord-294854-rvrgcugn	125	17	an	an	DT
cord-294854-rvrgcugn	125	18	open	open	JJ
cord-294854-rvrgcugn	125	19	-	-	HYPH
cord-294854-rvrgcugn	125	20	label	label	NN
cord-294854-rvrgcugn	125	21	non	non	JJ
cord-294854-rvrgcugn	125	22	-	-	JJ
cord-294854-rvrgcugn	125	23	randomized	randomized	JJ
cord-294854-rvrgcugn	125	24	clinical	clinical	JJ
cord-294854-rvrgcugn	125	25	trial	trial	NN
cord-294854-rvrgcugn	125	26	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-294854-rvrgcugn	126	1	Versus	versus	IN
cord-294854-rvrgcugn	127	1	COVID-19	covid-19	VB
cord-294854-rvrgcugn	127	2	:	:	:
cord-294854-rvrgcugn	127	3	A	a	DT
cord-294854-rvrgcugn	127	4	Rapid	Rapid	NNP
cord-294854-rvrgcugn	127	5	Systematic	Systematic	NNP
cord-294854-rvrgcugn	127	6	Review	Review	NNP
cord-294854-rvrgcugn	127	7	and	and	CC
cord-294854-rvrgcugn	127	8	Meta	Meta	NNP
cord-294854-rvrgcugn	127	9	-	-	HYPH
cord-294854-rvrgcugn	127	10	Analysis	Analysis	NNP
cord-294854-rvrgcugn	127	11	Chloroquine	Chloroquine	NNP
cord-294854-rvrgcugn	127	12	analogues	analogue	NNS
cord-294854-rvrgcugn	127	13	in	in	IN
cord-294854-rvrgcugn	127	14	drug	drug	NN
cord-294854-rvrgcugn	127	15	discovery	discovery	NN
cord-294854-rvrgcugn	127	16	:	:	:
cord-294854-rvrgcugn	128	1	new	new	JJ
cord-294854-rvrgcugn	128	2	directions	direction	NNS
cord-294854-rvrgcugn	128	3	of	of	IN
cord-294854-rvrgcugn	128	4	uses	use	NNS
cord-294854-rvrgcugn	128	5	,	,	,
cord-294854-rvrgcugn	128	6	mechanisms	mechanism	NNS
cord-294854-rvrgcugn	128	7	of	of	IN
cord-294854-rvrgcugn	128	8	actions	action	NNS
cord-294854-rvrgcugn	128	9	and	and	CC
cord-294854-rvrgcugn	128	10	toxic	toxic	JJ
cord-294854-rvrgcugn	128	11	manifestations	manifestation	NNS
cord-294854-rvrgcugn	128	12	from	from	IN
cord-294854-rvrgcugn	128	13	malaria	malaria	NN
cord-294854-rvrgcugn	128	14	to	to	IN
cord-294854-rvrgcugn	128	15	multifarious	multifarious	JJ
cord-294854-rvrgcugn	128	16	diseases	disease	NNS
cord-294854-rvrgcugn	128	17	Chloroquine	Chloroquine	NNP
cord-294854-rvrgcugn	128	18	diphosphate	diphosphate	JJ
cord-294854-rvrgcugn	128	19	in	in	IN
cord-294854-rvrgcugn	128	20	two	two	CD
cord-294854-rvrgcugn	128	21	different	different	JJ
cord-294854-rvrgcugn	128	22	dosages	dosage	NNS
cord-294854-rvrgcugn	128	23	as	as	IN
cord-294854-rvrgcugn	128	24	adjunctive	adjunctive	JJ
cord-294854-rvrgcugn	128	25	therapy	therapy	NN
cord-294854-rvrgcugn	128	26	of	of	IN
cord-294854-rvrgcugn	128	27	hospitalized	hospitalize	VBN
cord-294854-rvrgcugn	128	28	patients	patient	NNS
cord-294854-rvrgcugn	128	29	with	with	IN
cord-294854-rvrgcugn	128	30	severe	severe	JJ
cord-294854-rvrgcugn	128	31	respiratory	respiratory	JJ
cord-294854-rvrgcugn	128	32	syndrome	syndrome	NN
cord-294854-rvrgcugn	128	33	in	in	IN
cord-294854-rvrgcugn	128	34	the	the	DT
cord-294854-rvrgcugn	128	35	context	context	NN
cord-294854-rvrgcugn	128	36	of	of	IN
cord-294854-rvrgcugn	128	37	Accepted	Accepted	NNP
cord-294854-rvrgcugn	128	38	Article	Article	NNP
cord-294854-rvrgcugn	128	39	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	128	40	(	(	-LRB-
cord-294854-rvrgcugn	128	41	SARS	SARS	NNP
cord-294854-rvrgcugn	128	42	-	-	HYPH
cord-294854-rvrgcugn	128	43	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	128	44	)	)	-RRB-
cord-294854-rvrgcugn	128	45	infection	infection	NN
cord-294854-rvrgcugn	128	46	:	:	:
cord-294854-rvrgcugn	128	47	Preliminary	preliminary	JJ
cord-294854-rvrgcugn	128	48	safety	safety	NN
cord-294854-rvrgcugn	128	49	results	result	NNS
cord-294854-rvrgcugn	128	50	of	of	IN
cord-294854-rvrgcugn	128	51	a	a	DT
cord-294854-rvrgcugn	128	52	randomized	randomized	JJ
cord-294854-rvrgcugn	128	53	,	,	,
cord-294854-rvrgcugn	128	54	double	double	JJ
cord-294854-rvrgcugn	128	55	-	-	HYPH
cord-294854-rvrgcugn	128	56	blinded	blinded	JJ
cord-294854-rvrgcugn	128	57	,	,	,
cord-294854-rvrgcugn	128	58	phase	phase	NN
cord-294854-rvrgcugn	128	59	IIb	iib	JJ
cord-294854-rvrgcugn	128	60	clinical	clinical	JJ
cord-294854-rvrgcugn	128	61	trial	trial	NN
cord-294854-rvrgcugn	128	62	(	(	-LRB-
cord-294854-rvrgcugn	128	63	CloroCovid-19	CloroCovid-19	NNP
cord-294854-rvrgcugn	128	64	Study	Study	NNP
cord-294854-rvrgcugn	128	65	)	)	-RRB-
cord-294854-rvrgcugn	128	66	Safety	Safety	NNP
cord-294854-rvrgcugn	128	67	of	of	IN
cord-294854-rvrgcugn	128	68	hydroxychloroquine	hydroxychloroquine	NN
cord-294854-rvrgcugn	128	69	,	,	,
cord-294854-rvrgcugn	128	70	alone	alone	JJ
cord-294854-rvrgcugn	128	71	and	and	CC
cord-294854-rvrgcugn	128	72	in	in	IN
cord-294854-rvrgcugn	128	73	combination	combination	NN
cord-294854-rvrgcugn	128	74	with	with	IN
cord-294854-rvrgcugn	128	75	azithromycin	azithromycin	NNP
cord-294854-rvrgcugn	128	76	,	,	,
cord-294854-rvrgcugn	128	77	in	in	IN
cord-294854-rvrgcugn	128	78	light	light	NN
cord-294854-rvrgcugn	128	79	of	of	IN
cord-294854-rvrgcugn	128	80	rapid	rapid	JJ
cord-294854-rvrgcugn	128	81	wide	wide	JJ
cord-294854-rvrgcugn	128	82	-	-	HYPH
cord-294854-rvrgcugn	128	83	spread	spread	VBN
cord-294854-rvrgcugn	128	84	use	use	NN
cord-294854-rvrgcugn	128	85	for	for	IN
cord-294854-rvrgcugn	128	86	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	128	87	:	:	:
cord-294854-rvrgcugn	128	88	a	a	DT
cord-294854-rvrgcugn	128	89	multinational	multinational	JJ
cord-294854-rvrgcugn	128	90	,	,	,
cord-294854-rvrgcugn	128	91	network	network	NN
cord-294854-rvrgcugn	128	92	cohort	cohort	NN
cord-294854-rvrgcugn	128	93	and	and	CC
cord-294854-rvrgcugn	128	94	self	self	NN
cord-294854-rvrgcugn	128	95	-	-	HYPH
cord-294854-rvrgcugn	128	96	controlled	control	VBN
cord-294854-rvrgcugn	128	97	case	case	NN
cord-294854-rvrgcugn	128	98	series	series	NN
cord-294854-rvrgcugn	128	99	study	study	NN
cord-294854-rvrgcugn	128	100	The	the	DT
cord-294854-rvrgcugn	128	101	cytokine	cytokine	NN
cord-294854-rvrgcugn	128	102	release	release	NN
cord-294854-rvrgcugn	128	103	syndrome	syndrome	NN
cord-294854-rvrgcugn	128	104	(	(	-LRB-
cord-294854-rvrgcugn	128	105	CRS	CRS	NNP
cord-294854-rvrgcugn	128	106	)	)	-RRB-
cord-294854-rvrgcugn	128	107	of	of	IN
cord-294854-rvrgcugn	128	108	severe	severe	JJ
cord-294854-rvrgcugn	128	109	COVID-19	covid-19	NN
cord-294854-rvrgcugn	128	110	and	and	CC
cord-294854-rvrgcugn	128	111	Interleukin-6	Interleukin-6	NNP
cord-294854-rvrgcugn	129	1	receptor	receptor	NN
cord-294854-rvrgcugn	129	2	(	(	-LRB-
cord-294854-rvrgcugn	129	3	IL-6R	IL-6R	NNP
cord-294854-rvrgcugn	129	4	)	)	-RRB-
cord-294854-rvrgcugn	129	5	antagonist	antagonist	NN
cord-294854-rvrgcugn	130	1	Tocilizumab	Tocilizumab	NNP
cord-294854-rvrgcugn	130	2	may	may	MD
cord-294854-rvrgcugn	130	3	be	be	VB
cord-294854-rvrgcugn	130	4	the	the	DT
cord-294854-rvrgcugn	130	5	key	key	NN
cord-294854-rvrgcugn	130	6	to	to	TO
cord-294854-rvrgcugn	130	7	reduce	reduce	VB
cord-294854-rvrgcugn	130	8	the	the	DT
cord-294854-rvrgcugn	130	9	mortality	mortality	NN
cord-294854-rvrgcugn	130	10	Chinese	Chinese	NNP
cord-294854-rvrgcugn	130	11	Clinical	Clinical	NNP
cord-294854-rvrgcugn	130	12	Trail	Trail	NNP
cord-294854-rvrgcugn	130	13	Registry	Registry	NNP
cord-294854-rvrgcugn	130	14	.	.	.
cord-294854-rvrgcugn	131	1	A	a	DT
cord-294854-rvrgcugn	131	2	multicenter	multicenter	NN
cord-294854-rvrgcugn	131	3	,	,	,
cord-294854-rvrgcugn	131	4	randomized	randomized	JJ
cord-294854-rvrgcugn	131	5	controlled	control	VBN
cord-294854-rvrgcugn	131	6	trial	trial	NN
cord-294854-rvrgcugn	131	7	for	for	IN
cord-294854-rvrgcugn	131	8	the	the	DT
cord-294854-rvrgcugn	131	9	efficacy	efficacy	NN
cord-294854-rvrgcugn	131	10	and	and	CC
cord-294854-rvrgcugn	131	11	safety	safety	NN
cord-294854-rvrgcugn	131	12	of	of	IN
cord-294854-rvrgcugn	131	13	tocilizumab	tocilizumab	NNP
cord-294854-rvrgcugn	131	14	in	in	IN
cord-294854-rvrgcugn	131	15	the	the	DT
cord-294854-rvrgcugn	131	16	treatment	treatment	NN
cord-294854-rvrgcugn	131	17	of	of	IN
cord-294854-rvrgcugn	131	18	new	new	JJ
cord-294854-rvrgcugn	131	19	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	131	20	pneumonia	pneumonia	NN
cord-294854-rvrgcugn	131	21	Effective	effective	JJ
cord-294854-rvrgcugn	131	22	treatment	treatment	NN
cord-294854-rvrgcugn	131	23	of	of	IN
cord-294854-rvrgcugn	131	24	severe	severe	JJ
cord-294854-rvrgcugn	131	25	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	131	26	patients	patient	NNS
cord-294854-rvrgcugn	131	27	with	with	IN
cord-294854-rvrgcugn	131	28	tocilizumab	tocilizumab	NNP
cord-294854-rvrgcugn	131	29	Improved	Improved	NNP
cord-294854-rvrgcugn	131	30	survival	survival	NN
cord-294854-rvrgcugn	131	31	outcome	outcome	NN
cord-294854-rvrgcugn	131	32	in	in	IN
cord-294854-rvrgcugn	131	33	SARs	SARs	NNP
cord-294854-rvrgcugn	131	34	-	-	HYPH
cord-294854-rvrgcugn	131	35	CoV-2	CoV-2	NNP
cord-294854-rvrgcugn	131	36	(	(	-LRB-
cord-294854-rvrgcugn	131	37	COVID-19	covid-19	VB
cord-294854-rvrgcugn	131	38	)	)	-RRB-
cord-294854-rvrgcugn	131	39	Acute	acute	JJ
cord-294854-rvrgcugn	131	40	Respiratory	Respiratory	NNP
cord-294854-rvrgcugn	131	41	Distress	Distress	NNP
cord-294854-rvrgcugn	131	42	Syndrome	Syndrome	NNP
cord-294854-rvrgcugn	131	43	patients	patient	NNS
cord-294854-rvrgcugn	131	44	with	with	IN
cord-294854-rvrgcugn	131	45	Tocilizumab	tocilizumab	JJ
cord-294854-rvrgcugn	131	46	administration	administration	NN
cord-294854-rvrgcugn	131	47	Rational	rational	JJ
cord-294854-rvrgcugn	131	48	Use	Use	NNP
cord-294854-rvrgcugn	131	49	of	of	IN
cord-294854-rvrgcugn	131	50	Tocilizumab	Tocilizumab	NNP
cord-294854-rvrgcugn	131	51	in	in	IN
cord-294854-rvrgcugn	131	52	the	the	DT
cord-294854-rvrgcugn	131	53	Treatment	Treatment	NNP
cord-294854-rvrgcugn	131	54	of	of	IN
cord-294854-rvrgcugn	131	55	Novel	Novel	NNP
cord-294854-rvrgcugn	131	56	Coronavirus	Coronavirus	NNP
cord-294854-rvrgcugn	131	57	Pneumonia	Pneumonia	NNP
cord-294854-rvrgcugn	132	1	The	the	DT
cord-294854-rvrgcugn	132	2	Society	Society	NNP
cord-294854-rvrgcugn	132	3	for	for	IN
cord-294854-rvrgcugn	132	4	Immunotherapy	Immunotherapy	NNP
cord-294854-rvrgcugn	132	5	of	of	IN
cord-294854-rvrgcugn	132	6	Cancer	Cancer	NNP
cord-294854-rvrgcugn	132	7	perspective	perspective	NN
cord-294854-rvrgcugn	132	8	on	on	IN
cord-294854-rvrgcugn	132	9	regulation	regulation	NN
cord-294854-rvrgcugn	132	10	of	of	IN
cord-294854-rvrgcugn	132	11	interleukin-6	interleukin-6	NNP
cord-294854-rvrgcugn	132	12	signaling	signal	VBG
cord-294854-rvrgcugn	132	13	in	in	IN
cord-294854-rvrgcugn	132	14	COVID-19-related	covid-19-related	JJ
cord-294854-rvrgcugn	132	15	systemic	systemic	JJ
cord-294854-rvrgcugn	132	16	inflammatory	inflammatory	JJ
cord-294854-rvrgcugn	132	17	response	response	NN
cord-294854-rvrgcugn	132	18	BSR	BSR	NNP
cord-294854-rvrgcugn	132	19	guidance	guidance	NN
cord-294854-rvrgcugn	132	20	for	for	IN
cord-294854-rvrgcugn	132	21	patients	patient	NNS
cord-294854-rvrgcugn	132	22	during	during	IN
cord-294854-rvrgcugn	132	23	Covid-19	covid-19	JJ
cord-294854-rvrgcugn	132	24	outbreak	outbreak	NN
cord-294854-rvrgcugn	132	25	ACR	ACR	NNP
cord-294854-rvrgcugn	132	26	guidance	guidance	NN
cord-294854-rvrgcugn	132	27	for	for	IN
cord-294854-rvrgcugn	132	28	patients	patient	NNS
cord-294854-rvrgcugn	132	29	during	during	IN
cord-294854-rvrgcugn	132	30	Covid-19	covid-19	JJ
cord-294854-rvrgcugn	132	31	outbreak	outbreak	NN
cord-294854-rvrgcugn	132	32	2020	2020	CD
cord-294854-rvrgcugn	132	33	Australian	Australian	NNP
cord-294854-rvrgcugn	132	34	Rheumatology	Rheumatology	NNP
cord-294854-rvrgcugn	132	35	Association	Association	NNP
cord-294854-rvrgcugn	132	36	guidance	guidance	NN
cord-294854-rvrgcugn	132	37	for	for	IN
cord-294854-rvrgcugn	132	38	patients	patient	NNS
cord-294854-rvrgcugn	132	39	during	during	IN
cord-294854-rvrgcugn	132	40	Covid-19	covid-19	JJ
cord-294854-rvrgcugn	132	41	outbreak	outbreak	NN
cord-294854-rvrgcugn	132	42	2020	2020	CD
cord-294854-rvrgcugn	133	1	The	the	DT
cord-294854-rvrgcugn	133	2	immunomodulatory	immunomodulatory	JJ
cord-294854-rvrgcugn	133	3	function	function	NN
cord-294854-rvrgcugn	133	4	of	of	IN
cord-294854-rvrgcugn	133	5	mesenchymal	mesenchymal	JJ
cord-294854-rvrgcugn	133	6	stem	stem	NN
cord-294854-rvrgcugn	133	7	cells	cell	NNS
cord-294854-rvrgcugn	133	8	:	:	:
cord-294854-rvrgcugn	133	9	mode	mode	NN
cord-294854-rvrgcugn	133	10	of	of	IN
cord-294854-rvrgcugn	133	11	action	action	NN
cord-294854-rvrgcugn	133	12	and	and	CC
cord-294854-rvrgcugn	133	13	pathways	pathway	NNS
cord-294854-rvrgcugn	133	14	Clinical	clinical	JJ
cord-294854-rvrgcugn	133	15	study	study	NN
cord-294854-rvrgcugn	133	16	of	of	IN
cord-294854-rvrgcugn	133	17	mesenchymal	mesenchymal	JJ
cord-294854-rvrgcugn	133	18	stem	stem	NN
cord-294854-rvrgcugn	133	19	cell	cell	NN
cord-294854-rvrgcugn	133	20	treating	treat	VBG
cord-294854-rvrgcugn	133	21	acute	acute	JJ
cord-294854-rvrgcugn	133	22	respiratory	respiratory	JJ
cord-294854-rvrgcugn	133	23	distress	distress	NN
cord-294854-rvrgcugn	133	24	syndrome	syndrome	NN
cord-294854-rvrgcugn	133	25	induced	induce	VBN
cord-294854-rvrgcugn	133	26	by	by	IN
cord-294854-rvrgcugn	133	27	epidemic	epidemic	NN
cord-294854-rvrgcugn	133	28	Influenza	Influenza	NNP
cord-294854-rvrgcugn	133	29	A	A	NNP
cord-294854-rvrgcugn	133	30	(	(	-LRB-
cord-294854-rvrgcugn	133	31	H7N9	H7N9	NNP
cord-294854-rvrgcugn	133	32	)	)	-RRB-
cord-294854-rvrgcugn	133	33	infection	infection	NN
cord-294854-rvrgcugn	133	34	,	,	,
cord-294854-rvrgcugn	133	35	a	a	DT
cord-294854-rvrgcugn	133	36	hint	hint	NN
cord-294854-rvrgcugn	133	37	for	for	IN
cord-294854-rvrgcugn	133	38	COVID-19	covid-19	JJ
cord-294854-rvrgcugn	133	39	treatment	treatment	NN
cord-294854-rvrgcugn	133	40	Transplantation	transplantation	NN
cord-294854-rvrgcugn	133	41	of	of	IN
cord-294854-rvrgcugn	133	42	ACE2(-	ace2(-	NN
cord-294854-rvrgcugn	133	43	)	)	-RRB-
cord-294854-rvrgcugn	134	1	Mesenchymal	Mesenchymal	NNP
cord-294854-rvrgcugn	134	2	Stem	Stem	NNP
cord-294854-rvrgcugn	134	3	Cells	cell	NNS
cord-294854-rvrgcugn	134	4	Improves	improve	VBZ
cord-294854-rvrgcugn	134	5	the	the	DT
cord-294854-rvrgcugn	134	6	Outcome	outcome	NN
cord-294854-rvrgcugn	134	7	of	of	IN
cord-294854-rvrgcugn	134	8	Patients	patient	NNS
cord-294854-rvrgcugn	134	9	with	with	IN
cord-294854-rvrgcugn	134	10	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	134	11	Pneumonia	Pneumonia	NNP
cord-294854-rvrgcugn	134	12	Interleukin-1	Interleukin-1	NNP
cord-294854-rvrgcugn	134	13	blockade	blockade	NN
cord-294854-rvrgcugn	134	14	with	with	IN
cord-294854-rvrgcugn	134	15	high	high	JJ
cord-294854-rvrgcugn	134	16	-	-	HYPH
cord-294854-rvrgcugn	134	17	dose	dose	NN
cord-294854-rvrgcugn	134	18	anakinra	anakinra	NN
cord-294854-rvrgcugn	134	19	in	in	IN
cord-294854-rvrgcugn	134	20	patients	patient	NNS
cord-294854-rvrgcugn	134	21	with	with	IN
cord-294854-rvrgcugn	134	22	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	134	23	,	,	,
cord-294854-rvrgcugn	134	24	acute	acute	JJ
cord-294854-rvrgcugn	134	25	respiratory	respiratory	JJ
cord-294854-rvrgcugn	134	26	distress	distress	NN
cord-294854-rvrgcugn	134	27	syndrome	syndrome	NN
cord-294854-rvrgcugn	134	28	,	,	,
cord-294854-rvrgcugn	134	29	and	and	CC
cord-294854-rvrgcugn	134	30	hyperinflammation	hyperinflammation	NN
cord-294854-rvrgcugn	134	31	:	:	:
cord-294854-rvrgcugn	134	32	a	a	DT
cord-294854-rvrgcugn	134	33	retrospective	retrospective	JJ
cord-294854-rvrgcugn	134	34	cohort	cohort	NN
cord-294854-rvrgcugn	134	35	study	study	NN
cord-294854-rvrgcugn	134	36	Ribavirin	Ribavirin	NNP
cord-294854-rvrgcugn	134	37	and	and	CC
cord-294854-rvrgcugn	134	38	Interferon	Interferon	NNP
cord-294854-rvrgcugn	134	39	Therapy	Therapy	NNP
cord-294854-rvrgcugn	134	40	for	for	IN
cord-294854-rvrgcugn	134	41	Critically	Critically	NNP
cord-294854-rvrgcugn	134	42	Ill	Ill	NNP
cord-294854-rvrgcugn	134	43	Patients	patient	NNS
cord-294854-rvrgcugn	134	44	With	with	IN
cord-294854-rvrgcugn	134	45	Middle	Middle	NNP
cord-294854-rvrgcugn	134	46	East	East	NNP
cord-294854-rvrgcugn	134	47	Respiratory	Respiratory	NNP
cord-294854-rvrgcugn	134	48	Syndrome	Syndrome	NNP
cord-294854-rvrgcugn	134	49	:	:	:
cord-294854-rvrgcugn	134	50	A	a	DT
cord-294854-rvrgcugn	134	51	Multicenter	Multicenter	NNP
cord-294854-rvrgcugn	134	52	Observational	Observational	NNP
cord-294854-rvrgcugn	134	53	Study	Study	NNP
cord-294854-rvrgcugn	134	54	Baricitinib	Baricitinib	NNP
cord-294854-rvrgcugn	134	55	therapy	therapy	NN
cord-294854-rvrgcugn	134	56	in	in	IN
cord-294854-rvrgcugn	134	57	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	134	58	:	:	:
cord-294854-rvrgcugn	135	1	A	a	DT
cord-294854-rvrgcugn	135	2	pilot	pilot	NN
cord-294854-rvrgcugn	135	3	study	study	NN
cord-294854-rvrgcugn	135	4	on	on	IN
cord-294854-rvrgcugn	135	5	safety	safety	NN
cord-294854-rvrgcugn	135	6	and	and	CC
cord-294854-rvrgcugn	135	7	clinical	clinical	JJ
cord-294854-rvrgcugn	135	8	impact	impact	NN
cord-294854-rvrgcugn	135	9	.	.	.
cord-294854-rvrgcugn	136	1	The	the	DT
cord-294854-rvrgcugn	136	2	Journal	Journal	NNP
cord-294854-rvrgcugn	136	3	of	of	IN
cord-294854-rvrgcugn	136	4	infection	infection	NN
cord-294854-rvrgcugn	136	5	Baricitinib	Baricitinib	NNP
cord-294854-rvrgcugn	136	6	as	as	IN
cord-294854-rvrgcugn	136	7	potential	potential	JJ
cord-294854-rvrgcugn	136	8	treatment	treatment	NN
cord-294854-rvrgcugn	136	9	for	for	IN
cord-294854-rvrgcugn	136	10	2019-nCoV	2019-ncov	CD
cord-294854-rvrgcugn	136	11	acute	acute	JJ
cord-294854-rvrgcugn	136	12	respiratory	respiratory	JJ
cord-294854-rvrgcugn	136	13	disease	disease	NN
cord-294854-rvrgcugn	137	1	The	the	DT
cord-294854-rvrgcugn	137	2	cytokine	cytokine	NN
cord-294854-rvrgcugn	137	3	storm	storm	NN
cord-294854-rvrgcugn	137	4	of	of	IN
cord-294854-rvrgcugn	137	5	severe	severe	JJ
cord-294854-rvrgcugn	137	6	influenza	influenza	NN
cord-294854-rvrgcugn	137	7	and	and	CC
cord-294854-rvrgcugn	137	8	development	development	NN
cord-294854-rvrgcugn	137	9	of	of	IN
cord-294854-rvrgcugn	137	10	immunomodulatory	immunomodulatory	NNP
cord-294854-rvrgcugn	137	11	therapy	therapy	NN
cord-294854-rvrgcugn	137	12	Epidemiological	epidemiological	JJ
cord-294854-rvrgcugn	137	13	and	and	CC
cord-294854-rvrgcugn	137	14	clinical	clinical	JJ
cord-294854-rvrgcugn	137	15	characteristics	characteristic	NNS
cord-294854-rvrgcugn	137	16	of	of	IN
cord-294854-rvrgcugn	137	17	99	99	CD
cord-294854-rvrgcugn	137	18	cases	case	NNS
cord-294854-rvrgcugn	137	19	of	of	IN
cord-294854-rvrgcugn	137	20	2019	2019	CD
cord-294854-rvrgcugn	137	21	novel	novel	JJ
cord-294854-rvrgcugn	137	22	coronavirus	coronavirus	NN
cord-294854-rvrgcugn	137	23	pneumonia	pneumonia	NN
cord-294854-rvrgcugn	137	24	in	in	IN
cord-294854-rvrgcugn	137	25	Wuhan	Wuhan	NNP
cord-294854-rvrgcugn	137	26	,	,	,
cord-294854-rvrgcugn	137	27	China	China	NNP
cord-294854-rvrgcugn	137	28	:	:	:
cord-294854-rvrgcugn	137	29	a	a	DT
cord-294854-rvrgcugn	137	30	descriptive	descriptive	JJ
cord-294854-rvrgcugn	137	31	study	study	NN
cord-294854-rvrgcugn	137	32	Immunomodulatory	Immunomodulatory	NNP
cord-294854-rvrgcugn	137	33	therapy	therapy	NN
cord-294854-rvrgcugn	137	34	for	for	IN
cord-294854-rvrgcugn	137	35	the	the	DT
cord-294854-rvrgcugn	137	36	management	management	NN
cord-294854-rvrgcugn	137	37	of	of	IN
cord-294854-rvrgcugn	137	38	severe	severe	JJ
cord-294854-rvrgcugn	137	39	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	137	40	.	.	.
cord-294854-rvrgcugn	138	1	Beyond	beyond	IN
cord-294854-rvrgcugn	138	2	the	the	DT
cord-294854-rvrgcugn	138	3	anti	anti	JJ
cord-294854-rvrgcugn	138	4	-	-	JJ
cord-294854-rvrgcugn	138	5	viral	viral	JJ
cord-294854-rvrgcugn	138	6	therapy	therapy	NN
cord-294854-rvrgcugn	138	7	:	:	:
cord-294854-rvrgcugn	138	8	A	a	DT
cord-294854-rvrgcugn	138	9	comprehensive	comprehensive	JJ
cord-294854-rvrgcugn	138	10	review	review	NN
cord-294854-rvrgcugn	139	1	The	the	DT
cord-294854-rvrgcugn	139	2	effectiveness	effectiveness	NN
cord-294854-rvrgcugn	139	3	of	of	IN
cord-294854-rvrgcugn	139	4	convalescent	convalescent	JJ
cord-294854-rvrgcugn	139	5	plasma	plasma	NN
cord-294854-rvrgcugn	139	6	and	and	CC
cord-294854-rvrgcugn	139	7	hyperimmune	hyperimmune	NNP
cord-294854-rvrgcugn	139	8	immunoglobulin	immunoglobulin	NN
cord-294854-rvrgcugn	139	9	for	for	IN
cord-294854-rvrgcugn	139	10	the	the	DT
cord-294854-rvrgcugn	139	11	treatment	treatment	NN
cord-294854-rvrgcugn	139	12	of	of	IN
cord-294854-rvrgcugn	139	13	severe	severe	JJ
cord-294854-rvrgcugn	139	14	acute	acute	JJ
cord-294854-rvrgcugn	139	15	respiratory	respiratory	JJ
cord-294854-rvrgcugn	139	16	infections	infection	NNS
cord-294854-rvrgcugn	139	17	of	of	IN
cord-294854-rvrgcugn	139	18	viral	viral	JJ
cord-294854-rvrgcugn	139	19	etiology	etiology	NN
cord-294854-rvrgcugn	139	20	:	:	:
cord-294854-rvrgcugn	139	21	a	a	DT
cord-294854-rvrgcugn	139	22	systematic	systematic	JJ
cord-294854-rvrgcugn	139	23	review	review	NN
cord-294854-rvrgcugn	139	24	and	and	CC
cord-294854-rvrgcugn	139	25	exploratory	exploratory	JJ
cord-294854-rvrgcugn	139	26	meta	meta	JJ
cord-294854-rvrgcugn	139	27	-	-	HYPH
cord-294854-rvrgcugn	139	28	analysis	analysis	NN
cord-294854-rvrgcugn	139	29	Convalescent	convalescent	JJ
cord-294854-rvrgcugn	139	30	plasma	plasma	NN
cord-294854-rvrgcugn	139	31	treatment	treatment	NN
cord-294854-rvrgcugn	139	32	reduced	reduce	VBN
cord-294854-rvrgcugn	139	33	mortality	mortality	NN
cord-294854-rvrgcugn	139	34	in	in	IN
cord-294854-rvrgcugn	139	35	patients	patient	NNS
cord-294854-rvrgcugn	139	36	with	with	IN
cord-294854-rvrgcugn	139	37	severe	severe	JJ
cord-294854-rvrgcugn	139	38	pandemic	pandemic	NN
cord-294854-rvrgcugn	139	39	influenza	influenza	NN
cord-294854-rvrgcugn	139	40	A	a	NN
cord-294854-rvrgcugn	139	41	(	(	-LRB-
cord-294854-rvrgcugn	139	42	H1N1	H1N1	NNP
cord-294854-rvrgcugn	139	43	)	)	-RRB-
cord-294854-rvrgcugn	139	44	2009	2009	CD
cord-294854-rvrgcugn	139	45	virus	virus	NN
cord-294854-rvrgcugn	139	46	infection	infection	NN
cord-294854-rvrgcugn	140	1	We	-PRON-	PRP
cord-294854-rvrgcugn	140	2	thank	thank	VBP
cord-294854-rvrgcugn	140	3	all	all	PDT
cord-294854-rvrgcugn	140	4	the	the	DT
cord-294854-rvrgcugn	140	5	doctors	doctor	NNS
cord-294854-rvrgcugn	140	6	and	and	CC
cord-294854-rvrgcugn	140	7	nurses	nurse	NNS
cord-294854-rvrgcugn	140	8	who	who	WP
cord-294854-rvrgcugn	140	9	have	have	VBP
cord-294854-rvrgcugn	140	10	bravely	bravely	RB
cord-294854-rvrgcugn	140	11	fought	fight	VBN
cord-294854-rvrgcugn	140	12	the	the	DT
cord-294854-rvrgcugn	140	13	virus	virus	NN
cord-294854-rvrgcugn	140	14	during	during	IN
cord-294854-rvrgcugn	140	15	the	the	DT
cord-294854-rvrgcugn	140	16	COVID-19	COVID-19	NNP
cord-294854-rvrgcugn	140	17	pandemic	pandemic	NN
cord-294854-rvrgcugn	140	18	.	.	.
cord-294854-rvrgcugn	141	1	The	the	DT
cord-294854-rvrgcugn	141	2	authors	author	NNS
cord-294854-rvrgcugn	141	3	declare	declare	VBP
cord-294854-rvrgcugn	141	4	no	no	DT
cord-294854-rvrgcugn	141	5	conflicts	conflict	NNS
cord-294854-rvrgcugn	141	6	of	of	IN
cord-294854-rvrgcugn	141	7	interest	interest	NN
cord-294854-rvrgcugn	141	8	.	.	.
cord-294854-rvrgcugn	142	1	1	1	CD
cord-294854-rvrgcugn	142	2	 	 	_SP